1 | ( L ) ASCORBATO DI CALCIO | [1] Calcium Calcium | - | - | - | [2] 96 96, 97 |
2 | -aminosalicylic acid | [1] Aminosalicylic acid Aminosalicylic acid | [1] D00162
D00162
| - | - | [2] 96 96, 97 |
3 | 0,25 mg RPC1063 | - | - | - | - | [1] 96 96 |
4 | 0.25 mg RPC1063 | - | - | - | - | [3] 13 13, 96, 97 |
5 | 00000 | - | - | - | - | [2] 6 6, 96 |
6 | 0114-0006B | - | - | - | - | [2] 46 46, 96 |
7 | 10 mg | - | - | - | - | [1] 96 96 |
8 | 10% Metronidazole Ointment | [1] Metronidazole Metronidazole | [3] D00409
D00409
,
D05016
,
D05017
| - | - | [1] 96 96 |
9 | 1000 IU D3 | - | - | - | - | [1] 96 96 |
10 | 13-valent pneumococcal conjugated vaccine (PCV13) | - | - | - | - | [1] 96 96 |
11 | 14C]-RPC1063 Solution (0.1 mg/mL) for Oral Administration | - | - | - | - | [3] 13 13, 96, 97 |
12 | 18F-FDG | [1] Fludeoxyglucose (18F) Fludeoxyglucose (18F) | - | - | - | [13] 5 5, 6, 7, 8, 13, 41, 46, 53, 84, 85, 96, 127, 300 |
13 | 1mg RPC1063 | - | - | - | - | [1] 96 96 |
14 | 2'-Fucosyllactose | - | - | - | - | [2] 96 96, 97 |
15 | 23-valent polysaccharide pneumococcal vaccine | - | - | - | - | [1] 96 96 |
16 | 23-valent polysaccharide pneumococcal vaccine (Pneumovax TM) | - | - | - | - | [2] 96 96, 97 |
17 | 25 mg Ontamalimab | [1] Ontamalimab Ontamalimab | - | - | - | [2] 96 96, 97 |
18 | 3-hydroxy-2-methyl-4H-pyrane-4-one iron (III) complex (3:1), Ferric (3-hydroxy-2-methyl-4-pyrone), Tris-maltol-iron (III), Tri=maltol-iron (III) | [1] Tromethamine Tromethamine | [1] D00396
D00396
| - | - | [2] 96 96, 97 |
19 | 331731-18-1 | - | - | - | - | [4] 46 46, 96, 97, 271 |
20 | 4-Aminosalicylic acid | [1] Aminosalicylic acid Aminosalicylic acid | [1] D00162
D00162
| - | - | [1] 96 96 |
21 | 4-Aminosalicylic acid extended release granules | [1] Aminosalicylic acid Aminosalicylic acid | [1] D00162
D00162
| - | - | [1] 96 96 |
22 | 40 mg | - | - | - | - | [1] 96 96 |
23 | 40 mg MSB11022 | - | - | - | - | [5] 46 46, 96, 97, 107, 271 |
24 | 42942019 | - | - | - | - | [4] 46 46, 96, 97, 271 |
25 | 5-aminolevulinic acid | [1] Aminolevulinic acid Aminolevulinic acid | [2] D02908
D02908
,
D07567
| - | - | [1] 96 96 |
26 | 5-Aminosalicyl acid | - | - | - | - | [1] 96 96 |
27 | 5-aminosalicylate (Pentasa, Ferring) | - | - | - | - | [2] 96 96, 97 |
28 | 5-Aminosalicylic acid | [2] Aminosalicylic acid Aminosalicylic acid, Mesalazine | [2] D00162
D00162
,
D00377
| - | - | [2] 96 96, 97 |
29 | 5-ASA | [1] Mesalazine Mesalazine | [1] D00377
D00377
| - | - | [2] 96 96, 97 |
30 | 5-HTP | - | - | - | - | [2] 96 96, 97 |
31 | 5000 IU D3 | - | - | - | - | [1] 96 96 |
32 | 549-0261/F02-01 | - | - | - | - | [2] 96 96, 97 |
33 | 6 Mercaptopurine | [1] Mercaptopurine Mercaptopurine | [2] D00161
D00161
,
D04931
| [1] HPRT1 HPRT1 💬 | [3] Drug metabolism - other enzymes Drug metabolism - other enzymes, Metabolic pathways, Purine metabolism 💬 | [2] 96 96, 97 |
34 | 6-[(methyl-4-nitro-1H-imidazol-5-yl)thio]-1H-purine | - | - | - | - | [1] 96 96 |
35 | 6-Mercaptopurine | [1] Mercaptopurine Mercaptopurine | [2] D00161
D00161
,
D04931
| [1] HPRT1 HPRT1 💬 | [3] Drug metabolism - other enzymes Drug metabolism - other enzymes, Metabolic pathways, Purine metabolism 💬 | [3] 96 96, 97, 164 |
36 | 6-Mercaptopurine (Puri-Nethol) | [1] Mercaptopurine Mercaptopurine | [2] D00161
D00161
,
D04931
| [1] HPRT1 HPRT1 💬 | [3] Drug metabolism - other enzymes Drug metabolism - other enzymes, Metabolic pathways, Purine metabolism 💬 | [1] 96 96 |
37 | 6-MP | [1] Mercaptopurine Mercaptopurine | [2] D00161
D00161
,
D04931
| [1] HPRT1 HPRT1 💬 | [3] Drug metabolism - other enzymes Drug metabolism - other enzymes, Metabolic pathways, Purine metabolism 💬 | [2] 96 96, 97 |
38 | 683699 | - | - | - | - | [1] 96 96 |
39 | 75 mg Ontamalimab | [1] Ontamalimab Ontamalimab | - | - | - | [2] 96 96, 97 |
40 | 80 mg DR-6MP | - | - | - | - | [1] 96 96 |
41 | 99mTc-S-HYNIC Certolizumab pegol | [1] Certolizumab pegol Certolizumab pegol | [1] D03441
D03441
| [1] TNF TNF 💬 | [67] AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | [2] 46 46, 96 |
42 | ?-3 polyunsaturated fatty acid | - | - | - | - | [1] 96 96 |
43 | [124I]IB PF 06687234 | - | - | - | - | [2] 96 96, 97 |
44 | [18F]FSPG | - | - | - | - | [2] 96 96, 97 |
45 | A fixed-dose combination of 95 mg clarithromycin, 45 mg rifabutin, and 10 mg clofazimine | [3] Clarithromycin Clarithromycin, Clofazimine, Rifabutin | [3] D00276
D00276
,
D00278
,
D00424
| - | - | [1] 96 96 |
46 | A-1293543.74 | - | - | - | - | [1] 96 96 |
47 | AB1010 | - | - | - | - | [6] 2 2, 5, 6, 13, 46, 96 |
48 | Abatacept | [1] Abatacept Abatacept | [1] D03203
D03203
| [2] CD80 CD80, CD86 💬 | [12] Allograft rejection Allograft rejection, Autoimmune thyroid disease, Cell adhesion molecules, Graft-versus-host disease, Intestinal immune network for IgA production, Kaposi sarcoma-associated herpesvirus infection, Rheumatoid arthritis, Systemic lupus erythematosus, Toll-like receptor signaling pathway, Transcriptional misregulation in cancer, Type I diabetes mellitus, Viral myocarditis 💬 | [26] 11 11, 13, 19, 41, 44, 46, 49, 50, 51, 53, 55, 60, 65, 84, 93, 95, 96, 97, 107, 160, 164, 222, 271, 284, 285, 300 |
49 | ABBV-066 | - | - | - | - | [2] 96 96, 97 |
50 | ABBV-154 | - | - | - | - | [2] 46 46, 96 |
51 | ABR-215062 sodium salt | - | - | - | - | [2] 13 13, 96 |
52 | Abrilumab | [1] Abrilumab Abrilumab | [1] D10540
D10540
| [2] ITGA4 ITGA4, ITGB7 💬 | [15] Arrhythmogenic right ventricular cardiomyopathy Arrhythmogenic right ventricular cardiomyopathy, Cell adhesion molecules, Dilated cardiomyopathy, ECM-receptor interaction, Focal adhesion, Hematopoietic cell lineage, Human papillomavirus infection, Hypertrophic cardiomyopathy, Intestinal immune network for IgA production, Leishmaniasis, Leukocyte transendothelial migration, PI3K-Akt signaling pathway, Regulation of actin cytoskeleton, Transcriptional misregulation in cancer, Yersinia infection 💬 | [2] 96 96, 97 |
53 | ABT 494 12mg | - | - | - | - | [2] 46 46, 96 |
54 | ABT 494 3mg | - | - | - | - | [2] 46 46, 96 |
55 | ABT Humira | - | - | - | - | [1] 96 96 |
56 | ABT-494 | - | - | - | - | [7] 41 41, 46, 49, 96, 97, 107, 271 |
57 | ABT-874 | - | - | - | - | [1] 96 96 |
58 | ABX464 | - | - | - | - | [3] 46 46, 96, 97 |
59 | Accelerated 1 hour-infusion | - | - | - | - | [2] 96 96, 97 |
60 | Accelerated 30 minutes-infusion | - | - | - | - | [2] 96 96, 97 |
61 | Acetaminophen | [1] Acetaminophen Acetaminophen | [1] D00217
D00217
| [2] PTGS1 PTGS1, PTGS2 💬 | [23] Alzheimer disease Alzheimer disease, Arachidonic acid metabolism, C-type lectin receptor signaling pathway, Chemical carcinogenesis - DNA adducts, Human cytomegalovirus infection, Human papillomavirus infection, IL-17 signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Metabolic pathways, MicroRNAs in cancer, NF-kappa B signaling pathway, Ovarian steroidogenesis, Oxytocin signaling pathway, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Platelet activation, Regulation of lipolysis in adipocytes, Retrograde endocannabinoid signaling, Serotonergic synapse, Small cell lung cancer, TNF signaling pathway, VEGF signaling pathway 💬 | [16] 11 11, 13, 34, 35, 46, 49, 51, 70, 86, 96, 222, 231, 256, 271, 300, 337 |
62 | Acetate | [1] Acetate Acetate | - | - | - | [43] 1 1, 2, 6, 10, 13, 35, 40, 46, 49, 51, 60, 64, 67, 70, 71, 73, 75, 76, 78, 79, 81, 83, 85, 86, 88, 90, 96, 97, 113, 145, 156, 162, 171, 206, 222, 224, 225, 227, 235, 265, 288, 298, 299 |
63 | Adalimumab | [1] Adalimumab Adalimumab | [1] D02597
D02597
| [1] TNF TNF 💬 | [67] AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | [18] 19 19, 37, 40, 41, 46, 56, 84, 96, 97, 107, 151, 160, 164, 222, 226, 269, 270, 271 |
64 | Adalimumab (40 mg) | [1] Adalimumab Adalimumab | [1] D02597
D02597
| [1] TNF TNF 💬 | [67] AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | [1] 96 96 |
65 | Adalimumab (D2E7) | [1] Adalimumab Adalimumab | [1] D02597
D02597
| [1] TNF TNF 💬 | [67] AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | [2] 96 96, 271 |
66 | Adalimumab 40 mg eow or ew | [1] Adalimumab Adalimumab | [1] D02597
D02597
| [1] TNF TNF 💬 | [67] AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | [1] 96 96 |
67 | Adalimumab and Infliximab | [2] Adalimumab Adalimumab, Infliximab | [2] D02597
D02597
,
D02598
| [1] TNF TNF 💬 | [67] AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | [1] 96 96 |
68 | Adalimumab Injection | [1] Adalimumab Adalimumab | [1] D02597
D02597
| [1] TNF TNF 💬 | [67] AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | [3] 40 40, 46, 96 |
69 | Adalimumab PRN | [1] Adalimumab Adalimumab | [1] D02597
D02597
| [1] TNF TNF 💬 | [67] AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | [1] 96 96 |
70 | ADSVF | - | - | - | - | [2] 15 15, 96 |
71 | Adult human mesenchymal stem cells | [1] Remestemcel-L Remestemcel-L | [1] D09719
D09719
| - | - | [2] 85 85, 96 |
72 | Agri-King Synbiotic (AKSB) | - | - | - | - | [1] 96 96 |
73 | AIN457 | - | - | - | - | [8] 13 13, 37, 41, 46, 56, 96, 107, 271 |
74 | Albendazole | [1] Albendazole Albendazole | [1] D00134
D00134
| - | - | [1] 96 96 |
75 | Albendazole (Eskazole) | [1] Albendazole Albendazole | [1] D00134
D00134
| - | - | [1] 96 96 |
76 | Albumen | [1] Egg white Egg white | - | - | - | [1] 96 96 |
77 | ALBUMINE HUMAINE | - | - | - | - | [1] 96 96 |
78 | ALDESLEUKIN | [1] Aldesleukin Aldesleukin | [1] D00748
D00748
| [3] IL2RA IL2RA, IL2RB, IL2RG 💬 | [14] Cytokine-cytokine receptor interaction Cytokine-cytokine receptor interaction, Endocytosis, Hematopoietic cell lineage, Human T-cell leukemia virus 1 infection, Inflammatory bowel disease, JAK-STAT signaling pathway, Measles, PI3K-Akt signaling pathway, Pathways in cancer, Primary immunodeficiency, Th1 and Th2 cell differentiation, Th17 cell differentiation, Transcriptional misregulation in cancer, Viral protein interaction with cytokine and cytokine receptor 💬 | [4] 49 49, 65, 96, 97 |
79 | ALEMTUZUMAB | [1] Alemtuzumab Alemtuzumab | [1] D02802
D02802
| [1] CD52 CD52 💬 | - | [17] 13 13, 15, 19, 20, 36, 43, 44, 46, 51, 60, 63, 65, 85, 96, 164, 283, 284 |
80 | Alequel | - | - | - | - | [1] 96 96 |
81 | Alfacalcidol | [1] Alfacalcidol Alfacalcidol | [1] D01518
D01518
| [1] VDR VDR 💬 | [5] Chemical carcinogenesis - receptor activation Chemical carcinogenesis - receptor activation, Endocrine and other factor-regulated calcium reabsorption, Mineral absorption, Parathyroid hormone synthesis, secretion and action, Tuberculosis 💬 | [8] 41 41, 46, 49, 50, 96, 107, 235, 238 |
82 | Alicaforsen | [1] Alicaforsen Alicaforsen | - | - | - | [2] 96 96, 97 |
83 | Alicalm (polymeric liquid formula) | - | - | - | - | [1] 96 96 |
84 | ALLO-ASC | - | - | - | - | [1] 96 96 |
85 | ALLO-ASC-CD | - | - | - | - | [1] 96 96 |
86 | Allogeneic Bone Marrow derived Human Mesenchymal Stem Cells (hMSCs) | - | - | - | - | [1] 96 96 |
87 | Allogeneic Bone Marrow Transplantation | - | - | - | - | [9] 60 60, 62, 65, 96, 164, 283, 284, 285, 286 |
88 | Allogeneic Stem Cell Therapy | - | - | - | - | [1] 96 96 |
89 | Allogenic eASCs 5 milion cells/ml suspension for injection. Cx601 | - | - | - | - | [1] 96 96 |
90 | Allogenic eASCs 5 million cells/ml suspension for injection CX601 | - | - | - | - | [1] 96 96 |
91 | Allogenic eASCs 5 million cells/ml suspension for injection. CX601 | - | - | - | - | [1] 96 96 |
92 | Allogenic eASCs 5 million/ml suspension for injection. | - | - | - | - | [1] 96 96 |
93 | Allopurinol | [1] Allopurinol Allopurinol | [1] D00224
D00224
| [1] XDH XDH 💬 | [5] Caffeine metabolism Caffeine metabolism, Drug metabolism - other enzymes, Metabolic pathways, Peroxisome, Purine metabolism 💬 | [6] 6 6, 46, 57, 66, 96, 97 |
94 | Allopurinol Sandoz 100 mg, tabletten | [1] Allopurinol Allopurinol | [1] D00224
D00224
| [1] XDH XDH 💬 | [5] Caffeine metabolism Caffeine metabolism, Drug metabolism - other enzymes, Metabolic pathways, Peroxisome, Purine metabolism 💬 | [1] 96 96 |
95 | ALLOPURINOL SODIUM | [1] Allopurinol Allopurinol | [1] D00224
D00224
| [1] XDH XDH 💬 | [5] Caffeine metabolism Caffeine metabolism, Drug metabolism - other enzymes, Metabolic pathways, Peroxisome, Purine metabolism 💬 | [1] 96 96 |
96 | Alofisel | [1] Darvadstrocel Darvadstrocel | [1] D11397
D11397
| - | - | [1] 96 96 |
97 | Also referred to as 'MEDI2070' | - | - | - | - | [2] 96 96, 97 |
98 | Also referred to as MED2070 | - | - | - | - | [1] 96 96 |
99 | Also referred to as MEDI2070 | - | - | - | - | [2] 96 96, 97 |
100 | ALX-0600 | - | - | - | - | [1] 96 96 |
101 | AMG 139 | - | - | - | - | [1] 96 96 |
102 | AMG 181 | - | - | - | - | [2] 96 96, 97 |
103 | AMG 827 | - | - | - | - | [2] 46 46, 96 |
104 | AMG 827 210 mg | - | - | - | - | [2] 46 46, 96 |
105 | AMG 827 350 MG | - | - | - | - | [1] 96 96 |
106 | AMG 827 700 MG | - | - | - | - | [1] 96 96 |
107 | Amgevita | [1] Adalimumab Adalimumab | [1] D02597
D02597
| [1] TNF TNF 💬 | [67] AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | [2] 96 96, 97 |
108 | AMGEVITA (Adalimumab biosimilar ) | [1] Adalimumab Adalimumab | [1] D02597
D02597
| [1] TNF TNF 💬 | [67] AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | [2] 96 96, 97 |
109 | Amgevita 40 mg Injektionslösung im Fertigpen | [1] Adalimumab Adalimumab | [1] D02597
D02597
| [1] TNF TNF 💬 | [67] AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | [2] 96 96, 97 |
110 | Amgevita 40 mg Injektionslösung in einer Fertigspritze | [1] Adalimumab Adalimumab | [1] D02597
D02597
| [1] TNF TNF 💬 | [67] AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | [2] 96 96, 97 |
111 | Amgevita 40Mg Solution for Injection | - | - | - | - | [2] 96 96, 97 |
112 | AMGEVITA® | [1] Adalimumab Adalimumab | [1] D02597
D02597
| [1] TNF TNF 💬 | [67] AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | [2] 96 96, 97 |
113 | Aminolevulinic acid | [1] Aminolevulinic acid Aminolevulinic acid | [2] D02908
D02908
,
D07567
| - | - | [4] 34 34, 96, 254, 286 |
114 | AMINOSALICYLIC ACID | [1] Aminosalicylic acid Aminosalicylic acid | [1] D00162
D00162
| - | - | [2] 96 96, 97 |
115 | Ammonium chloride | [2] Ammonium chloride Ammonium chloride, Chloride ion | [1] D01139
D01139
| - | - | [3] 96 96, 107, 251 |
116 | Amoxicillin | [1] Amoxicillin Amoxicillin | [3] D00229
D00229
,
D02925
,
D07452
| - | - | [7] 6 6, 46, 63, 96, 97, 222, 299 |
117 | AN100226 | - | - | - | - | [2] 13 13, 96 |
118 | Andecaliximab | - | - | - | - | [4] 46 46, 96, 97, 299 |
119 | AndoSan | - | - | - | - | [2] 96 96, 97 |
120 | Anti TNF | - | - | - | - | [1] 96 96 |
121 | Anti TNF Alfa. | - | - | - | - | [1] 96 96 |
122 | Anti TNF humanized antibody Fab fragment-PEG conjugate | - | - | - | - | [1] 96 96 |
123 | Anti TNF therapy including infliximab | [1] Infliximab Infliximab | [1] D02598
D02598
| [1] TNF TNF 💬 | [67] AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | [2] 96 96, 97 |
124 | Anti-CD3 | [1] Muromonab Muromonab | [1] D05092
D05092
| [3] CD3D CD3D, CD3E, CD3G 💬 | [11] Chagas disease Chagas disease, Epstein-Barr virus infection, Hematopoietic cell lineage, Human T-cell leukemia virus 1 infection, Human immunodeficiency virus 1 infection, Measles, PD-L1 expression and PD-1 checkpoint pathway in cancer, Primary immunodeficiency, T cell receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation 💬 | [2] 96 96, 97 |
125 | Anti-CD3 Monoclonal antibody | [1] Muromonab Muromonab | [1] D05092
D05092
| [3] CD3D CD3D, CD3E, CD3G 💬 | [11] Chagas disease Chagas disease, Epstein-Barr virus infection, Hematopoietic cell lineage, Human T-cell leukemia virus 1 infection, Human immunodeficiency virus 1 infection, Measles, PD-L1 expression and PD-1 checkpoint pathway in cancer, Primary immunodeficiency, T cell receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation 💬 | [2] 96 96, 97 |
126 | Anti-IL-12 | - | - | - | - | [2] 13 13, 96 |
127 | Anti-IL-23 monoclonal antibody | - | - | - | - | [1] 96 96 |
128 | Anti-IL-6 mAb | - | - | - | - | [2] 46 46, 96 |
129 | Anti-Interferon-gamma monoclonal antibody | - | - | - | - | [1] 96 96 |
130 | Anti-Interleukin-23 Immunoglobulin G2 (IgG2) Huma | - | - | - | - | [2] 96 96, 97 |
131 | Anti-Interleukin-23 Immunoglobulin G2 (IgG2) Human | - | - | - | - | [2] 96 96, 97 |
132 | Anti-Interleukin-23 Immunoglobulin G2 (IgG2) Human Monoclonal Antibody | - | - | - | - | [2] 96 96, 97 |
133 | Anti-Interleukin-6 Monoclonal Antibody | - | - | - | - | [2] 46 46, 96 |
134 | Anti-MAdCAM antibody | - | - | - | - | [2] 96 96, 97 |
135 | Anti-Thymocyte Globulin (Rabbit) | [1] Rabbit Rabbit | - | - | - | [4] 60 60, 65, 96, 285 |
136 | Anti-TNF | - | - | - | - | [4] 46 46, 96, 107, 271 |
137 | Anti-TNF discontinuation: Physiological saline solution | - | - | - | - | [2] 96 96, 97 |
138 | Anti-TNF Drug | - | - | - | - | [2] 96 96, 97 |
139 | Anti-TNF therapy | - | - | - | - | [3] 46 46, 96, 97 |
140 | Anti-TNF: Infliximab (Infusion) | [1] Infliximab Infliximab | [1] D02598
D02598
| [1] TNF TNF 💬 | [67] AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | [2] 96 96, 97 |
141 | Anti-TNF:Adalimumab (Subcutaneus) | [1] Adalimumab Adalimumab | [1] D02597
D02597
| [1] TNF TNF 💬 | [67] AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | [2] 96 96, 97 |
142 | Antibiotics | - | - | - | - | [1] 96 96 |
143 | Anticorpo monoclonale anti IL-23 | - | - | - | - | [1] 96 96 |
144 | Anticorpo monoclonale anti-IL-23 | - | - | - | - | [1] 96 96 |
145 | Anticorpo monoclonale umano anti-Interleuchina-23 Immunoglobulina G2 (IgG2) | - | - | - | - | [1] 96 96 |
146 | ANTITHYMOCYTE IMMUNOGLOBULIN | [1] Antithymocyte immunoglobulin (rabbit) Antithymocyte immunoglobulin (rabbit) | - | - | - | [2] 13 13, 96 |
147 | Antithymocyte immunoglobulin (rabbit) | [2] Antithymocyte immunoglobulin (rabbit) Antithymocyte immunoglobulin (rabbit), Rabbit | - | - | - | [2] 13 13, 96 |
148 | APD334 | - | - | - | - | [5] 93 93, 96, 97, 98, 269 |
149 | APD371 | - | - | - | - | [1] 96 96 |
150 | Apheresis catheter placement | - | - | - | - | [1] 96 96 |
151 | Apixaban | [1] Apixaban Apixaban | [1] D03213
D03213
| [1] F10 F10 💬 | [1] Complement and coagulation cascades Complement and coagulation cascades 💬 | [3] 96 96, 97, 222 |
152 | Apixaban 2.5 milligram | [1] Apixaban Apixaban | [1] D03213
D03213
| [1] F10 F10 💬 | [1] Complement and coagulation cascades Complement and coagulation cascades 💬 | [2] 96 96, 97 |
153 | Application of Adalimumab | [1] Adalimumab Adalimumab | [1] D02597
D02597
| [1] TNF TNF 💬 | [67] AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | [1] 96 96 |
154 | AR401959 L-arginine | [1] Arginine Arginine | [1] D02982
D02982
| - | - | [3] 96 96, 97, 98 |
155 | Arginine | [1] Arginine Arginine | [1] D02982
D02982
| - | - | [11] 46 46, 58, 67, 78, 96, 97, 98, 113, 210, 251, 299 |
156 | Artesunate | [1] Artesunate Artesunate | [1] D02482
D02482
| - | - | [3] 18 18, 66, 96 |
157 | AS | - | - | - | - | [6] 46 46, 53, 96, 97, 215, 271 |
158 | ASA | - | - | - | - | [4] 13 13, 96, 97, 251 |
159 | ASC | - | - | - | - | [4] 36 36, 51, 96, 97 |
160 | ASCs | - | - | - | - | [2] 53 53, 96 |
161 | ASCs: Adipose derived Stem Cells | - | - | - | - | [1] 96 96 |
162 | AST-120 | - | - | - | - | [2] 96 96, 97 |
163 | ATG | - | - | - | - | [4] 13 13, 60, 96, 285 |
164 | Atorvastatin | [1] Atorvastatin Atorvastatin | [3] D00258
D00258
,
D00887
,
D07474
| [1] HMGCR HMGCR 💬 | [4] AMPK signaling pathway AMPK signaling pathway, Bile secretion, Metabolic pathways, Terpenoid backbone biosynthesis 💬 | [18] 13 13, 46, 49, 51, 58, 63, 79, 84, 88, 93, 96, 97, 160, 222, 225, 265, 271, 299 |
165 | Autologous ADIpose derived stromal vascular fraction | - | - | - | - | [1] 96 96 |
166 | Autologous CD34-selected peripheral blood stem cells transplant | - | - | - | - | [1] 96 96 |
167 | Autologous mesenchymal stromal cell | - | - | - | - | [2] 96 96, 298 |
168 | Autologous ovalbumin-specific type 1 regulatory T lymphocytes expanded population | - | - | - | - | [1] 96 96 |
169 | Autologous stem cell transplant | - | - | - | - | [4] 28 28, 53, 56, 96 |
170 | Autologous Stem Cell Transplantation | - | - | - | - | [4] 13 13, 28, 56, 96 |
171 | AVB-114 | - | - | - | - | [1] 96 96 |
172 | AZA | - | - | - | - | [4] 11 11, 40, 96, 97 |
173 | AZA capsules | - | - | - | - | [1] 96 96 |
174 | Azathioprin | - | - | - | - | [2] 46 46, 96 |
175 | Azathioprin-ratiopharm 25 mg | - | - | - | - | [1] 96 96 |
176 | Azathioprin-ratiopharm 25mg Filmtabletten | - | - | - | - | [1] 96 96 |
177 | Azathioprin-ratiopharm 50 mg Filmtabletten | - | - | - | - | [1] 96 96 |
178 | Azathioprine | [1] Azathioprine Azathioprine | [2] D00238
D00238
,
D03033
| - | - | [21] 6 6, 11, 13, 19, 35, 42, 43, 44, 45, 46, 49, 63, 65, 66, 85, 93, 94, 95, 96, 97, 162 |
179 | Azathioprine (AZA) caps | [1] Azathioprine Azathioprine | [2] D00238
D00238
,
D03033
| - | - | [1] 96 96 |
180 | Azathioprine (AZA) or 6-mercaptopurine (6-MP) | [2] Azathioprine Azathioprine, Mercaptopurine | [4] D00161
D00161
,
D00238
,
D03033
,
D04931
| [1] HPRT1 HPRT1 💬 | [3] Drug metabolism - other enzymes Drug metabolism - other enzymes, Metabolic pathways, Purine metabolism 💬 | [2] 96 96, 97 |
181 | Azathioprine - ratiopharm 50 mg | [1] Azathioprine Azathioprine | [2] D00238
D00238
,
D03033
| - | - | [1] 96 96 |
182 | Azathioprine / 6 Mercaptopurine | [2] Azathioprine Azathioprine, Mercaptopurine | [4] D00161
D00161
,
D00238
,
D03033
,
D04931
| [1] HPRT1 HPRT1 💬 | [3] Drug metabolism - other enzymes Drug metabolism - other enzymes, Metabolic pathways, Purine metabolism 💬 | [1] 96 96 |
183 | Azathioprine in case of endoscopic recurrence | [1] Azathioprine Azathioprine | [2] D00238
D00238
,
D03033
| - | - | [1] 96 96 |
184 | Azathioprine individualised dose | [1] Azathioprine Azathioprine | [2] D00238
D00238
,
D03033
| - | - | [1] 96 96 |
185 | Azathioprine or 6-mercaptopurine | [2] Azathioprine Azathioprine, Mercaptopurine | [4] D00161
D00161
,
D00238
,
D03033
,
D04931
| [1] HPRT1 HPRT1 💬 | [3] Drug metabolism - other enzymes Drug metabolism - other enzymes, Metabolic pathways, Purine metabolism 💬 | [2] 96 96, 97 |
186 | Azathioprine or adalimumab and infliximab | [3] Adalimumab Adalimumab, Azathioprine, Infliximab | [4] D00238
D00238
,
D02597
,
D02598
,
D03033
| [1] TNF TNF 💬 | [67] AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | [1] 96 96 |
187 | Azathioprine OR Mesalazine | [2] Azathioprine Azathioprine, Mesalazine | [3] D00238
D00238
,
D00377
,
D03033
| - | - | [1] 96 96 |
188 | AZATHIOPRINE or METHOTREXATE | [2] Azathioprine Azathioprine, Methotrexate | [4] D00142
D00142
,
D00238
,
D02115
,
D03033
| [2] DHFR DHFR, DHFR2 💬 | [5] Antifolate resistance Antifolate resistance, Biosynthesis of cofactors, Folate biosynthesis, Metabolic pathways, One carbon pool by folate 💬 | [1] 96 96 |
189 | Azathioprine weight-based dose | [1] Azathioprine Azathioprine | [2] D00238
D00238
,
D03033
| - | - | [1] 96 96 |
190 | Azathioprine+enteral nutrition | [1] Azathioprine Azathioprine | [2] D00238
D00238
,
D03033
| - | - | [1] 96 96 |
191 | Azatioprina | [1] Azathioprine Azathioprine | [2] D00238
D00238
,
D03033
| - | - | [3] 13 13, 96, 97 |
192 | AZATIOPRINA ASPEN - 50 COMPRESSE | [1] Azathioprine Azathioprine | [2] D00238
D00238
,
D03033
| - | - | [1] 96 96 |
193 | AZD9056 | - | - | - | - | [2] 46 46, 96 |
194 | Azithromycin | [1] Azithromycin Azithromycin | [3] D02134
D02134
,
D06390
,
D07486
| - | - | [6] 13 13, 84, 85, 96, 228, 299 |
195 | Azithromycin + Metronidazole | [2] Azithromycin Azithromycin, Metronidazole | [6] D00409
D00409
,
D02134
,
D05016
,
D05017
,
D06390
,
D07486
| - | - | [1] 96 96 |
196 | B. theta | - | - | - | - | [1] 96 96 |
197 | Bacteriophage preparation | - | - | - | - | [1] 96 96 |
198 | Bacteriotherapy | - | - | - | - | [2] 96 96, 97 |
199 | Bean | [1] Bean Bean | - | - | - | [1] 96 96 |
200 | Behavioral: AbbVie Care 2.0 | - | - | - | - | [4] 46 46, 96, 97, 271 |
201 | Behavioral: Diet Counseling | - | - | - | - | [1] 96 96 |
202 | Behavioral: Dyadic Psychological Support (DPS) | - | - | - | - | [1] 96 96 |
203 | Behavioral: Hypnosis | - | - | - | - | [1] 96 96 |
204 | Behavioral: TIP / IMPACT Plus Care Coordination | - | - | - | - | [3] 46 46, 96, 97 |
205 | Beta carotene | [1] Beta carotene Beta carotene | [1] D03101
D03101
| - | - | [1] 96 96 |
206 | Beta carotene from Dunaliella algae | [1] Beta carotene Beta carotene | [1] D03101
D03101
| - | - | [1] 96 96 |
207 | Betamethasone | [1] Betamethasone Betamethasone | [7] D00244
D00244
,
D00972
,
D01357
,
D01402
,
D01637
,
D02032
,
D02286
| [1] NR3C1 NR3C1 💬 | [1] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | [7] 2 2, 28, 46, 83, 90, 96, 235 |
208 | Bezlotoxumab | [1] Bezlotoxumab Bezlotoxumab | [1] D10453
D10453
| - | - | [2] 96 96, 97 |
209 | BFAHF-2 | - | - | - | - | [1] 96 96 |
210 | BI 655066 | - | - | - | - | [2] 96 96, 271 |
211 | BI 655066 10 mg/ml | - | - | - | - | [1] 96 96 |
212 | BI 655066 90 mg/ml | - | - | - | - | [2] 96 96, 271 |
213 | BI 655130 | - | - | - | - | [3] 37 37, 96, 97 |
214 | BI 695501 | - | - | - | - | [2] 46 46, 96 |
215 | BI 706321 | - | - | - | - | [1] 96 96 |
216 | BIBR 796 BS, 20 mg | - | - | - | - | [1] 96 96 |
217 | BIBR 796 BS, 5 mg | - | - | - | - | [1] 96 96 |
218 | Bif195 capsules | - | - | - | - | [1] 96 96 |
219 | Bifidobacterium infantis | [1] Bifidobacterium longum infantis Bifidobacterium longum infantis | - | - | - | [2] 96 96, 97 |
220 | Bifidobacterium infantis 35624 | [1] Bifidobacterium longum infantis Bifidobacterium longum infantis | - | - | - | [2] 96 96, 97 |
221 | Biological samplings | - | - | - | - | [1] 96 96 |
222 | Biosimilar | - | - | - | - | [4] 46 46, 96, 97, 271 |
223 | Biosimilar Infliximab | [1] Infliximab Infliximab | [1] D02598
D02598
| [1] TNF TNF 💬 | [67] AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | [3] 46 46, 96, 97 |
224 | Bleomycin | [1] Bleomycin Bleomycin | [3] D02177
D02177
,
D03229
,
D07535
| - | - | [4] 96 96, 278, 279, 280 |
225 | BLI-1300 high dose | - | - | - | - | [1] 96 96 |
226 | BLI-1300 low dose | - | - | - | - | [1] 96 96 |
227 | Blood and stools samples | - | - | - | - | [1] 96 96 |
228 | Blood sample | - | - | - | - | [18] 8 8, 13, 46, 49, 51, 53, 61, 65, 66, 84, 96, 97, 107, 127, 235, 274, 288, 299 |
229 | Blood sampling | - | - | - | - | [6] 13 13, 17, 19, 46, 51, 96 |
230 | Blood sampling from infant | - | - | - | - | [3] 46 46, 96, 271 |
231 | Blood sampling from mother | - | - | - | - | [3] 46 46, 96, 271 |
232 | Blood sampling from umbilical cord | - | - | - | - | [3] 46 46, 96, 271 |
233 | Blue light photopheresis | - | - | - | - | [1] 96 96 |
234 | BMS-188667 | - | - | - | - | [9] 46 46, 49, 53, 65, 96, 97, 107, 222, 271 |
235 | BMS-936557 | - | - | - | - | [2] 96 96, 97 |
236 | BMS-936557 (Anti-IP-10 Antibody) | - | - | - | - | [1] 96 96 |
237 | BMS-945429 | [1] Clazakizumab Clazakizumab | [1] D10312
D10312
| - | - | [2] 46 46, 96 |
238 | BMS-986165 | - | - | - | - | [3] 49 49, 96, 97 |
239 | BMS986165 | - | - | - | - | [2] 96 96, 97 |
240 | Bone Marrow Derived Mesenchymal Stem cells (MSCs) | - | - | - | - | [1] 96 96 |
241 | Bone Marrow MSC Derived Extracellular Vesicle Isolate | - | - | - | - | [1] 96 96 |
242 | Boulardii | - | - | - | - | [2] 96 96, 97 |
243 | BRAZIKUMAB | [1] Brazikumab Brazikumab | [1] D10912
D10912
| [1] IL23A IL23A 💬 | [9] C-type lectin receptor signaling pathway C-type lectin receptor signaling pathway, Cytokine-cytokine receptor interaction, Inflammatory bowel disease, JAK-STAT signaling pathway, Pathways in cancer, Pertussis, Rheumatoid arthritis, Th17 cell differentiation, Tuberculosis 💬 | [2] 96 96, 97 |
244 | Brazikumab high dose | [1] Brazikumab Brazikumab | [1] D10912
D10912
| [1] IL23A IL23A 💬 | [9] C-type lectin receptor signaling pathway C-type lectin receptor signaling pathway, Cytokine-cytokine receptor interaction, Inflammatory bowel disease, JAK-STAT signaling pathway, Pathways in cancer, Pertussis, Rheumatoid arthritis, Th17 cell differentiation, Tuberculosis 💬 | [1] 96 96 |
245 | Brazikumab Induction Dose | [1] Brazikumab Brazikumab | [1] D10912
D10912
| [1] IL23A IL23A 💬 | [9] C-type lectin receptor signaling pathway C-type lectin receptor signaling pathway, Cytokine-cytokine receptor interaction, Inflammatory bowel disease, JAK-STAT signaling pathway, Pathways in cancer, Pertussis, Rheumatoid arthritis, Th17 cell differentiation, Tuberculosis 💬 | [2] 96 96, 97 |
246 | Brazikumab IV Infusion | [1] Brazikumab Brazikumab | [1] D10912
D10912
| [1] IL23A IL23A 💬 | [9] C-type lectin receptor signaling pathway C-type lectin receptor signaling pathway, Cytokine-cytokine receptor interaction, Inflammatory bowel disease, JAK-STAT signaling pathway, Pathways in cancer, Pertussis, Rheumatoid arthritis, Th17 cell differentiation, Tuberculosis 💬 | [1] 96 96 |
247 | Brazikumab low dose | [1] Brazikumab Brazikumab | [1] D10912
D10912
| [1] IL23A IL23A 💬 | [9] C-type lectin receptor signaling pathway C-type lectin receptor signaling pathway, Cytokine-cytokine receptor interaction, Inflammatory bowel disease, JAK-STAT signaling pathway, Pathways in cancer, Pertussis, Rheumatoid arthritis, Th17 cell differentiation, Tuberculosis 💬 | [1] 96 96 |
248 | Brazikumab Maintenance Dose | [1] Brazikumab Brazikumab | [1] D10912
D10912
| [1] IL23A IL23A 💬 | [9] C-type lectin receptor signaling pathway C-type lectin receptor signaling pathway, Cytokine-cytokine receptor interaction, Inflammatory bowel disease, JAK-STAT signaling pathway, Pathways in cancer, Pertussis, Rheumatoid arthritis, Th17 cell differentiation, Tuberculosis 💬 | [2] 96 96, 97 |
249 | Brazikumab SC Injection | [1] Brazikumab Brazikumab | [1] D10912
D10912
| [1] IL23A IL23A 💬 | [9] C-type lectin receptor signaling pathway C-type lectin receptor signaling pathway, Cytokine-cytokine receptor interaction, Inflammatory bowel disease, JAK-STAT signaling pathway, Pathways in cancer, Pertussis, Rheumatoid arthritis, Th17 cell differentiation, Tuberculosis 💬 | [1] 96 96 |
250 | Breast milk sampling | - | - | - | - | [3] 46 46, 96, 271 |
251 | Brepocitinib 25 mg | - | - | - | - | [2] 96 96, 97 |
252 | Brepocitinib 5 mg | - | - | - | - | [2] 96 96, 97 |
253 | Brepocitinib 5mg | - | - | - | - | [1] 96 96 |
254 | BT | - | - | - | - | [4] 6 6, 96, 97, 98 |
255 | BT-11 | - | - | - | - | [2] 96 96, 97 |
256 | BT-11 (Omilancor) | - | - | - | - | [1] 96 96 |
257 | BT-11 1,000 mg | - | - | - | - | [1] 96 96 |
258 | BT-11 1000mg | - | - | - | - | [3] 96 96, 97, 98 |
259 | BT-11 500 mg | - | - | - | - | [2] 96 96, 97 |
260 | BT-11 Active | - | - | - | - | [2] 96 96, 97 |
261 | Budenofalk | - | - | - | - | [1] 96 96 |
262 | Budenofalk 3mg gastro-resistant capsules | - | - | - | - | [1] 96 96 |
263 | Budenofalk 9mg gastro-resistant granules | - | - | - | - | [1] 96 96 |
264 | BUDESONIDE | [1] Budesonide Budesonide | [1] D00246
D00246
| [1] NR3C1 NR3C1 💬 | [1] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | [9] 66 66, 93, 94, 95, 96, 97, 98, 228, 299 |
265 | Budesonide ( Zentacort Capsules 3mg ) | [1] Budesonide Budesonide | [1] D00246
D00246
| [1] NR3C1 NR3C1 💬 | [1] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | [1] 96 96 |
266 | Bupivacaine | [1] Bupivacaine Bupivacaine | [2] D01450
D01450
,
D07552
| [5] SCN1A SCN1A, SCN2A, SCN3A, SCN5A, SCN9A 💬 | [3] Adrenergic signaling in cardiomyocytes Adrenergic signaling in cardiomyocytes, Dopaminergic synapse, Taste transduction 💬 | [8] 46 46, 51, 53, 70, 96, 168, 226, 298 |
267 | Bupivacaine/epinephrine/dexamethasone | [3] Bupivacaine Bupivacaine, Dexamethasone, Epinephrine | [14] D00095
D00095
,
D00292
,
D00975
,
D00996
,
D01450
,
D01510
,
D01615
,
D01632
,
D01948
,
D02149
,
D02174
,
D02591
,
D02592
,
D07552
| [15] ADRA1A ADRA1A, ADRA1B, ADRA1D, ADRA2A, ADRA2B, ADRA2C, ADRB1, ADRB2, ADRB3, NR3C1, SCN1A, SCN2A, SCN3A, SCN5A, SCN9A 💬 | [16] AMPK signaling pathway AMPK signaling pathway, Adrenergic signaling in cardiomyocytes, Calcium signaling pathway, Chemical carcinogenesis - receptor activation, Dilated cardiomyopathy, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Regulation of lipolysis in adipocytes, Renin secretion, Salivary secretion, Taste transduction, Thermogenesis, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬 | [1] 96 96 |
268 | Bupropion | [1] Bupropion Bupropion | [3] D00817
D00817
,
D07591
,
D07938
| [2] SLC6A2 SLC6A2, SLC6A3 💬 | [7] Alcoholism Alcoholism, Amphetamine addiction, Cocaine addiction, Dopaminergic synapse, Parkinson disease, Pathways of neurodegeneration - multiple diseases, Synaptic vesicle cycle 💬 | [5] 8 8, 18, 21, 96, 171 |
269 | By demand | - | - | - | - | [2] 96 96, 97 |
270 | C326, IL-6 Inhibitory Avimer protein | - | - | - | - | [1] 96 96 |
271 | Caffeine | [1] Caffeine Caffeine | [2] D00528
D00528
,
D01453
| [11] ADORA1 ADORA1, ADORA2A, PDE1B, PDE2A, PDE3A, PDE3B, PDE4A, PDE4B, PDE4C, PDE4D, PDE5A 💬 | [22] Alcoholism Alcoholism, Aldosterone synthesis and secretion, Apelin signaling pathway, Calcium signaling pathway, Glucagon signaling pathway, Insulin signaling pathway, Metabolic pathways, Morphine addiction, Neuroactive ligand-receptor interaction, Olfactory transduction, Parathyroid hormone synthesis, secretion and action, Parkinson disease, Progesterone-mediated oocyte maturation, Purine metabolism, Rap1 signaling pathway, Regulation of lipolysis in adipocytes, Renin secretion, Sphingolipid signaling pathway, Taste transduction, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬 | [9] 2 2, 6, 13, 21, 46, 78, 96, 97, 265 |
272 | Caffeine 100 mg | [1] Caffeine Caffeine | [2] D00528
D00528
,
D01453
| [11] ADORA1 ADORA1, ADORA2A, PDE1B, PDE2A, PDE3A, PDE3B, PDE4A, PDE4B, PDE4C, PDE4D, PDE5A 💬 | [22] Alcoholism Alcoholism, Aldosterone synthesis and secretion, Apelin signaling pathway, Calcium signaling pathway, Glucagon signaling pathway, Insulin signaling pathway, Metabolic pathways, Morphine addiction, Neuroactive ligand-receptor interaction, Olfactory transduction, Parathyroid hormone synthesis, secretion and action, Parkinson disease, Progesterone-mediated oocyte maturation, Purine metabolism, Rap1 signaling pathway, Regulation of lipolysis in adipocytes, Renin secretion, Sphingolipid signaling pathway, Taste transduction, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬 | [2] 96 96, 97 |
273 | Calcio | [1] Calcium Calcium | - | - | - | [4] 13 13, 96, 97, 274 |
274 | Calcitonin nasal spray (salmon) | [1] Salmon, unspecified Salmon, unspecified | - | - | - | [2] 96 96, 97 |
275 | Calcitriol | [1] Calcitriol Calcitriol | [1] D00129
D00129
| [1] VDR VDR 💬 | [5] Chemical carcinogenesis - receptor activation Chemical carcinogenesis - receptor activation, Endocrine and other factor-regulated calcium reabsorption, Mineral absorption, Parathyroid hormone synthesis, secretion and action, Tuberculosis 💬 | [9] 18 18, 37, 46, 49, 66, 96, 158, 235, 326 |
276 | Calcium | [1] Calcium Calcium | - | - | - | [30] 3 3, 6, 13, 15, 19, 46, 49, 51, 53, 56, 68, 75, 79, 84, 93, 94, 95, 96, 97, 186, 214, 215, 222, 224, 235, 256, 265, 274, 298, 299 |
277 | Calcium carbonate | [3] Calcium Calcium, Calcium carbonate, Carbonate ion | [2] D00932
D00932
,
D10802
| - | - | [8] 13 13, 19, 46, 53, 75, 96, 235, 299 |
278 | Caltrate Pill | - | - | - | - | [1] 96 96 |
279 | Cannabidiol | [1] Cannabidiol Cannabidiol | [1] D10915
D10915
| [2] CNR1 CNR1, CNR2 💬 | [4] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction, Rap1 signaling pathway, Retrograde endocannabinoid signaling, Thermogenesis 💬 | [18] 6 6, 8, 13, 36, 46, 95, 96, 97, 140, 144, 145, 156, 157, 158, 193, 206, 226, 271 |
280 | Cannabidiol , synthetic form | [1] Cannabidiol Cannabidiol | [1] D10915
D10915
| [2] CNR1 CNR1, CNR2 💬 | [4] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction, Rap1 signaling pathway, Retrograde endocannabinoid signaling, Thermogenesis 💬 | [1] 96 96 |
281 | Cannabis | [1] Medical Cannabis Medical Cannabis | - | - | - | [9] 2 2, 6, 13, 19, 46, 90, 96, 97, 271 |
282 | Cannabis, Medical | [1] Medical Cannabis Medical Cannabis | - | - | - | [5] 2 2, 6, 13, 96, 97 |
283 | Capsule endoscopy | - | - | - | - | [1] 96 96 |
284 | Capsule fecal microbiota material (cap-FMT) | - | - | - | - | [1] 96 96 |
285 | Carbon | [1] Activated charcoal Activated charcoal | - | - | - | [9] 6 6, 46, 50, 51, 85, 86, 96, 97, 298 |
286 | Carbonate | [1] Carbonate ion Carbonate ion | - | - | - | [12] 2 2, 13, 17, 18, 19, 46, 53, 75, 96, 127, 235, 299 |
287 | Carnitine | [1] Levocarnitine Levocarnitine | [3] D02030
D02030
,
D02176
,
D04713
| - | - | [9] 5 5, 13, 58, 86, 96, 97, 265, 298, 316 |
288 | CC | - | - | - | - | [14] 13 13, 28, 46, 49, 51, 56, 84, 85, 96, 97, 98, 162, 202, 271 |
289 | CC-5013 | - | - | - | - | [2] 28 28, 96 |
290 | CCX282-B | - | - | - | - | [1] 96 96 |
291 | CD | - | - | - | - | [7] 6 6, 13, 46, 51, 96, 97, 265 |
292 | CD-C-Food | - | - | - | - | [1] 96 96 |
293 | CD7 CAR T-cells | - | - | - | - | [3] 50 50, 96, 97 |
294 | CDP6038 | - | - | - | - | [2] 46 46, 96 |
295 | CDP870 | - | - | - | - | [3] 46 46, 96, 271 |
296 | CELEBREX | [1] Celecoxib Celecoxib | [1] D00567
D00567
| [1] PTGS2 PTGS2 💬 | [22] Alzheimer disease Alzheimer disease, Arachidonic acid metabolism, C-type lectin receptor signaling pathway, Chemical carcinogenesis - DNA adducts, Human cytomegalovirus infection, Human papillomavirus infection, IL-17 signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Metabolic pathways, MicroRNAs in cancer, NF-kappa B signaling pathway, Ovarian steroidogenesis, Oxytocin signaling pathway, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Regulation of lipolysis in adipocytes, Retrograde endocannabinoid signaling, Serotonergic synapse, Small cell lung cancer, TNF signaling pathway, VEGF signaling pathway 💬 | [4] 46 46, 96, 107, 271 |
297 | Cellulose | [1] Microcrystalline cellulose Microcrystalline cellulose | [1] D00093
D00093
| - | - | [4] 35 35, 53, 96, 162 |
298 | Certican | [1] Everolimus Everolimus | [1] D02714
D02714
| [1] MTOR MTOR 💬 | [51] AMPK signaling pathway AMPK signaling pathway, Acute myeloid leukemia, Adipocytokine signaling pathway, Alzheimer disease, Amyotrophic lateral sclerosis, Apelin signaling pathway, Autophagy - animal, Autophagy - other, Breast cancer, Cellular senescence, Central carbon metabolism in cancer, Chemical carcinogenesis - receptor activation, Choline metabolism in cancer, Colorectal cancer, Diabetic cardiomyopathy, EGFR tyrosine kinase inhibitor resistance, Endocrine resistance, ErbB signaling pathway, Gastric cancer, Glioma, Growth hormone synthesis, secretion and action, HIF-1 signaling pathway, Hepatocellular carcinoma, Herpes simplex virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Huntington disease, Insulin resistance, Insulin signaling pathway, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Longevity regulating pathway, Longevity regulating pathway - multiple species, MicroRNAs in cancer, Neutrophil extracellular trap formation, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Phospholipase D signaling pathway, Prostate cancer, Proteoglycans in cancer, Shigellosis, Spinocerebellar ataxia, Th17 cell differentiation, Thermogenesis, Thyroid hormone signaling pathway, Type II diabetes mellitus, mTOR signaling pathway 💬 | [4] 67 67, 96, 158, 228 |
299 | Certolizumab | - | - | - | - | [5] 46 46, 49, 96, 270, 271 |
300 | Certolizumab Pegol | [1] Certolizumab pegol Certolizumab pegol | [1] D03441
D03441
| [1] TNF TNF 💬 | [67] AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | [8] 37 37, 46, 49, 96, 97, 107, 226, 271 |
301 | Certolizumab pegol (CDP870) | [1] Certolizumab pegol Certolizumab pegol | [1] D03441
D03441
| [1] TNF TNF 💬 | [67] AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | [2] 46 46, 96 |
302 | Certolizumab pegol (CDP870, CZP) | [1] Certolizumab pegol Certolizumab pegol | [1] D03441
D03441
| [1] TNF TNF 💬 | [67] AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | [1] 96 96 |
303 | Certolizumab Pegol (CZP) | [1] Certolizumab pegol Certolizumab pegol | [1] D03441
D03441
| [1] TNF TNF 💬 | [67] AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | [4] 46 46, 96, 107, 271 |
304 | Certolizumab pegol (rINN) | [1] Certolizumab pegol Certolizumab pegol | [1] D03441
D03441
| [1] TNF TNF 💬 | [67] AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | [1] 96 96 |
305 | Certolizumab Pegol /Cimzia | [1] Certolizumab pegol Certolizumab pegol | [1] D03441
D03441
| [1] TNF TNF 💬 | [67] AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | [1] 96 96 |
306 | Certolizumab pegol 400 mg | [1] Certolizumab pegol Certolizumab pegol | [1] D03441
D03441
| [1] TNF TNF 💬 | [67] AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | [1] 96 96 |
307 | ChAdOx2 HAV | - | - | - | - | [1] 96 96 |
308 | Chenodeoxycholic acid | [1] Chenodeoxycholic acid Chenodeoxycholic acid | [1] D00163
D00163
| [1] NR1H4 NR1H4 💬 | [1] Bile secretion Bile secretion 💬 | [4] 20 20, 96, 234, 263 |
309 | Chenodiol | [1] Chenodeoxycholic acid Chenodeoxycholic acid | [1] D00163
D00163
| [1] NR1H4 NR1H4 💬 | [1] Bile secretion Bile secretion 💬 | [1] 96 96 |
310 | Chenofalk | - | - | - | - | [1] 96 96 |
311 | Chimeric IgG1 monoclonal antibody | - | - | - | - | [1] 96 96 |
312 | Chloride | [1] Chloride ion Chloride ion | - | - | - | [29] 6 6, 11, 13, 14, 34, 46, 50, 51, 53, 60, 65, 67, 78, 96, 97, 107, 127, 168, 171, 193, 227, 228, 251, 271, 288, 296, 297, 299, 338 |
313 | CHLORURE DE SODIUM | - | - | - | - | [1] 96 96 |
314 | CHOLECALCIFEROL | [1] Cholecalciferol Cholecalciferol | [1] D00188
D00188
| [1] VDR VDR 💬 | [5] Chemical carcinogenesis - receptor activation Chemical carcinogenesis - receptor activation, Endocrine and other factor-regulated calcium reabsorption, Mineral absorption, Parathyroid hormone synthesis, secretion and action, Tuberculosis 💬 | [10] 13 13, 19, 34, 46, 49, 75, 96, 97, 298, 299 |
315 | Cholecalciferol 10,000 IU | [1] Cholecalciferol Cholecalciferol | [1] D00188
D00188
| [1] VDR VDR 💬 | [5] Chemical carcinogenesis - receptor activation Chemical carcinogenesis - receptor activation, Endocrine and other factor-regulated calcium reabsorption, Mineral absorption, Parathyroid hormone synthesis, secretion and action, Tuberculosis 💬 | [1] 96 96 |
316 | Cholecalciferol 400 IU | [1] Cholecalciferol Cholecalciferol | [1] D00188
D00188
| [1] VDR VDR 💬 | [5] Chemical carcinogenesis - receptor activation Chemical carcinogenesis - receptor activation, Endocrine and other factor-regulated calcium reabsorption, Mineral absorption, Parathyroid hormone synthesis, secretion and action, Tuberculosis 💬 | [1] 96 96 |
317 | CHOLECALCIFEROL CONCENTRATE | [1] Cholecalciferol Cholecalciferol | [1] D00188
D00188
| [1] VDR VDR 💬 | [5] Chemical carcinogenesis - receptor activation Chemical carcinogenesis - receptor activation, Endocrine and other factor-regulated calcium reabsorption, Mineral absorption, Parathyroid hormone synthesis, secretion and action, Tuberculosis 💬 | [1] 96 96 |
318 | CHOLECALCIFEROL CONCENTRATE (WATER-DISPERSIBLE FORM) | [2] Cholecalciferol Cholecalciferol, Water | [2] D00001
D00001
,
D00188
| [1] VDR VDR 💬 | [5] Chemical carcinogenesis - receptor activation Chemical carcinogenesis - receptor activation, Endocrine and other factor-regulated calcium reabsorption, Mineral absorption, Parathyroid hormone synthesis, secretion and action, Tuberculosis 💬 | [1] 96 96 |
319 | Cholestagel | [1] Colesevelam Colesevelam | [2] D03582
D03582
,
D07743
| - | - | [1] 96 96 |
320 | Chondroitin sulfate | [2] Chondroitin sulfate Chondroitin sulfate, Sulfate ion | - | - | - | [2] 96 96, 226 |
321 | CIMZIA | [1] Certolizumab pegol Certolizumab pegol | [1] D03441
D03441
| [1] TNF TNF 💬 | [67] AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | [5] 46 46, 49, 96, 97, 271 |
322 | Cimzia 200 mg solution for injection | [1] Certolizumab pegol Certolizumab pegol | [1] D03441
D03441
| [1] TNF TNF 💬 | [67] AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | [3] 46 46, 96, 271 |
323 | Ciprofloxacin | [1] Ciprofloxacin Ciprofloxacin | [2] D00186
D00186
,
D02216
| - | - | [5] 2 2, 60, 96, 97, 299 |
324 | Ciprofloxacin hydrochloride | [1] Ciprofloxacin Ciprofloxacin | [2] D00186
D00186
,
D02216
| - | - | [2] 96 96, 299 |
325 | Clarithromycin | [1] Clarithromycin Clarithromycin | [1] D00276
D00276
| - | - | [8] 6 6, 63, 84, 96, 97, 222, 228, 299 |
326 | Clofarabine | [1] Clofarabine Clofarabine | [1] D03546
D03546
| [3] POLA1 POLA1, POLA2, RRM1 💬 | [6] DNA replication DNA replication, Drug metabolism - other enzymes, Glutathione metabolism, Metabolic pathways, Purine metabolism, Pyrimidine metabolism 💬 | [9] 19 19, 20, 40, 46, 49, 60, 96, 234, 326 |
327 | CLOFAZIMINE | [1] Clofazimine Clofazimine | [1] D00278
D00278
| - | - | [1] 96 96 |
328 | CNTO 1275 | - | - | - | - | [2] 13 13, 96 |
329 | CNTO1275 | - | - | - | - | [6] 46 46, 49, 84, 93, 96, 97 |
330 | CNTO1959 | - | - | - | - | [4] 37 37, 41, 96, 97 |
331 | Coffee | [1] Arabica coffee bean Arabica coffee bean | - | - | - | [2] 96 96, 97 |
332 | COLECALCIFEROL | [1] Cholecalciferol Cholecalciferol | [1] D00188
D00188
| [1] VDR VDR 💬 | [5] Chemical carcinogenesis - receptor activation Chemical carcinogenesis - receptor activation, Endocrine and other factor-regulated calcium reabsorption, Mineral absorption, Parathyroid hormone synthesis, secretion and action, Tuberculosis 💬 | [4] 13 13, 46, 96, 228 |
333 | Colecalciferol D3 (Vigantol Oil) | [1] Cholecalciferol Cholecalciferol | [1] D00188
D00188
| [1] VDR VDR 💬 | [5] Chemical carcinogenesis - receptor activation Chemical carcinogenesis - receptor activation, Endocrine and other factor-regulated calcium reabsorption, Mineral absorption, Parathyroid hormone synthesis, secretion and action, Tuberculosis 💬 | [1] 96 96 |
334 | Colesevelam | [1] Colesevelam Colesevelam | [2] D03582
D03582
,
D07743
| - | - | [2] 96 96, 260 |
335 | Colonoscopic fecal microbiota material (colo-FMT) | - | - | - | - | [1] 96 96 |
336 | Colony-purified Bacteroides thetaiotaomicron (B.theta) | - | - | - | - | [1] 96 96 |
337 | ColoVit capsule | - | - | - | - | [1] 96 96 |
338 | Companion diagnostic (CDx) | - | - | - | - | [1] 96 96 |
339 | Computed Tomography | - | - | - | - | [5] 34 34, 40, 46, 49, 96 |
340 | Continuous Mononuclear Cell Collection (CMNC) | - | - | - | - | [1] 96 96 |
341 | Contrast Enhanced Ultrasound | - | - | - | - | [1] 96 96 |
342 | Cortecosteroid | - | - | - | - | [1] 96 96 |
343 | Corticosteroid | - | - | - | - | [10] 13 13, 42, 43, 44, 45, 66, 84, 96, 97, 222 |
344 | CosmoFer | - | - | - | - | [3] 86 86, 96, 97 |
345 | CosmoFer 50mg/ml solution for infusion or injection | - | - | - | - | [2] 96 96, 97 |
346 | CP | - | - | - | - | [6] 6 6, 46, 96, 97, 107, 271 |
347 | CP-461 | - | - | - | - | [1] 96 96 |
348 | CP-690,550 | - | - | - | - | [5] 46 46, 96, 97, 107, 271 |
349 | CP-690,550-10 | - | - | - | - | [5] 46 46, 96, 97, 107, 271 |
350 | CPSI-2364 | - | - | - | - | [1] 96 96 |
351 | Crohn's Disease | - | - | - | - | [1] 96 96 |
352 | Crohn's disease exclusion diet | - | - | - | - | [1] 96 96 |
353 | Crohn's disease exclusion diet (CDED) | - | - | - | - | [1] 96 96 |
354 | Crohns Disease Exclusion Diet + PEN | - | - | - | - | [1] 96 96 |
355 | CROWN | - | - | - | - | [1] 96 96 |
356 | CT-P13 | - | - | - | - | [4] 46 46, 96, 97, 271 |
357 | CT-P13 SC (Infliximab) | [1] Infliximab Infliximab | [1] D02598
D02598
| [1] TNF TNF 💬 | [67] AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | [2] 96 96, 97 |
358 | CTLA4Ig | - | - | - | - | [4] 46 46, 49, 96, 271 |
359 | Curcuma | - | - | - | - | [1] 96 96 |
360 | Curcuma Longa | [1] Turmeric Turmeric | - | - | - | [2] 96 96, 299 |
361 | CURCUMA LONGA RHIZOMA | [1] Turmeric Turmeric | - | - | - | [1] 96 96 |
362 | Curcumin | [1] Curcumin Curcumin | - | - | - | [11] 2 2, 13, 46, 49, 67, 74, 94, 96, 97, 139, 299 |
363 | Cx401 | - | - | - | - | [1] 96 96 |
364 | Cx601 | - | - | - | - | [1] 96 96 |
365 | Cyclophosphamide | [1] Cyclophosphamide Cyclophosphamide | [2] D00287
D00287
,
D07760
| - | - | [45] 11 11, 13, 14, 16, 19, 20, 26, 28, 35, 36, 40, 41, 42, 43, 44, 45, 46, 49, 50, 51, 52, 56, 60, 62, 65, 66, 84, 85, 93, 96, 162, 164, 172, 205, 222, 224, 256, 265, 274, 283, 284, 285, 288, 326, 331 |
366 | CYCLOPHOSPHAMIDE MONOHYDRATE | [1] Cyclophosphamide Cyclophosphamide | [2] D00287
D00287
,
D07760
| - | - | [4] 13 13, 60, 96, 256 |
367 | Cyltezo | - | - | - | - | [1] 96 96 |
368 | Cytochrome P450 (CYP) Substrates | - | - | - | - | [2] 96 96, 97 |
369 | Cytoxan | [1] Cyclophosphamide Cyclophosphamide | [2] D00287
D00287
,
D07760
| - | - | [2] 60 60, 96 |
370 | D-CURA | - | - | - | - | [1] 96 96 |
371 | D9421-C | - | - | - | - | [1] 96 96 |
372 | D9421-C capsule 3 mg | - | - | - | - | [1] 96 96 |
373 | D9421-C, 15mg | - | - | - | - | [1] 96 96 |
374 | D9421-C, 9mg | - | - | - | - | [1] 96 96 |
375 | DARVADSTROCEL | [1] Darvadstrocel Darvadstrocel | [1] D11397
D11397
| - | - | [1] 96 96 |
376 | DB adalimumab 40 mg eow | [1] Adalimumab Adalimumab | [1] D02597
D02597
| [1] TNF TNF 💬 | [67] AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | [1] 96 96 |
377 | DB adalimumab 40 mg ew | [1] Adalimumab Adalimumab | [1] D02597
D02597
| [1] TNF TNF 💬 | [67] AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | [1] 96 96 |
378 | Decortin 20 mg | - | - | - | - | [1] 96 96 |
379 | Decortin 5 mg | - | - | - | - | [1] 96 96 |
380 | Dehydroepiandrosterone | [1] Prasterone Prasterone | [1] D08409
D08409
| [3] AR AR, ESR1, ESR2 💬 | [12] Breast cancer Breast cancer, Chemical carcinogenesis - receptor activation, Endocrine and other factor-regulated calcium reabsorption, Endocrine resistance, Estrogen signaling pathway, GnRH secretion, Oocyte meiosis, Pathways in cancer, Prolactin signaling pathway, Prostate cancer, Proteoglycans in cancer, Thyroid hormone signaling pathway 💬 | [5] 49 49, 53, 83, 96, 113 |
381 | Dehydroepiandrosterone [DHEA] | [1] Prasterone Prasterone | [1] D08409
D08409
| [3] AR AR, ESR1, ESR2 💬 | [12] Breast cancer Breast cancer, Chemical carcinogenesis - receptor activation, Endocrine and other factor-regulated calcium reabsorption, Endocrine resistance, Estrogen signaling pathway, GnRH secretion, Oocyte meiosis, Pathways in cancer, Prolactin signaling pathway, Prostate cancer, Proteoglycans in cancer, Thyroid hormone signaling pathway 💬 | [1] 96 96 |
382 | Dekristol 20.000 ie | - | - | - | - | [1] 96 96 |
383 | Delayed Release 6 mercaptopurine | [1] Mercaptopurine Mercaptopurine | [2] D00161
D00161
,
D04931
| [1] HPRT1 HPRT1 💬 | [3] Drug metabolism - other enzymes Drug metabolism - other enzymes, Metabolic pathways, Purine metabolism 💬 | [1] 96 96 |
384 | Delayed Release 6MP or Calcitriol vs. Purinethol | [1] Calcitriol Calcitriol | [1] D00129
D00129
| [1] VDR VDR 💬 | [5] Chemical carcinogenesis - receptor activation Chemical carcinogenesis - receptor activation, Endocrine and other factor-regulated calcium reabsorption, Mineral absorption, Parathyroid hormone synthesis, secretion and action, Tuberculosis 💬 | [1] 96 96 |
385 | Denosumab | [1] Denosumab Denosumab | [1] D03684
D03684
| [1] TNFSF11 TNFSF11 💬 | [8] Breast cancer Breast cancer, Chemical carcinogenesis - receptor activation, Cytokine-cytokine receptor interaction, NF-kappa B signaling pathway, Osteoclast differentiation, Parathyroid hormone synthesis, secretion and action, Prolactin signaling pathway, Rheumatoid arthritis 💬 | [7] 46 46, 50, 93, 95, 96, 274, 299 |
386 | Deucravacitinib | [1] Deucravacitinib Deucravacitinib | [1] D11817
D11817
| [1] TYK2 TYK2 💬 | [16] Coronavirus disease - COVID-19 Coronavirus disease - COVID-19, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Necroptosis, Osteoclast differentiation, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toxoplasmosis 💬 | [2] 96 96, 97 |
387 | DEXA scan | - | - | - | - | [3] 19 19, 46, 96 |
388 | Dexametasona | [1] Dexamethasone Dexamethasone | [9] D00292
D00292
,
D00975
,
D01510
,
D01615
,
D01632
,
D01948
,
D02174
,
D02591
,
D02592
| [1] NR3C1 NR3C1 💬 | [1] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | [1] 96 96 |
389 | Dexamethasone | [1] Dexamethasone Dexamethasone | [9] D00292
D00292
,
D00975
,
D01510
,
D01615
,
D01632
,
D01948
,
D02174
,
D02591
,
D02592
| [1] NR3C1 NR3C1 💬 | [1] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | [25] 13 13, 14, 16, 28, 35, 46, 53, 63, 64, 65, 70, 74, 75, 81, 84, 90, 96, 97, 162, 222, 235, 257, 283, 296, 299 |
390 | DEXAMETHASONE SODIUM PHOSPHATE | [2] Dexamethasone Dexamethasone, Phosphate ion | [9] D00292
D00292
,
D00975
,
D01510
,
D01615
,
D01632
,
D01948
,
D02174
,
D02591
,
D02592
| [1] NR3C1 NR3C1 💬 | [1] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | [3] 65 65, 70, 96 |
391 | Dexamethasone sodium phosphate 250 mg/ 10 ml | [2] Dexamethasone Dexamethasone, Phosphate ion | [9] D00292
D00292
,
D00975
,
D01510
,
D01615
,
D01632
,
D01948
,
D02174
,
D02591
,
D02592
| [1] NR3C1 NR3C1 💬 | [1] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | [1] 96 96 |
392 | Dextran | [1] Dextran Dextran | [1] D00060
D00060
| - | - | [5] 2 2, 62, 79, 96, 97 |
393 | Dextromethorphan | [1] Dextromethorphan Dextromethorphan | [3] D00848
D00848
,
D03742
,
D03744
| [6] GRIN1 GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D, SIGMAR1 💬 | [20] Alcoholism Alcoholism, Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Calcium signaling pathway, Circadian entrainment, Cocaine addiction, Dopaminergic synapse, Glutamatergic synapse, Huntington disease, Long-term potentiation, Neuroactive ligand-receptor interaction, Nicotine addiction, Pathways of neurodegeneration - multiple diseases, Prion disease, Rap1 signaling pathway, Ras signaling pathway, Spinocerebellar ataxia, Systemic lupus erythematosus, cAMP signaling pathway 💬 | [11] 2 2, 6, 8, 13, 21, 46, 78, 85, 96, 97, 156 |
394 | Dextromethorphan 30 mg | [1] Dextromethorphan Dextromethorphan | [3] D00848
D00848
,
D03742
,
D03744
| [6] GRIN1 GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D, SIGMAR1 💬 | [20] Alcoholism Alcoholism, Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Calcium signaling pathway, Circadian entrainment, Cocaine addiction, Dopaminergic synapse, Glutamatergic synapse, Huntington disease, Long-term potentiation, Neuroactive ligand-receptor interaction, Nicotine addiction, Pathways of neurodegeneration - multiple diseases, Prion disease, Rap1 signaling pathway, Ras signaling pathway, Spinocerebellar ataxia, Systemic lupus erythematosus, cAMP signaling pathway 💬 | [2] 96 96, 97 |
395 | DHEA | [1] Prasterone Prasterone | [1] D08409
D08409
| [3] AR AR, ESR1, ESR2 💬 | [12] Breast cancer Breast cancer, Chemical carcinogenesis - receptor activation, Endocrine and other factor-regulated calcium reabsorption, Endocrine resistance, Estrogen signaling pathway, GnRH secretion, Oocyte meiosis, Pathways in cancer, Prolactin signaling pathway, Prostate cancer, Proteoglycans in cancer, Thyroid hormone signaling pathway 💬 | [3] 49 49, 86, 96 |
396 | Diagnostic Test: 18F-FDG and 68Ga-FAPI PET/CT | [1] Fludeoxyglucose (18F) Fludeoxyglucose (18F) | - | - | - | [1] 96 96 |
397 | Diagnostic Test: serum leucine-rich alpha-2 glycoprotein (LRG) levels | [1] Leucine Leucine | [1] D00030
D00030
| - | - | [2] 96 96, 97 |
398 | Diet 1 | - | - | - | - | [1] 96 96 |
399 | Diet 2 | - | - | - | - | [1] 96 96 |
400 | Dietary therapy | - | - | - | - | [1] 96 96 |
401 | Diethyl-[6-(4-hydroxycarbamoyl-phenylcarbamoyloxymethyl)-naphtalen-2-ylmethyl]-ammonium chloride mon | [2] Ammonium chloride Ammonium chloride, Chloride ion | [1] D01139
D01139
| - | - | [1] 96 96 |
402 | Dietician designed diet | - | - | - | - | [1] 96 96 |
403 | Diflucan | [1] Fluconazole Fluconazole | [2] D00322
D00322
,
D01429
| - | - | [1] 96 96 |
404 | Diphenhydramine | [1] Diphenhydramine Diphenhydramine | [6] D00300
D00300
,
D00669
,
D02419
,
D03285
,
D03360
,
D03854
| [1] HRH1 HRH1 💬 | [3] Calcium signaling pathway Calcium signaling pathway, Inflammatory mediator regulation of TRP channels, Neuroactive ligand-receptor interaction 💬 | [10] 11 11, 13, 49, 51, 70, 86, 96, 222, 256, 300 |
405 | Dipyridamole | [1] Dipyridamole Dipyridamole | [1] D00302
D00302
| [2] PDE4A PDE4A, PDE5A 💬 | [6] Metabolic pathways Metabolic pathways, Morphine addiction, Parathyroid hormone synthesis, secretion and action, Purine metabolism, cAMP signaling pathway, cGMP-PKG signaling pathway 💬 | [6] 46 46, 49, 51, 66, 96, 224 |
406 | DLX105 | - | - | - | - | [1] 96 96 |
407 | Doxycycline | [1] Doxycycline Doxycycline | [5] D00307
D00307
,
D02129
,
D03903
,
D03904
,
D07876
| - | - | [16] 13 13, 23, 28, 46, 84, 85, 89, 96, 97, 158, 161, 162, 167, 227, 280, 299 |
408 | DOXYCYCLINE HYCLATE | [1] Doxycycline Doxycycline | [5] D00307
D00307
,
D02129
,
D03903
,
D03904
,
D07876
| - | - | [3] 23 23, 96, 227 |
409 | E-Device | - | - | - | - | [3] 46 46, 96, 271 |
410 | E6011 | - | - | - | - | [3] 46 46, 93, 96 |
411 | E6011 10 mg/kg | - | - | - | - | [1] 96 96 |
412 | E6011 15 mg/kg | - | - | - | - | [1] 96 96 |
413 | E6011 2 mg/kg | - | - | - | - | [1] 96 96 |
414 | E6011 5 mg/kg | - | - | - | - | [1] 96 96 |
415 | Early immunosuppressants (azathioprine, methotrexate) | [2] Azathioprine Azathioprine, Methotrexate | [4] D00142
D00142
,
D00238
,
D02115
,
D03033
| [2] DHFR DHFR, DHFR2 💬 | [5] Antifolate resistance Antifolate resistance, Biosynthesis of cofactors, Folate biosynthesis, Metabolic pathways, One carbon pool by folate 💬 | [1] 96 96 |
416 | EB8018 | - | - | - | - | [1] 96 96 |
417 | EB8018 (First-in-class FimH blocker) | - | - | - | - | [1] 96 96 |
418 | Ebetrex | - | - | - | - | [1] 96 96 |
419 | Ebetrex 15 mg = 0,75 ml, oplossing voor injectie in voorgevulde injectiespuit 20 mg/ml | - | - | - | - | [1] 96 96 |
420 | EEN | - | - | - | - | [1] 96 96 |
421 | EEN (Nestle Modulen®) | - | - | - | - | [1] 96 96 |
422 | EEN intervention group | - | - | - | - | [1] 96 96 |
423 | EFALIZUMAB | [1] Efalizumab Efalizumab | [1] D03959
D03959
| [1] ITGAL ITGAL 💬 | [12] Cell adhesion molecules Cell adhesion molecules, Epstein-Barr virus infection, Human T-cell leukemia virus 1 infection, Leukocyte transendothelial migration, Malaria, Natural killer cell mediated cytotoxicity, Neutrophil extracellular trap formation, Rap1 signaling pathway, Regulation of actin cytoskeleton, Rheumatoid arthritis, Staphylococcus aureus infection, Viral myocarditis 💬 | [8] 11 11, 13, 37, 46, 53, 61, 95, 96 |
424 | Efmarodocokin alfa | [1] Efmarodocokin alfa Efmarodocokin alfa | [1] D11953
D11953
| [1] IL22 IL22 💬 | [4] Cytokine-cytokine receptor interaction Cytokine-cytokine receptor interaction, Inflammatory bowel disease, JAK-STAT signaling pathway, Th17 cell differentiation 💬 | [2] 96 96, 97 |
425 | Egg | [1] Egg Egg | - | - | - | [2] 96 96, 310 |
426 | Egg Albumen Powder | [2] Egg Egg, Egg white | - | - | - | [1] 96 96 |
427 | Egg white | [2] Egg Egg, Egg white | - | - | - | [1] 96 96 |
428 | EGG WHITE PROTEIN | [2] Egg Egg, Egg white | - | - | - | [1] 96 96 |
429 | Eicosapentaenoic acid | [1] Icosapent Icosapent | [1] D08061
D08061
| - | - | [6] 49 49, 96, 97, 296, 297, 338 |
430 | EMEA/H/C/000240 | - | - | - | - | [2] 96 96, 97 |
431 | EMEA/H/C/002576 | - | - | - | - | [1] 96 96 |
432 | EMEA/H/C/002778 | - | - | - | - | [1] 96 96 |
433 | Empagliflozin | [1] Empagliflozin Empagliflozin | [1] D10459
D10459
| [1] SLC5A2 SLC5A2 💬 | - | [5] 65 65, 72, 96, 97, 257 |
434 | Endopath from Itamar medical - FDA approved device. | - | - | - | - | [1] 96 96 |
435 | Endoscopic balloon dilatation | - | - | - | - | [1] 96 96 |
436 | ENDOXAN | - | - | - | - | [7] 13 13, 28, 43, 44, 85, 96, 222 |
437 | ENDOXAN BAXTER | - | - | - | - | [3] 13 13, 43, 96 |
438 | Entecavir | [1] Entecavir Entecavir | [2] D04008
D04008
,
D07896
| - | - | [6] 46 46, 56, 96, 97, 107, 271 |
439 | Enteral nutrition | - | - | - | - | [1] 96 96 |
440 | Enteral nutrition. | - | - | - | - | [1] 96 96 |
441 | Entocort | - | - | - | - | [1] 96 96 |
442 | Entocort CR | [1] Budesonide Budesonide | [1] D00246
D00246
| [1] NR3C1 NR3C1 💬 | [1] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | [2] 96 96, 97 |
443 | Entocort® Kapseln | [1] Budesonide Budesonide | [1] D00246
D00246
| [1] NR3C1 NR3C1 💬 | [1] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | [1] 96 96 |
444 | Entyvio | [1] Vedolizumab Vedolizumab | [1] D08083
D08083
| [2] ITGA4 ITGA4, ITGB7 💬 | [15] Arrhythmogenic right ventricular cardiomyopathy Arrhythmogenic right ventricular cardiomyopathy, Cell adhesion molecules, Dilated cardiomyopathy, ECM-receptor interaction, Focal adhesion, Hematopoietic cell lineage, Human papillomavirus infection, Hypertrophic cardiomyopathy, Intestinal immune network for IgA production, Leishmaniasis, Leukocyte transendothelial migration, PI3K-Akt signaling pathway, Regulation of actin cytoskeleton, Transcriptional misregulation in cancer, Yersinia infection 💬 | [3] 94 94, 96, 97 |
445 | ENTYVIO - 300 MG - POLVERE PE RCONCENTRATO PER SOLUZIONE PER INFUSIONE - USO ENDOVENOSO - FLACONCINO (VETRO) (20ML) - 1 FLACONCINO | [1] Vedolizumab Vedolizumab | [1] D08083
D08083
| [2] ITGA4 ITGA4, ITGB7 💬 | [15] Arrhythmogenic right ventricular cardiomyopathy Arrhythmogenic right ventricular cardiomyopathy, Cell adhesion molecules, Dilated cardiomyopathy, ECM-receptor interaction, Focal adhesion, Hematopoietic cell lineage, Human papillomavirus infection, Hypertrophic cardiomyopathy, Intestinal immune network for IgA production, Leishmaniasis, Leukocyte transendothelial migration, PI3K-Akt signaling pathway, Regulation of actin cytoskeleton, Transcriptional misregulation in cancer, Yersinia infection 💬 | [2] 96 96, 97 |
446 | Epanova | [1] Omega-3-carboxylic acids Omega-3-carboxylic acids | - | - | - | [1] 96 96 |
447 | Epanova™ (Omega-3 Free Fatty Acids) | [1] Omega-3 fatty acids Omega-3 fatty acids | - | - | - | [1] 96 96 |
448 | Epaxal Berna (virosomal hepatitis A vaccine) | [1] Hepatitis A Vaccine Hepatitis A Vaccine | - | - | - | [2] 96 96, 97 |
449 | Epinephrine | [1] Epinephrine Epinephrine | [3] D00095
D00095
,
D00996
,
D02149
| [9] ADRA1A ADRA1A, ADRA1B, ADRA1D, ADRA2A, ADRA2B, ADRA2C, ADRB1, ADRB2, ADRB3 💬 | [14] AMPK signaling pathway AMPK signaling pathway, Adrenergic signaling in cardiomyocytes, Calcium signaling pathway, Chemical carcinogenesis - receptor activation, Dilated cardiomyopathy, Gap junction, Neuroactive ligand-receptor interaction, Regulation of lipolysis in adipocytes, Renin secretion, Salivary secretion, Thermogenesis, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬 | [3] 46 46, 70, 96 |
450 | ERB-041 | - | - | - | - | [3] 46 46, 96, 226 |
451 | Ergocalciferol | [1] Ergocalciferol Ergocalciferol | [1] D00187
D00187
| [1] VDR VDR 💬 | [5] Chemical carcinogenesis - receptor activation Chemical carcinogenesis - receptor activation, Endocrine and other factor-regulated calcium reabsorption, Mineral absorption, Parathyroid hormone synthesis, secretion and action, Tuberculosis 💬 | [5] 46 46, 84, 96, 97, 299 |
452 | ERY-DEX | - | - | - | - | [1] 96 96 |
453 | ERYTHROPOIETIN | [1] Erythropoietin Erythropoietin | [1] D03231
D03231
| [1] EPOR EPOR 💬 | [5] Cytokine-cytokine receptor interaction Cytokine-cytokine receptor interaction, Hematopoietic cell lineage, JAK-STAT signaling pathway, PI3K-Akt signaling pathway, Pathways in cancer 💬 | [9] 2 2, 6, 13, 18, 22, 47, 70, 95, 96 |
454 | Eskazole | [1] Albendazole Albendazole | [1] D00134
D00134
| - | - | [1] 96 96 |
455 | Etiprednol dicloacetate | [1] Etiprednol dicloacetate Etiprednol dicloacetate | [1] D04100
D04100
| - | - | [1] 96 96 |
456 | Etrasimod | [1] Etrasimod Etrasimod | [1] D10930
D10930
| [5] S1PR1 S1PR1, S1PR2, S1PR3, S1PR4, S1PR5 💬 | [3] FoxO signaling pathway FoxO signaling pathway, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway 💬 | [3] 96 96, 97, 98 |
457 | Etrasimod L-arginine | [2] Arginine Arginine, Etrasimod | [2] D02982
D02982
,
D10930
| [5] S1PR1 S1PR1, S1PR2, S1PR3, S1PR4, S1PR5 💬 | [3] FoxO signaling pathway FoxO signaling pathway, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway 💬 | [3] 96 96, 97, 98 |
458 | ETROLIZUMAB | [1] Etrolizumab Etrolizumab | [1] D09901
D09901
| [1] ITGB7 ITGB7 💬 | [11] Arrhythmogenic right ventricular cardiomyopathy Arrhythmogenic right ventricular cardiomyopathy, Cell adhesion molecules, Dilated cardiomyopathy, ECM-receptor interaction, Focal adhesion, Human papillomavirus infection, Hypertrophic cardiomyopathy, Intestinal immune network for IgA production, PI3K-Akt signaling pathway, Regulation of actin cytoskeleton, Transcriptional misregulation in cancer 💬 | [2] 96 96, 97 |
459 | EU/1/03/268/002 | - | - | - | - | [1] 96 96 |
460 | EU/1/99/116/003 | - | - | - | - | [1] 96 96 |
461 | EUA with seton placement if necessary | - | - | - | - | [1] 96 96 |
462 | EUS | - | - | - | - | [1] 96 96 |
463 | Evaluation of biological predictive factors of clinical response to ustekinumab | [1] Ustekinumab Ustekinumab | [1] D09214
D09214
| [3] IL12A IL12A, IL12B, IL23A 💬 | [28] African trypanosomiasis African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Amoebiasis, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Herpes simplex virus 1 infection, Inflammatory bowel disease, Influenza A, JAK-STAT signaling pathway, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, Malaria, Measles, Pathways in cancer, Pertussis, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus 💬 | [1] 96 96 |
464 | Everolimus | [1] Everolimus Everolimus | [1] D02714
D02714
| [1] MTOR MTOR 💬 | [51] AMPK signaling pathway AMPK signaling pathway, Acute myeloid leukemia, Adipocytokine signaling pathway, Alzheimer disease, Amyotrophic lateral sclerosis, Apelin signaling pathway, Autophagy - animal, Autophagy - other, Breast cancer, Cellular senescence, Central carbon metabolism in cancer, Chemical carcinogenesis - receptor activation, Choline metabolism in cancer, Colorectal cancer, Diabetic cardiomyopathy, EGFR tyrosine kinase inhibitor resistance, Endocrine resistance, ErbB signaling pathway, Gastric cancer, Glioma, Growth hormone synthesis, secretion and action, HIF-1 signaling pathway, Hepatocellular carcinoma, Herpes simplex virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Huntington disease, Insulin resistance, Insulin signaling pathway, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Longevity regulating pathway, Longevity regulating pathway - multiple species, MicroRNAs in cancer, Neutrophil extracellular trap formation, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Phospholipase D signaling pathway, Prostate cancer, Proteoglycans in cancer, Shigellosis, Spinocerebellar ataxia, Th17 cell differentiation, Thermogenesis, Thyroid hormone signaling pathway, Type II diabetes mellitus, mTOR signaling pathway 💬 | [9] 34 34, 67, 89, 96, 137, 157, 158, 228, 277 |
465 | Exclusive Enteral Nutrition | - | - | - | - | [1] 96 96 |
466 | Exclusive Enteral Nutrition Therapy | - | - | - | - | [1] 96 96 |
467 | Expanded allogenic adipose-derived adult stem cells | - | - | - | - | [1] 96 96 |
468 | Expanded autologous adipose-derived adult stem cells (eASCs) | - | - | - | - | [1] 96 96 |
469 | Expanded human allogenic mesemchymal adult stem cells extracted from adipose tissue (eASCs) | - | - | - | - | [1] 96 96 |
470 | Expanded human allogenic mesenchymal adult stem cells extractd from adipose tissue (eASCs) | - | - | - | - | [1] 96 96 |
471 | Expanded human allogenic mesenchymal adult stem cells extracted from adipose | - | - | - | - | [1] 96 96 |
472 | Expanded human allogenic mesenchymal adult stem cells extracted from adipose tissue | - | - | - | - | [1] 96 96 |
473 | Expanded human allogenic mesenchymal adult stem cells extracted from adipose tissue (eASCs | - | - | - | - | [1] 96 96 |
474 | Expanded human allogenic mesenchymal adult stem cells extracted from adipose tissue (eASCs) | - | - | - | - | [1] 96 96 |
475 | Extracorporeal Photopheresis | - | - | - | - | [3] 13 13, 46, 96 |
476 | Faecal microbiota transplantation | - | - | - | - | [5] 46 46, 84, 96, 97, 271 |
477 | FE 999301 | - | - | - | - | [2] 96 96, 97 |
478 | Fecal Microbial transplant | - | - | - | - | [2] 96 96, 97 |
479 | Fecal Microbial Transplantation | - | - | - | - | [2] 96 96, 97 |
480 | Fecal microbiota | - | - | - | - | [3] 13 13, 96, 97 |
481 | Fecal Microbiota Transplant | - | - | - | - | [2] 96 96, 97 |
482 | Fecal Microbiota Transplant (FMT) | - | - | - | - | [2] 96 96, 97 |
483 | Fecal microbiota transplantation | - | - | - | - | [5] 2 2, 66, 94, 96, 97 |
484 | Fecal Microbiota Transplantation (FMT) | - | - | - | - | [2] 96 96, 97 |
485 | Ferric Carboxy Maltose | [1] Maltose Maltose | [1] D00044
D00044
| - | - | [1] 96 96 |
486 | FERRIC CARBOXYMALTOSE | [1] Ferric carboxymaltose Ferric carboxymaltose | [1] D08920
D08920
| - | - | [4] 86 86, 96, 97, 299 |
487 | Ferric Maltol | [1] Ferric maltol Ferric maltol | [1] D10833
D10833
| - | - | [1] 96 96 |
488 | Ferrous sulphate | - | - | - | - | [2] 96 96, 97 |
489 | FFP104 | - | - | - | - | [2] 93 93, 96 |
490 | Fibrin | [1] Fibrin Fibrin | - | - | - | [1] 96 96 |
491 | Fibrin glue injection in fistula | [1] Fibrin Fibrin | - | - | - | [1] 96 96 |
492 | FILGOTINIB | [1] Filgotinib Filgotinib | [1] D10871
D10871
| [1] JAK1 JAK1 💬 | [27] Coronavirus disease - COVID-19 Coronavirus disease - COVID-19, EGFR tyrosine kinase inhibitor resistance, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Measles, NOD-like receptor signaling pathway, Necroptosis, Osteoclast differentiation, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Pathways in cancer, Signaling pathways regulating pluripotency of stem cells, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toxoplasmosis, Tuberculosis, Viral carcinogenesis 💬 | [6] 46 46, 53, 96, 97, 222, 271 |
493 | Filgrastim | [1] Filgrastim Filgrastim | [1] D03235
D03235
| [1] CSF3R CSF3R 💬 | [5] Cytokine-cytokine receptor interaction Cytokine-cytokine receptor interaction, Hematopoietic cell lineage, JAK-STAT signaling pathway, PI3K-Akt signaling pathway, Pathways in cancer 💬 | [28] 2 2, 6, 13, 25, 26, 28, 34, 35, 38, 40, 41, 42, 45, 46, 49, 51, 60, 62, 65, 96, 113, 164, 256, 283, 284, 285, 296, 331 |
494 | Fish Oil | [1] Fish oil Fish oil | - | - | - | [7] 13 13, 46, 49, 66, 96, 260, 299 |
495 | FITC-Adalimumab | [1] Adalimumab Adalimumab | [1] D02597
D02597
| [1] TNF TNF 💬 | [67] AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | [2] 96 96, 97 |
496 | Flagyl | [1] Metronidazole Metronidazole | [3] D00409
D00409
,
D05016
,
D05017
| - | - | [2] 96 96, 97 |
497 | Flixabi | [1] Infliximab Infliximab | [1] D02598
D02598
| [1] TNF TNF 💬 | [67] AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | [2] 96 96, 97 |
498 | FLUCONAZOLE | [1] Fluconazole Fluconazole | [2] D00322
D00322
,
D01429
| - | - | [2] 96 96, 225 |
499 | Fludarabine | [1] Fludarabine Fludarabine | [2] D01907
D01907
,
D07966
| [1] RRM1 RRM1 💬 | [5] Drug metabolism - other enzymes Drug metabolism - other enzymes, Glutathione metabolism, Metabolic pathways, Purine metabolism, Pyrimidine metabolism 💬 | [18] 13 13, 28, 36, 46, 49, 51, 60, 61, 62, 65, 85, 96, 164, 283, 284, 285, 286, 326 |
500 | Fludarabine phosphate | [2] Fludarabine Fludarabine, Phosphate ion | [2] D01907
D01907
,
D07966
| [1] RRM1 RRM1 💬 | [5] Drug metabolism - other enzymes Drug metabolism - other enzymes, Glutathione metabolism, Metabolic pathways, Purine metabolism, Pyrimidine metabolism 💬 | [12] 28 28, 36, 49, 51, 60, 62, 65, 96, 283, 284, 285, 286 |
501 | Fluorescence endoscopy and spectroscopy | - | - | - | - | [1] 96 96 |
502 | FMT | - | - | - | - | [2] 96 96, 97 |
503 | FolateScan (Technetium Tc 99mEC20) | - | - | - | - | [4] 13 13, 46, 49, 96 |
504 | Foralumab | [1] Foralumab Foralumab | - | - | - | [2] 13 13, 96 |
505 | FOS | - | - | - | - | [2] 66 66, 96 |
506 | Fosfato sodico de dexametasona | [1] Dexamethasone Dexamethasone | [9] D00292
D00292
,
D00975
,
D01510
,
D01615
,
D01632
,
D01948
,
D02174
,
D02591
,
D02592
| [1] NR3C1 NR3C1 💬 | [1] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | [1] 96 96 |
507 | Fosfomycin | [1] Fosfomycin Fosfomycin | [4] D00925
D00925
,
D02187
,
D02188
,
D04253
| - | - | [2] 96 96, 97 |
508 | Fully humanised, recombinant monoclonal antibody (IgG1) | - | - | - | - | [1] 96 96 |
509 | G-CSF | [1] Filgrastim Filgrastim | [1] D03235
D03235
| [1] CSF3R CSF3R 💬 | [5] Cytokine-cytokine receptor interaction Cytokine-cytokine receptor interaction, Hematopoietic cell lineage, JAK-STAT signaling pathway, PI3K-Akt signaling pathway, Pathways in cancer 💬 | [16] 2 2, 6, 11, 13, 16, 47, 49, 51, 60, 62, 65, 85, 96, 284, 285, 331 |
510 | G321605 | - | - | - | - | [3] 85 85, 96, 97 |
511 | GED-0301 | - | - | - | - | [2] 96 96, 97 |
512 | Genetic: genetic analysis | - | - | - | - | [1] 96 96 |
513 | Genetic: TPMT genotyping | - | - | - | - | [2] 96 96, 97 |
514 | Glatiramer | [1] Glatiramer Glatiramer | [1] D04318
D04318
| [20] HLA-A HLA-A, HLA-B, HLA-C, HLA-DMA, HLA-DMB, HLA-DOA, HLA-DOB, HLA-DPA1, HLA-DPB1, HLA-DQA1, HLA-DQA2, HLA-DQB1, HLA-DRA, HLA-DRB1, HLA-DRB3, HLA-DRB4, HLA-DRB5, HLA-E, HLA-F, HLA-G 💬 | [32] Allograft rejection Allograft rejection, Antigen processing and presentation, Asthma, Autoimmune thyroid disease, Cell adhesion molecules, Cellular senescence, Endocytosis, Epstein-Barr virus infection, Graft-versus-host disease, Hematopoietic cell lineage, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Inflammatory bowel disease, Influenza A, Intestinal immune network for IgA production, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Natural killer cell mediated cytotoxicity, Phagosome, Rheumatoid arthritis, Staphylococcus aureus infection, Systemic lupus erythematosus, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Viral carcinogenesis, Viral myocarditis 💬 | [4] 2 2, 13, 96, 156 |
515 | GLATIRAMER ACETATE | [2] Acetate Acetate, Glatiramer | [1] D04318
D04318
| [20] HLA-A HLA-A, HLA-B, HLA-C, HLA-DMA, HLA-DMB, HLA-DOA, HLA-DOB, HLA-DPA1, HLA-DPB1, HLA-DQA1, HLA-DQA2, HLA-DQB1, HLA-DRA, HLA-DRB1, HLA-DRB3, HLA-DRB4, HLA-DRB5, HLA-E, HLA-F, HLA-G 💬 | [32] Allograft rejection Allograft rejection, Antigen processing and presentation, Asthma, Autoimmune thyroid disease, Cell adhesion molecules, Cellular senescence, Endocytosis, Epstein-Barr virus infection, Graft-versus-host disease, Hematopoietic cell lineage, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Inflammatory bowel disease, Influenza A, Intestinal immune network for IgA production, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Natural killer cell mediated cytotoxicity, Phagosome, Rheumatoid arthritis, Staphylococcus aureus infection, Systemic lupus erythematosus, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Viral carcinogenesis, Viral myocarditis 💬 | [3] 13 13, 96, 156 |
516 | GLPG0634 | - | - | - | - | [3] 46 46, 96, 271 |
517 | GLPG1205 | - | - | - | - | [3] 85 85, 96, 97 |
518 | Glucose | [1] Dextrose, unspecified form Dextrose, unspecified form | - | - | - | [15] 2 2, 6, 13, 49, 50, 65, 75, 86, 88, 96, 160, 195, 254, 257, 299 |
519 | Glutamine | [1] L-Glutamine L-Glutamine | [1] D00015
D00015
| - | - | [7] 87 87, 89, 96, 97, 113, 245, 299 |
520 | Gold | [1] Gold Gold | - | - | - | [43] 2 2, 5, 6, 13, 17, 34, 35, 46, 49, 50, 53, 58, 65, 68, 76, 84, 86, 91, 93, 95, 96, 97, 98, 113, 137, 158, 162, 171, 193, 218, 222, 224, 227, 230, 235, 271, 291, 294, 296, 298, 299, 310, 318 |
521 | GOLIMUMAB | [1] Golimumab Golimumab | [1] D04358
D04358
| [1] TNF TNF 💬 | [67] AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | [8] 46 46, 56, 84, 96, 97, 107, 270, 271 |
522 | Green Tea | [1] Green tea leaf Green tea leaf | [1] D06903
D06903
| - | - | [5] 6 6, 17, 28, 46, 96 |
523 | Group 2 ustekinumab 130 mg | [1] Ustekinumab Ustekinumab | [1] D09214
D09214
| [3] IL12A IL12A, IL12B, IL23A 💬 | [28] African trypanosomiasis African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Amoebiasis, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Herpes simplex virus 1 infection, Inflammatory bowel disease, Influenza A, JAK-STAT signaling pathway, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, Malaria, Measles, Pathways in cancer, Pertussis, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus 💬 | [1] 96 96 |
524 | Group 3: ustekinumab approximately 6 mg/kg | [1] Ustekinumab Ustekinumab | [1] D09214
D09214
| [3] IL12A IL12A, IL12B, IL23A 💬 | [28] African trypanosomiasis African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Amoebiasis, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Herpes simplex virus 1 infection, Inflammatory bowel disease, Influenza A, JAK-STAT signaling pathway, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, Malaria, Measles, Pathways in cancer, Pertussis, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus 💬 | [1] 96 96 |
525 | Growth hormone | [1] Somatotropin Somatotropin | [1] D02691
D02691
| [1] GHR GHR 💬 | [5] Cytokine-cytokine receptor interaction Cytokine-cytokine receptor interaction, Growth hormone synthesis, secretion and action, JAK-STAT signaling pathway, Neuroactive ligand-receptor interaction, PI3K-Akt signaling pathway 💬 | [13] 2 2, 13, 19, 46, 78, 96, 107, 187, 191, 193, 195, 265, 299 |
526 | GS-5745 | [1] GS-5745 GS-5745 | - | - | - | [4] 46 46, 96, 97, 299 |
527 | GS-6034 | - | - | - | - | [4] 46 46, 53, 96, 97 |
528 | GSK1070806 | - | - | - | - | [2] 56 56, 96 |
529 | GSK1605786 | - | - | - | - | [2] 96 96, 97 |
530 | GSK1605786 500 mg | - | - | - | - | [1] 96 96 |
531 | GSK1605786 capsule | - | - | - | - | [1] 96 96 |
532 | GSK1605786 ChemoCentryx: formulation A | - | - | - | - | [1] 96 96 |
533 | GSK1605786 GSK direct-fill: formulation C | - | - | - | - | [1] 96 96 |
534 | GSK1605786 GSK modified-process: formulation D | - | - | - | - | [1] 96 96 |
535 | GSK1605786 GSK tablet: formulation E | - | - | - | - | [1] 96 96 |
536 | GSK1605786 GSK: formulation B | - | - | - | - | [1] 96 96 |
537 | GSK1605786A | - | - | - | - | [2] 96 96, 97 |
538 | GSK2330811 | - | - | - | - | [2] 51 51, 96 |
539 | GUSELKUMAB | [1] Guselkumab Guselkumab | [1] D10438
D10438
| [1] IL23A IL23A 💬 | [9] C-type lectin receptor signaling pathway C-type lectin receptor signaling pathway, Cytokine-cytokine receptor interaction, Inflammatory bowel disease, JAK-STAT signaling pathway, Pathways in cancer, Pertussis, Rheumatoid arthritis, Th17 cell differentiation, Tuberculosis 💬 | [5] 37 37, 41, 51, 96, 97 |
540 | Guselkumab Dose 1 | [1] Guselkumab Guselkumab | [1] D10438
D10438
| [1] IL23A IL23A 💬 | [9] C-type lectin receptor signaling pathway C-type lectin receptor signaling pathway, Cytokine-cytokine receptor interaction, Inflammatory bowel disease, JAK-STAT signaling pathway, Pathways in cancer, Pertussis, Rheumatoid arthritis, Th17 cell differentiation, Tuberculosis 💬 | [3] 51 51, 96, 97 |
541 | Guselkumab Dose 2 | [1] Guselkumab Guselkumab | [1] D10438
D10438
| [1] IL23A IL23A 💬 | [9] C-type lectin receptor signaling pathway C-type lectin receptor signaling pathway, Cytokine-cytokine receptor interaction, Inflammatory bowel disease, JAK-STAT signaling pathway, Pathways in cancer, Pertussis, Rheumatoid arthritis, Th17 cell differentiation, Tuberculosis 💬 | [3] 51 51, 96, 97 |
542 | Guselkumab Dose 3 | [1] Guselkumab Guselkumab | [1] D10438
D10438
| [1] IL23A IL23A 💬 | [9] C-type lectin receptor signaling pathway C-type lectin receptor signaling pathway, Cytokine-cytokine receptor interaction, Inflammatory bowel disease, JAK-STAT signaling pathway, Pathways in cancer, Pertussis, Rheumatoid arthritis, Th17 cell differentiation, Tuberculosis 💬 | [1] 96 96 |
543 | Guselkumab Dose 4 | [1] Guselkumab Guselkumab | [1] D10438
D10438
| [1] IL23A IL23A 💬 | [9] C-type lectin receptor signaling pathway C-type lectin receptor signaling pathway, Cytokine-cytokine receptor interaction, Inflammatory bowel disease, JAK-STAT signaling pathway, Pathways in cancer, Pertussis, Rheumatoid arthritis, Th17 cell differentiation, Tuberculosis 💬 | [1] 96 96 |
544 | Guselkumab Dose 5 | [1] Guselkumab Guselkumab | [1] D10438
D10438
| [1] IL23A IL23A 💬 | [9] C-type lectin receptor signaling pathway C-type lectin receptor signaling pathway, Cytokine-cytokine receptor interaction, Inflammatory bowel disease, JAK-STAT signaling pathway, Pathways in cancer, Pertussis, Rheumatoid arthritis, Th17 cell differentiation, Tuberculosis 💬 | [1] 96 96 |
545 | Hematopoietic Stem Cell Transplantation | - | - | - | - | [13] 11 11, 13, 14, 19, 20, 35, 46, 49, 51, 65, 96, 234, 285 |
546 | Hepatitis A Vaccine | [1] Hepatitis A Vaccine Hepatitis A Vaccine | - | - | - | [3] 46 46, 96, 97 |
547 | Herpes Zoster Vaccine | - | - | - | - | [3] 46 46, 96, 271 |
548 | Hextend | [1] Hydroxyethyl Starch Hydroxyethyl Starch | [1] D03335
D03335
| - | - | [2] 96 96, 97 |
549 | High dose TSO | - | - | - | - | [1] 96 96 |
550 | High Oligosaccharide Group | - | - | - | - | [1] 96 96 |
551 | High serine diet | [1] Serine Serine | [1] D00016
D00016
| - | - | [1] 96 96 |
552 | High-dose Cyclophosphamide | [1] Cyclophosphamide Cyclophosphamide | [2] D00287
D00287
,
D07760
| - | - | [1] 96 96 |
553 | HM201 | - | - | - | - | [2] 96 96, 97 |
554 | HMPL-004 | - | - | - | - | [2] 96 96, 97 |
555 | HMPL004-6599 | - | - | - | - | [2] 96 96, 97 |
556 | Hulio | [1] Adalimumab Adalimumab | [1] D02597
D02597
| [1] TNF TNF 💬 | [67] AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | [2] 96 96, 97 |
557 | HuM291 | - | - | - | - | [2] 96 96, 97 |
558 | Human albumin | [1] Albumin human Albumin human | [2] D02792
D02792
,
D05424
| - | - | [2] 2 2, 96 |
559 | HUMAN ALBUMIN AS MACROAGGREGATES | [1] Albumin human Albumin human | [2] D02792
D02792
,
D05424
| - | - | [1] 96 96 |
560 | Human Anti-IL-12 Antibody | - | - | - | - | [1] 96 96 |
561 | Human anti-IP10 monoclonal antibody | - | - | - | - | [2] 96 96, 97 |
562 | Human insulin | [1] Insulin human Insulin human | [2] D00085
D00085
,
D03230
| [1] INSR INSR 💬 | [22] AMPK signaling pathway AMPK signaling pathway, Adherens junction, Aldosterone-regulated sodium reabsorption, Alzheimer disease, Diabetic cardiomyopathy, FoxO signaling pathway, HIF-1 signaling pathway, Insulin resistance, Insulin signaling pathway, Longevity regulating pathway, Longevity regulating pathway - multiple species, MAPK signaling pathway, Non-alcoholic fatty liver disease, Ovarian steroidogenesis, PI3K-Akt signaling pathway, Phospholipase D signaling pathway, Rap1 signaling pathway, Ras signaling pathway, Regulation of lipolysis in adipocytes, Type II diabetes mellitus, cGMP-PKG signaling pathway, mTOR signaling pathway 💬 | [2] 96 96, 156 |
563 | Human Monoclonal Antibody (CNTO 1275) to Interleukin 12p-40 | - | - | - | - | [1] 96 96 |
564 | Human Placenta-Derived Cells PDA001 Intravenous Infusion | - | - | - | - | [1] 96 96 |
565 | HUMAN PLASMA FOR FRACTIONATION | - | - | - | - | [1] 96 96 |
566 | Human Umbilical Cord Mesenchymal Stem Cells | [1] Human Umbilical Cord Mesenchymal Stem Cells Human Umbilical Cord Mesenchymal Stem Cells | - | - | - | [3] 13 13, 96, 113 |
567 | Human umbilical cord mesenchymal stem cells (UC-MSCs) | [1] Human Umbilical Cord Mesenchymal Stem Cells Human Umbilical Cord Mesenchymal Stem Cells | - | - | - | [1] 96 96 |
568 | HUMIRA | - | - | - | - | [9] 46 46, 56, 84, 96, 97, 107, 160, 269, 271 |
569 | Humira (adalimumab original) | [1] Adalimumab Adalimumab | [1] D02597
D02597
| [1] TNF TNF 💬 | [67] AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | [2] 96 96, 97 |
570 | HUMIRA (ADALIMUMAB) | [1] Adalimumab Adalimumab | [1] D02597
D02597
| [1] TNF TNF 💬 | [67] AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | [2] 46 46, 96 |
571 | HUMIRA - 40MG/0.8ML SOLUZ. INIETTABILE- USO SOTTOCUTANEO-FLACONCINO(VETRO) 0.8ML 2 ASTUCCI:1 FLACONCINO+1SIRINGA+1AGO+1ADATT.STERILE-2TAMPONI IMBEVUTI ALCOOL | - | - | - | - | [2] 46 46, 96 |
572 | Humira 20 mg solution for injection in pre-filled syringe | [1] Adalimumab Adalimumab | [1] D02597
D02597
| [1] TNF TNF 💬 | [67] AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | [1] 96 96 |
573 | Humira 40 mg injekcní roztok v predplnené injekcní stríkacce | [1] Adalimumab Adalimumab | [1] D02597
D02597
| [1] TNF TNF 💬 | [67] AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | [1] 96 96 |
574 | HUMIRA 40 mg solución inyectable en jeringa precargada | [1] Adalimumab Adalimumab | [1] D02597
D02597
| [1] TNF TNF 💬 | [67] AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | [2] 46 46, 96 |
575 | Humira 40 mg solution for injection in pre-filled pen | [1] Adalimumab Adalimumab | [1] D02597
D02597
| [1] TNF TNF 💬 | [67] AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | [1] 96 96 |
576 | Humira 40 mg solution for injection in pre-filled syringe | [1] Adalimumab Adalimumab | [1] D02597
D02597
| [1] TNF TNF 💬 | [67] AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | [3] 46 46, 96, 97 |
577 | Humira 40 mg/0.8 ml solution for injection | [1] Adalimumab Adalimumab | [1] D02597
D02597
| [1] TNF TNF 💬 | [67] AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | [4] 46 46, 96, 97, 271 |
578 | HUMIRA 40Mg Solution for Injection | - | - | - | - | [2] 96 96, 97 |
579 | Humira 40mg/0.4ml pre-filled syringe | [1] Adalimumab Adalimumab | [1] D02597
D02597
| [1] TNF TNF 💬 | [67] AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | [1] 96 96 |
580 | Humira 40mg/0.8ml solution for injection for paediatric use | [1] Adalimumab Adalimumab | [1] D02597
D02597
| [1] TNF TNF 💬 | [67] AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | [1] 96 96 |
581 | Humira pre-filled PEN | - | - | - | - | [1] 96 96 |
582 | HUMIRA ® | [1] Adalimumab Adalimumab | [1] D02597
D02597
| [1] TNF TNF 💬 | [67] AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | [2] 96 96, 97 |
583 | HUMIRA*SC 2SIR+F 40MG 0,8ML+2T | [1] Adalimumab Adalimumab | [1] D02597
D02597
| [1] TNF TNF 💬 | [67] AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | [2] 46 46, 96 |
584 | Humira® | - | - | - | - | [5] 46 46, 96, 97, 107, 271 |
585 | Hydroxide | [1] Hydroxide ion Hydroxide ion | - | - | - | [5] 11 11, 46, 96, 97, 284 |
586 | Hydroxychloroquine | [1] Hydroxychloroquine Hydroxychloroquine | [1] D08050
D08050
| - | - | [27] 13 13, 34, 41, 43, 44, 45, 46, 48, 49, 53, 56, 63, 66, 84, 89, 90, 96, 97, 107, 218, 222, 224, 234, 254, 271, 298, 299 |
587 | HYDROXYCHLOROQUINE SULPHATE | [1] Hydroxychloroquine Hydroxychloroquine | [1] D08050
D08050
| - | - | [1] 96 96 |
588 | ICG-guided bowel perfusion assessment | - | - | - | - | [1] 96 96 |
589 | IGG2 ANTIBODIES | - | - | - | - | [1] 96 96 |
590 | IL-2 | [1] Human interleukin-2 Human interleukin-2 | - | - | - | [7] 2 2, 46, 49, 53, 56, 96, 107 |
591 | IL-22Fc | [1] Efmarodocokin alfa Efmarodocokin alfa | [1] D11953
D11953
| [1] IL22 IL22 💬 | [4] Cytokine-cytokine receptor interaction Cytokine-cytokine receptor interaction, Inflammatory bowel disease, JAK-STAT signaling pathway, Th17 cell differentiation 💬 | [2] 96 96, 97 |
592 | Ileocecal resection | - | - | - | - | [1] 96 96 |
593 | Ileocolonoscopy | - | - | - | - | [1] 96 96 |
594 | IM90838 | - | - | - | - | [3] 13 13, 96, 97 |
595 | Immune Ablation and Hematopoietic Stem Cell Support | - | - | - | - | [1] 96 96 |
596 | Immunonutrition | - | - | - | - | [1] 96 96 |
597 | Immunosuppressor/TNFalpha | - | - | - | - | [1] 96 96 |
598 | Immunosuppressors (Thiopurines or Methotrexate) | [1] Methotrexate Methotrexate | [2] D00142
D00142
,
D02115
| [2] DHFR DHFR, DHFR2 💬 | [5] Antifolate resistance Antifolate resistance, Biosynthesis of cofactors, Folate biosynthesis, Metabolic pathways, One carbon pool by folate 💬 | [1] 96 96 |
599 | IMP will be labeled as ''PF-04236921 106mg/vial, Clonal SC lyophilized form''. | - | - | - | - | [1] 96 96 |
600 | IMP will be labeled as PF-04236921 106mg/vial, Clonal SC lyophilized form | - | - | - | - | [1] 96 96 |
601 | Impact | - | - | - | - | [8] 6 6, 13, 46, 50, 53, 96, 97, 299 |
602 | Imraldi | [1] Adalimumab Adalimumab | [1] D02597
D02597
| [1] TNF TNF 💬 | [67] AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | [1] 96 96 |
603 | IMU-838 | - | - | - | - | [3] 13 13, 96, 97 |
604 | Imuran | [1] Azathioprine Azathioprine | [2] D00238
D00238
,
D03033
| - | - | [2] 96 96, 97 |
605 | IMUREL | - | - | - | - | [4] 13 13, 46, 96, 97 |
606 | Imurel 25 mg | - | - | - | - | [1] 96 96 |
607 | Increlex | [1] Mecasermin Mecasermin | [2] D03297
D03297
,
D04870
| [2] GHR GHR, IGF1R 💬 | [33] AMPK signaling pathway AMPK signaling pathway, Adherens junction, Autophagy - animal, Breast cancer, Cytokine-cytokine receptor interaction, EGFR tyrosine kinase inhibitor resistance, Endocrine resistance, Endocytosis, Focal adhesion, FoxO signaling pathway, Glioma, Growth hormone synthesis, secretion and action, HIF-1 signaling pathway, Hepatocellular carcinoma, JAK-STAT signaling pathway, Long-term depression, Longevity regulating pathway, Longevity regulating pathway - multiple species, MAPK signaling pathway, Melanoma, Neuroactive ligand-receptor interaction, Oocyte meiosis, Ovarian steroidogenesis, PI3K-Akt signaling pathway, Pathways in cancer, Progesterone-mediated oocyte maturation, Prostate cancer, Proteoglycans in cancer, Rap1 signaling pathway, Ras signaling pathway, Signaling pathways regulating pluripotency of stem cells, Transcriptional misregulation in cancer, mTOR signaling pathway 💬 | [4] 65 65, 78, 96, 299 |
608 | Increlex 10mg/ml solution for injection | [1] Mecasermin Mecasermin | [2] D03297
D03297
,
D04870
| [2] GHR GHR, IGF1R 💬 | [33] AMPK signaling pathway AMPK signaling pathway, Adherens junction, Autophagy - animal, Breast cancer, Cytokine-cytokine receptor interaction, EGFR tyrosine kinase inhibitor resistance, Endocrine resistance, Endocytosis, Focal adhesion, FoxO signaling pathway, Glioma, Growth hormone synthesis, secretion and action, HIF-1 signaling pathway, Hepatocellular carcinoma, JAK-STAT signaling pathway, Long-term depression, Longevity regulating pathway, Longevity regulating pathway - multiple species, MAPK signaling pathway, Melanoma, Neuroactive ligand-receptor interaction, Oocyte meiosis, Ovarian steroidogenesis, PI3K-Akt signaling pathway, Pathways in cancer, Progesterone-mediated oocyte maturation, Prostate cancer, Proteoglycans in cancer, Rap1 signaling pathway, Ras signaling pathway, Signaling pathways regulating pluripotency of stem cells, Transcriptional misregulation in cancer, mTOR signaling pathway 💬 | [1] 96 96 |
609 | Indocyanine green | [1] Indocyanine green Indocyanine green | [1] D01342
D01342
| - | - | [8] 22 22, 46, 51, 96, 235, 278, 291, 296 |
610 | INFLECTRA | [1] Infliximab Infliximab | [1] D02598
D02598
| [1] TNF TNF 💬 | [67] AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | [3] 56 56, 96, 97 |
611 | Inflectra 100 mg powder for concentrate for solution for infusion | [1] Infliximab Infliximab | [1] D02598
D02598
| [1] TNF TNF 💬 | [67] AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | [2] 96 96, 97 |
612 | Infliximab | [1] Infliximab Infliximab | [1] D02598
D02598
| [1] TNF TNF 💬 | [67] AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | [26] 35 35, 37, 38, 39, 40, 41, 42, 43, 45, 46, 49, 50, 55, 56, 65, 84, 95, 96, 97, 98, 107, 162, 164, 269, 270, 271 |
613 | Infliximab (IFX alone) | [1] Infliximab Infliximab | [1] D02598
D02598
| [1] TNF TNF 💬 | [67] AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | [1] 96 96 |
614 | Infliximab (Remicade) | [1] Infliximab Infliximab | [1] D02598
D02598
| [1] TNF TNF 💬 | [67] AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | [3] 46 46, 96, 271 |
615 | Infliximab (Remicade): 100 mg of lyophilized infliximab | [1] Infliximab Infliximab | [1] D02598
D02598
| [1] TNF TNF 💬 | [67] AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | [1] 96 96 |
616 | Infliximab 10 mg/kg | [1] Infliximab Infliximab | [1] D02598
D02598
| [1] TNF TNF 💬 | [67] AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | [3] 46 46, 96, 97 |
617 | Infliximab 20 mg/kg | [1] Infliximab Infliximab | [1] D02598
D02598
| [1] TNF TNF 💬 | [67] AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | [1] 96 96 |
618 | Infliximab 5 mg/kg | [1] Infliximab Infliximab | [1] D02598
D02598
| [1] TNF TNF 💬 | [67] AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | [2] 96 96, 97 |
619 | Infliximab 5 mg/kg body weight infused over 2 hours | [1] Infliximab Infliximab | [1] D02598
D02598
| [1] TNF TNF 💬 | [67] AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | [1] 96 96 |
620 | Infliximab 5 mg/kg every 6 weeks | [1] Infliximab Infliximab | [1] D02598
D02598
| [1] TNF TNF 💬 | [67] AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | [1] 96 96 |
621 | Infliximab 7 mg/kg every 8 weeks | [1] Infliximab Infliximab | [1] D02598
D02598
| [1] TNF TNF 💬 | [67] AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | [1] 96 96 |
622 | Infliximab [infliximab biosimilar 3] | [1] Infliximab Infliximab | [1] D02598
D02598
| [1] TNF TNF 💬 | [67] AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | [4] 37 37, 46, 96, 97 |
623 | Infliximab and adalimumab | [2] Adalimumab Adalimumab, Infliximab | [2] D02597
D02597
,
D02598
| [1] TNF TNF 💬 | [67] AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | [2] 96 96, 97 |
624 | Infliximab and azathioprine combination at week 0 | [2] Azathioprine Azathioprine, Infliximab | [3] D00238
D00238
,
D02598
,
D03033
| [1] TNF TNF 💬 | [67] AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | [1] 96 96 |
625 | Infliximab and azathioprine combination at week 14 | [2] Azathioprine Azathioprine, Infliximab | [3] D00238
D00238
,
D02598
,
D03033
| [1] TNF TNF 💬 | [67] AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | [1] 96 96 |
626 | Infliximab and immunosuppressives | [1] Infliximab Infliximab | [1] D02598
D02598
| [1] TNF TNF 💬 | [67] AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | [1] 96 96 |
627 | Infliximab CT-P13 | [1] Infliximab Infliximab | [1] D02598
D02598
| [1] TNF TNF 💬 | [67] AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | [1] 96 96 |
628 | Infliximab infusion | [1] Infliximab Infliximab | [1] D02598
D02598
| [1] TNF TNF 💬 | [67] AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | [1] 96 96 |
629 | Infliximab or adalimumab or golimumab or vedolizumab or ustekinumab | [5] Adalimumab Adalimumab, Golimumab, Infliximab, Ustekinumab, Vedolizumab | [5] D02597
D02597
,
D02598
,
D04358
,
D08083
,
D09214
| [6] IL12A IL12A, IL12B, IL23A, ITGA4, ITGB7, TNF 💬 | [81] AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Arrhythmogenic right ventricular cardiomyopathy, Asthma, C-type lectin receptor signaling pathway, Cell adhesion molecules, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, ECM-receptor interaction, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Focal adhesion, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Intestinal immune network for IgA production, JAK-STAT signaling pathway, Legionellosis, Leishmaniasis, Leukocyte transendothelial migration, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, Measles, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathogenic Escherichia coli infection, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Regulation of actin cytoskeleton, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toll-like receptor signaling pathway, Toxoplasmosis, Transcriptional misregulation in cancer, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | [2] 96 96, 97 |
630 | Infliximab therapeutic drug monitoring | [1] Infliximab Infliximab | [1] D02598
D02598
| [1] TNF TNF 💬 | [67] AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | [2] 96 96, 97 |
631 | Infliximab with azathioprine (IIFX + AZA) | [2] Azathioprine Azathioprine, Infliximab | [3] D00238
D00238
,
D02598
,
D03033
| [1] TNF TNF 💬 | [67] AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | [1] 96 96 |
632 | Infliximab+azathioprine | [2] Azathioprine Azathioprine, Infliximab | [3] D00238
D00238
,
D02598
,
D03033
| [1] TNF TNF 💬 | [67] AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | [1] 96 96 |
633 | Infliximab, adalimumab, certolizumab pegol | [3] Adalimumab Adalimumab, Certolizumab pegol, Infliximab | [3] D02597
D02597
,
D02598
,
D03441
| [1] TNF TNF 💬 | [67] AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | [2] 96 96, 97 |
634 | Infliximab, azathioprine | [2] Azathioprine Azathioprine, Infliximab | [3] D00238
D00238
,
D02598
,
D03033
| [1] TNF TNF 💬 | [67] AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | [1] 96 96 |
635 | Infliximab-Biosimilar | [1] Infliximab Infliximab | [1] D02598
D02598
| [1] TNF TNF 💬 | [67] AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | [1] 96 96 |
636 | Infliximab-Innovator | [1] Infliximab Infliximab | [1] D02598
D02598
| [1] TNF TNF 💬 | [67] AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | [1] 96 96 |
637 | Injection of iron | - | - | - | - | [1] 96 96 |
638 | Innovator infliximab | [1] Infliximab Infliximab | [1] D02598
D02598
| [1] TNF TNF 💬 | [67] AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | [3] 46 46, 96, 97 |
639 | Inositol | [1] Inositol Inositol | [1] D08079
D08079
| - | - | [2] 96 96, 97 |
640 | Instillation of fibrin glue | [1] Fibrin Fibrin | - | - | - | [1] 96 96 |
641 | Interferon alfa | [1] Interferon alfa Interferon alfa | [1] D03305
D03305
| [2] IFNAR1 IFNAR1, IFNAR2 💬 | [18] Coronavirus disease - COVID-19 Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway 💬 | [5] 25 25, 26, 28, 56, 96 |
642 | Interferon Beta | [1] Human interferon beta Human interferon beta | - | - | - | [6] 13 13, 20, 26, 50, 96, 97 |
643 | INTERFERON BETA-1A | [2] Human interferon beta Human interferon beta, Interferon beta-1a | [1] D04554
D04554
| [2] IFNAR1 IFNAR1, IFNAR2 💬 | [18] Coronavirus disease - COVID-19 Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway 💬 | [4] 13 13, 26, 96, 97 |
644 | INTERLEUKIN 2 | - | - | - | - | [9] 46 46, 49, 51, 56, 63, 95, 96, 97, 271 |
645 | Interleukin-11 | [1] Oprelvekin Oprelvekin | [1] D05266
D05266
| [1] IL11RA IL11RA 💬 | [3] Cytokine-cytokine receptor interaction Cytokine-cytokine receptor interaction, Hematopoietic cell lineage, JAK-STAT signaling pathway 💬 | [2] 96 96, 288 |
646 | INTERLEUKIN-2 | [1] Human interleukin-2 Human interleukin-2 | - | - | - | [8] 2 2, 35, 49, 55, 65, 96, 97, 162 |
647 | Interleukin-2 (aldesleukin). | [2] Aldesleukin Aldesleukin, Human interleukin-2 | [1] D00748
D00748
| [3] IL2RA IL2RA, IL2RB, IL2RG 💬 | [14] Cytokine-cytokine receptor interaction Cytokine-cytokine receptor interaction, Endocytosis, Hematopoietic cell lineage, Human T-cell leukemia virus 1 infection, Inflammatory bowel disease, JAK-STAT signaling pathway, Measles, PI3K-Akt signaling pathway, Pathways in cancer, Primary immunodeficiency, Th1 and Th2 cell differentiation, Th17 cell differentiation, Transcriptional misregulation in cancer, Viral protein interaction with cytokine and cytokine receptor 💬 | [2] 96 96, 97 |
648 | Intestinal surgery for Crohn's Disease | - | - | - | - | [1] 96 96 |
649 | Intralipid | - | - | - | - | [1] 96 96 |
650 | Intralipid 10% | - | - | - | - | [1] 96 96 |
651 | Intralipid 20% | - | - | - | - | [1] 96 96 |
652 | Inulin | [1] Inulin Inulin | [1] D00171
D00171
| - | - | [2] 96 96, 299 |
653 | InVita D3 | - | - | - | - | [1] 96 96 |
654 | Iron | [1] Iron Iron | - | - | - | [6] 18 18, 96, 97, 238, 254, 284 |
655 | Iron sucrose | [2] Iron sucrose Iron sucrose, Sucrose | [2] D00025
D00025
,
D04616
| - | - | [3] 62 62, 96, 97 |
656 | Iron sulphate | [1] Iron Iron | - | - | - | [2] 96 96, 97 |
657 | Iron sulphate 200mg coated tablets | [1] Iron Iron | - | - | - | [2] 96 96, 97 |
658 | Iron supplement 300-600 mg/day | [1] Iron Iron | - | - | - | [2] 96 96, 97 |
659 | Iron(III)- hydroxide dextran complex | [3] Dextran Dextran, Hydroxide ion, Iron | [1] D00060
D00060
| - | - | [2] 96 96, 97 |
660 | ITF 2357 | - | - | - | - | [1] 96 96 |
661 | ITF2357 | - | - | - | - | [4] 96 96, 107, 113, 267 |
662 | Itraconazole | [1] Itraconazole Itraconazole | [1] D00350
D00350
| - | - | [5] 3 3, 65, 96, 227, 299 |
663 | Itraconazole 400 mg/day and terbinafine 500 mg/day administered orally. | [2] Itraconazole Itraconazole, Terbinafine | [3] D00350
D00350
,
D02219
,
D02375
| - | - | [1] 96 96 |
664 | J695 | - | - | - | - | [1] 96 96 |
665 | J695, BSF 415977 (formerly LU415977), WAY-165772, A-796874.0 | - | - | - | - | [1] 96 96 |
666 | JNJ-40346527 | [1] JNJ-40346527 JNJ-40346527 | - | - | - | [2] 46 46, 96 |
667 | JNJ-40346527-AAC | [1] JNJ-40346527 JNJ-40346527 | - | - | - | [1] 96 96 |
668 | JNJ-64304500 | - | - | - | - | [1] 96 96 |
669 | JNJ-64304500-AAA | - | - | - | - | [1] 96 96 |
670 | JNJ-67864238 | - | - | - | - | [1] 96 96 |
671 | JNJ-78934804 | - | - | - | - | [2] 96 96, 97 |
672 | Kanamycin | [1] Kanamycin Kanamycin | [3] D00866
D00866
,
D03262
,
D07497
| - | - | [2] 96 96, 291 |
673 | Kenacort | - | - | - | - | [2] 46 46, 96 |
674 | Kremezin | - | - | - | - | [2] 96 96, 97 |
675 | Kremezin®, Spherical Adsorptive Carbon | [1] Activated charcoal Activated charcoal | - | - | - | [2] 96 96, 97 |
676 | L 44 | - | - | - | - | [1] 96 96 |
677 | L-Carnitine | [1] Levocarnitine Levocarnitine | [3] D02030
D02030
,
D02176
,
D04713
| - | - | [7] 13 13, 86, 96, 97, 265, 298, 316 |
678 | L01BA | - | - | - | - | [1] 96 96 |
679 | Lactated Ringers | - | - | - | - | [2] 96 96, 97 |
680 | Lactobacillus salivarius | [1] Lactobacillus salivarius Lactobacillus salivarius | - | - | - | [2] 96 96, 97 |
681 | Lactobacillus salivarius UCC118 | [1] Lactobacillus salivarius Lactobacillus salivarius | - | - | - | [2] 96 96, 97 |
682 | Lactulose | [1] Lactulose Lactulose | [1] D00352
D00352
| - | - | [3] 13 13, 96, 291 |
683 | Lactulose/Rhamnose solution | [2] Lactulose Lactulose, Rhamnose | [1] D00352
D00352
| - | - | [1] 96 96 |
684 | Lap TAP Bupivacaine/Epinephrine | [2] Bupivacaine Bupivacaine, Epinephrine | [5] D00095
D00095
,
D00996
,
D01450
,
D02149
,
D07552
| [14] ADRA1A ADRA1A, ADRA1B, ADRA1D, ADRA2A, ADRA2B, ADRA2C, ADRB1, ADRB2, ADRB3, SCN1A, SCN2A, SCN3A, SCN5A, SCN9A 💬 | [16] AMPK signaling pathway AMPK signaling pathway, Adrenergic signaling in cardiomyocytes, Calcium signaling pathway, Chemical carcinogenesis - receptor activation, Dilated cardiomyopathy, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Regulation of lipolysis in adipocytes, Renin secretion, Salivary secretion, Taste transduction, Thermogenesis, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬 | [1] 96 96 |
685 | LAQUINIMOD | [1] Laquinimod Laquinimod | - | - | - | [4] 8 8, 13, 49, 96 |
686 | Laquinimod capsules 0.5 mg | [1] Laquinimod Laquinimod | - | - | - | [2] 8 8, 96 |
687 | Laquinimod Cápsulas 0.5 mg | [1] Laquinimod Laquinimod | - | - | - | [1] 96 96 |
688 | LDP-02 | - | - | - | - | [2] 96 96, 97 |
689 | Leucine | [1] Leucine Leucine | [1] D00030
D00030
| - | - | [11] 5 5, 6, 7, 19, 65, 96, 97, 127, 283, 284, 299 |
690 | Leukapheresis | - | - | - | - | [5] 49 49, 51, 96, 284, 285 |
691 | Lipitor | [1] Atorvastatin Atorvastatin | [3] D00258
D00258
,
D00887
,
D07474
| [1] HMGCR HMGCR 💬 | [4] AMPK signaling pathway AMPK signaling pathway, Bile secretion, Metabolic pathways, Terpenoid backbone biosynthesis 💬 | [3] 51 51, 96, 299 |
692 | Liposomal bupivacaine | [1] Bupivacaine Bupivacaine | [2] D01450
D01450
,
D07552
| [5] SCN1A SCN1A, SCN2A, SCN3A, SCN5A, SCN9A 💬 | [3] Adrenergic signaling in cardiomyocytes Adrenergic signaling in cardiomyocytes, Dopaminergic synapse, Taste transduction 💬 | [3] 51 51, 70, 96 |
693 | Losartan | [1] Losartan Losartan | [2] D00357
D00357
,
D08146
| [1] AGTR1 AGTR1 💬 | [16] AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adrenergic signaling in cardiomyocytes, Aldosterone synthesis and secretion, Apelin signaling pathway, Calcium signaling pathway, Coronavirus disease - COVID-19, Cortisol synthesis and secretion, Cushing syndrome, Diabetic cardiomyopathy, Neuroactive ligand-receptor interaction, Pathways in cancer, Phospholipase D signaling pathway, Renin secretion, Renin-angiotensin system, Vascular smooth muscle contraction, cGMP-PKG signaling pathway 💬 | [18] 17 17, 19, 36, 46, 58, 66, 67, 85, 96, 97, 98, 113, 164, 167, 179, 215, 222, 299 |
694 | Low dose naltrexone | [1] Naltrexone Naltrexone | [2] D02095
D02095
,
D05113
| [3] OPRD1 OPRD1, OPRK1, OPRM1 💬 | [5] Estrogen signaling pathway Estrogen signaling pathway, Morphine addiction, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway, cGMP-PKG signaling pathway 💬 | [2] 96 96, 97 |
695 | Low dose TSO | - | - | - | - | [1] 96 96 |
696 | Low serine diet | [1] Serine Serine | [1] D00016
D00016
| - | - | [1] 96 96 |
697 | Low-dose IL-2 administration | [1] Human interleukin-2 Human interleukin-2 | - | - | - | [1] 96 96 |
698 | Lumbar Puncture | - | - | - | - | [6] 6 6, 13, 19, 96, 97, 127 |
699 | Lumentin 44 | - | - | - | - | [1] 96 96 |
700 | LY3074828 | - | - | - | - | [3] 37 37, 96, 97 |
701 | Lymphocyte immune globulin | - | - | - | - | [1] 96 96 |
702 | Magnetic Resonance Enterography (MRE) | - | - | - | - | [1] 96 96 |
703 | Maltodextrin | [1] Maltodextrin Maltodextrin | [1] D02329
D02329
| - | - | [4] 6 6, 13, 96, 97 |
704 | Maltose | [1] Maltose Maltose | [1] D00044
D00044
| - | - | [2] 96 96, 97 |
705 | Mango | [1] Mango Mango | - | - | - | [2] 96 96, 97 |
706 | Mango polyphenolics | [1] Mango Mango | - | - | - | [2] 96 96, 97 |
707 | Mannitol | [1] Mannitol Mannitol | [1] D00062
D00062
| - | - | [7] 6 6, 13, 28, 60, 96, 113, 299 |
708 | Mare´s milk | - | - | - | - | [2] 96 96, 97 |
709 | MASITINIB | [1] Masitinib Masitinib | [1] D10229
D10229
| [1] KIT KIT 💬 | [11] Acute myeloid leukemia Acute myeloid leukemia, Breast cancer, Central carbon metabolism in cancer, Hematopoietic cell lineage, MAPK signaling pathway, Melanogenesis, PI3K-Akt signaling pathway, Pathways in cancer, Phospholipase D signaling pathway, Rap1 signaling pathway, Ras signaling pathway 💬 | [6] 2 2, 5, 6, 13, 46, 96 |
710 | MASITINIB MESYLATE | [1] Masitinib Masitinib | [1] D10229
D10229
| [1] KIT KIT 💬 | [11] Acute myeloid leukemia Acute myeloid leukemia, Breast cancer, Central carbon metabolism in cancer, Hematopoietic cell lineage, MAPK signaling pathway, Melanogenesis, PI3K-Akt signaling pathway, Pathways in cancer, Phospholipase D signaling pathway, Rap1 signaling pathway, Ras signaling pathway 💬 | [6] 2 2, 5, 6, 13, 46, 96 |
711 | MB-102 | - | - | - | - | [1] 96 96 |
712 | MDGN-002 | - | - | - | - | [1] 96 96 |
713 | MDX-1100 | - | - | - | - | [3] 46 46, 96, 97 |
714 | Measurement of serum infliximab and anti-infliximab antibodies | [1] Infliximab Infliximab | [1] D02598
D02598
| [1] TNF TNF 💬 | [67] AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | [1] 96 96 |
715 | Mecasermin | [1] Mecasermin Mecasermin | [2] D03297
D03297
,
D04870
| [2] GHR GHR, IGF1R 💬 | [33] AMPK signaling pathway AMPK signaling pathway, Adherens junction, Autophagy - animal, Breast cancer, Cytokine-cytokine receptor interaction, EGFR tyrosine kinase inhibitor resistance, Endocrine resistance, Endocytosis, Focal adhesion, FoxO signaling pathway, Glioma, Growth hormone synthesis, secretion and action, HIF-1 signaling pathway, Hepatocellular carcinoma, JAK-STAT signaling pathway, Long-term depression, Longevity regulating pathway, Longevity regulating pathway - multiple species, MAPK signaling pathway, Melanoma, Neuroactive ligand-receptor interaction, Oocyte meiosis, Ovarian steroidogenesis, PI3K-Akt signaling pathway, Pathways in cancer, Progesterone-mediated oocyte maturation, Prostate cancer, Proteoglycans in cancer, Rap1 signaling pathway, Ras signaling pathway, Signaling pathways regulating pluripotency of stem cells, Transcriptional misregulation in cancer, mTOR signaling pathway 💬 | [5] 78 78, 96, 168, 265, 299 |
716 | Mecasermin [rDNA Origin] 10mg/ml solution | [1] Mecasermin Mecasermin | [2] D03297
D03297
,
D04870
| [2] GHR GHR, IGF1R 💬 | [33] AMPK signaling pathway AMPK signaling pathway, Adherens junction, Autophagy - animal, Breast cancer, Cytokine-cytokine receptor interaction, EGFR tyrosine kinase inhibitor resistance, Endocrine resistance, Endocytosis, Focal adhesion, FoxO signaling pathway, Glioma, Growth hormone synthesis, secretion and action, HIF-1 signaling pathway, Hepatocellular carcinoma, JAK-STAT signaling pathway, Long-term depression, Longevity regulating pathway, Longevity regulating pathway - multiple species, MAPK signaling pathway, Melanoma, Neuroactive ligand-receptor interaction, Oocyte meiosis, Ovarian steroidogenesis, PI3K-Akt signaling pathway, Pathways in cancer, Progesterone-mediated oocyte maturation, Prostate cancer, Proteoglycans in cancer, Rap1 signaling pathway, Ras signaling pathway, Signaling pathways regulating pluripotency of stem cells, Transcriptional misregulation in cancer, mTOR signaling pathway 💬 | [1] 96 96 |
717 | MEDI2070 | - | - | - | - | [2] 96 96, 97 |
718 | Medium chain triglycerides | - | - | - | - | [1] 96 96 |
719 | Medium dose TSO | - | - | - | - | [1] 96 96 |
720 | Melphalan | [1] Melphalan Melphalan | [1] D00369
D00369
| - | - | [15] 11 11, 13, 14, 19, 20, 28, 60, 62, 65, 96, 164, 234, 284, 285, 299 |
721 | Mensa | - | - | - | - | [1] 96 96 |
722 | Mercaptopurine | [1] Mercaptopurine Mercaptopurine | [2] D00161
D00161
,
D04931
| [1] HPRT1 HPRT1 💬 | [3] Drug metabolism - other enzymes Drug metabolism - other enzymes, Metabolic pathways, Purine metabolism 💬 | [4] 65 65, 96, 97, 164 |
723 | Mesalamine | [1] Mesalazine Mesalazine | [1] D00377
D00377
| - | - | [3] 96 96, 97, 164 |
724 | Mesalamine, 5-aminosalicylic acid | [2] Aminosalicylic acid Aminosalicylic acid, Mesalazine | [2] D00162
D00162
,
D00377
| - | - | [1] 96 96 |
725 | Mesalazine | [1] Mesalazine Mesalazine | [1] D00377
D00377
| - | - | [3] 46 46, 96, 97 |
726 | Mesalazine (Mesalamine) | [1] Mesalazine Mesalazine | [1] D00377
D00377
| - | - | [1] 96 96 |
727 | Mesalazine EC 500 mg | [1] Mesalazine Mesalazine | [1] D00377
D00377
| - | - | [1] 96 96 |
728 | Mesalazine Sustained-Release Tablets | [1] Mesalazine Mesalazine | [1] D00377
D00377
| - | - | [1] 96 96 |
729 | Mesalazine tablets | [1] Mesalazine Mesalazine | [1] D00377
D00377
| - | - | [1] 96 96 |
730 | Mesalazine, Tripterygium glycosides | [2] Mesalazine Mesalazine, Tripterygium wilfordii whole | [1] D00377
D00377
| - | - | [1] 96 96 |
731 | Mesenchymal cell and fibroblast injection | - | - | - | - | [1] 96 96 |
732 | Mesenchymal cell transplantation | - | - | - | - | [2] 46 46, 96 |
733 | Mesenchymal stem cells | - | - | - | - | [11] 2 2, 6, 13, 20, 49, 51, 60, 96, 222, 274, 299 |
734 | Mesenchymal stem cells (MSC) | - | - | - | - | [3] 2 2, 13, 96 |
735 | Mesenchymal stem cells (MSCs) | - | - | - | - | [3] 13 13, 36, 96 |
736 | Mesenchymal Stromal Cells | [1] Human Umbilical Cord Mesenchymal Stem Cells Human Umbilical Cord Mesenchymal Stem Cells | - | - | - | [10] 2 2, 36, 49, 51, 60, 96, 97, 107, 274, 284 |
737 | Mesenchymal stromal cells (MSC) for infusion | [1] Human Umbilical Cord Mesenchymal Stem Cells Human Umbilical Cord Mesenchymal Stem Cells | - | - | - | [1] 96 96 |
738 | Mesna | [1] Coenzyme M Coenzyme M | - | - | - | [11] 11 11, 13, 44, 45, 49, 51, 60, 65, 85, 96, 164 |
739 | Methacholine | [1] Methacholine Methacholine | - | - | - | [1] 96 96 |
740 | Methotrexat | [1] Methotrexate Methotrexate | [2] D00142
D00142
,
D02115
| [2] DHFR DHFR, DHFR2 💬 | [5] Antifolate resistance Antifolate resistance, Biosynthesis of cofactors, Folate biosynthesis, Metabolic pathways, One carbon pool by folate 💬 | [4] 13 13, 46, 50, 96 |
741 | Methotrexate | [1] Methotrexate Methotrexate | [2] D00142
D00142
,
D02115
| [2] DHFR DHFR, DHFR2 💬 | [5] Antifolate resistance Antifolate resistance, Biosynthesis of cofactors, Folate biosynthesis, Metabolic pathways, One carbon pool by folate 💬 | [38] 11 11, 13, 19, 34, 35, 40, 41, 42, 43, 44, 45, 46, 49, 50, 51, 53, 55, 56, 60, 62, 65, 84, 93, 96, 97, 107, 162, 164, 172, 256, 270, 271, 283, 284, 285, 286, 326, 331 |
742 | METHOTREXATE - 20 MG/0.8 ML SOLUZIONE INIETTABILE 4 SIRINGHE PRERIEMPITE MONOUSO DA 1.25 ML | [1] Methotrexate Methotrexate | [2] D00142
D00142
,
D02115
| [2] DHFR DHFR, DHFR2 💬 | [5] Antifolate resistance Antifolate resistance, Biosynthesis of cofactors, Folate biosynthesis, Metabolic pathways, One carbon pool by folate 💬 | [1] 96 96 |
743 | METHOTREXATE DISODIUM | [1] Methotrexate Methotrexate | [2] D00142
D00142
,
D02115
| [2] DHFR DHFR, DHFR2 💬 | [5] Antifolate resistance Antifolate resistance, Biosynthesis of cofactors, Folate biosynthesis, Metabolic pathways, One carbon pool by folate 💬 | [5] 46 46, 96, 97, 107, 271 |
744 | Methotrexate injection | [1] Methotrexate Methotrexate | [2] D00142
D00142
,
D02115
| [2] DHFR DHFR, DHFR2 💬 | [5] Antifolate resistance Antifolate resistance, Biosynthesis of cofactors, Folate biosynthesis, Metabolic pathways, One carbon pool by folate 💬 | [2] 96 96, 97 |
745 | Methoxsalen | [1] Methoxsalen Methoxsalen | [1] D00139
D00139
| - | - | [4] 36 36, 46, 51, 96 |
746 | Methoxsalen +ECP | [1] Methoxsalen Methoxsalen | [1] D00139
D00139
| - | - | [1] 96 96 |
747 | Methyl prednisolone | [1] Prednisolone Prednisolone | [8] D00472
D00472
,
D00980
,
D00981
,
D00982
,
D01239
,
D01998
,
D02156
,
D03301
| [1] NR3C1 NR3C1 💬 | [1] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | [3] 43 43, 49, 96 |
748 | Methylprednisolone | [1] Methylprednisolone Methylprednisolone | [6] D00407
D00407
,
D00751
,
D00979
,
D05000
,
D05001
,
D05002
| [1] NR3C1 NR3C1 💬 | [1] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | [48] 2 2, 6, 11, 13, 14, 18, 19, 25, 26, 35, 38, 39, 40, 41, 42, 43, 45, 46, 49, 50, 51, 60, 62, 63, 64, 65, 66, 83, 84, 86, 93, 95, 96, 97, 127, 145, 162, 164, 211, 220, 222, 224, 271, 283, 284, 285, 296, 300 |
749 | Methylprednisolone or budesonide | [2] Budesonide Budesonide, Methylprednisolone | [7] D00246
D00246
,
D00407
,
D00751
,
D00979
,
D05000
,
D05001
,
D05002
| [1] NR3C1 NR3C1 💬 | [1] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | [1] 96 96 |
750 | METOJECT | [1] Methotrexate Methotrexate | [2] D00142
D00142
,
D02115
| [2] DHFR DHFR, DHFR2 💬 | [5] Antifolate resistance Antifolate resistance, Biosynthesis of cofactors, Folate biosynthesis, Metabolic pathways, One carbon pool by folate 💬 | [6] 41 41, 46, 96, 97, 107, 271 |
751 | Metotrexat | - | - | - | - | [2] 50 50, 96 |
752 | Metronidazol | [1] Metronidazole Metronidazole | [3] D00409
D00409
,
D05016
,
D05017
| - | - | [2] 46 46, 96 |
753 | METRONIDAZOLE | [1] Metronidazole Metronidazole | [3] D00409
D00409
,
D05016
,
D05017
| - | - | [8] 46 46, 51, 63, 94, 95, 96, 97, 291 |
754 | Metronidazole Oral | [1] Metronidazole Metronidazole | [3] D00409
D00409
,
D05016
,
D05017
| - | - | [1] 96 96 |
755 | MICROBIOTA | - | - | - | - | [1] 96 96 |
756 | Midazolam | [1] Midazolam Midazolam | [3] D00550
D00550
,
D00696
,
D05028
| [16] GABRA1 GABRA1, GABRA2, GABRA3, GABRA4, GABRA5, GABRA6, GABRB1, GABRB2, GABRB3, GABRD, GABRE, GABRG1, GABRG2, GABRG3, GABRP, GABRQ 💬 | [7] GABAergic synapse GABAergic synapse, Morphine addiction, Neuroactive ligand-receptor interaction, Nicotine addiction, Retrograde endocannabinoid signaling, Serotonergic synapse, Taste transduction 💬 | [12] 2 2, 3, 6, 13, 21, 46, 70, 96, 97, 231, 272, 298 |
757 | Midazolam 2 mg | [1] Midazolam Midazolam | [3] D00550
D00550
,
D00696
,
D05028
| [16] GABRA1 GABRA1, GABRA2, GABRA3, GABRA4, GABRA5, GABRA6, GABRB1, GABRB2, GABRB3, GABRD, GABRE, GABRG1, GABRG2, GABRG3, GABRP, GABRQ 💬 | [7] GABAergic synapse GABAergic synapse, Morphine addiction, Neuroactive ligand-receptor interaction, Nicotine addiction, Retrograde endocannabinoid signaling, Serotonergic synapse, Taste transduction 💬 | [2] 96 96, 97 |
758 | Midazolam 3 mg | [1] Midazolam Midazolam | [3] D00550
D00550
,
D00696
,
D05028
| [16] GABRA1 GABRA1, GABRA2, GABRA3, GABRA4, GABRA5, GABRA6, GABRB1, GABRB2, GABRB3, GABRD, GABRE, GABRG1, GABRG2, GABRG3, GABRP, GABRQ 💬 | [7] GABAergic synapse GABAergic synapse, Morphine addiction, Neuroactive ligand-receptor interaction, Nicotine addiction, Retrograde endocannabinoid signaling, Serotonergic synapse, Taste transduction 💬 | [1] 96 96 |
759 | Mirikizumab | [1] Mirikizumab Mirikizumab | [1] D11123
D11123
| [1] IL23A IL23A 💬 | [9] C-type lectin receptor signaling pathway C-type lectin receptor signaling pathway, Cytokine-cytokine receptor interaction, Inflammatory bowel disease, JAK-STAT signaling pathway, Pathways in cancer, Pertussis, Rheumatoid arthritis, Th17 cell differentiation, Tuberculosis 💬 | [3] 37 37, 96, 97 |
760 | MLN0002 | - | - | - | - | [3] 94 94, 96, 97 |
761 | MLN0002 (Vedolizumab) | [1] Vedolizumab Vedolizumab | [1] D08083
D08083
| [2] ITGA4 ITGA4, ITGB7 💬 | [15] Arrhythmogenic right ventricular cardiomyopathy Arrhythmogenic right ventricular cardiomyopathy, Cell adhesion molecules, Dilated cardiomyopathy, ECM-receptor interaction, Focal adhesion, Hematopoietic cell lineage, Human papillomavirus infection, Hypertrophic cardiomyopathy, Intestinal immune network for IgA production, Leishmaniasis, Leukocyte transendothelial migration, PI3K-Akt signaling pathway, Regulation of actin cytoskeleton, Transcriptional misregulation in cancer, Yersinia infection 💬 | [2] 96 96, 97 |
762 | MLN0002 SC | - | - | - | - | [2] 96 96, 97 |
763 | MLN002 | - | - | - | - | [2] 96 96, 97 |
764 | Mobilization of stem cells to prepare for Leukapheresis | - | - | - | - | [1] 96 96 |
765 | Moderate Oligosaccharide Group | - | - | - | - | [1] 96 96 |
766 | Modulen | - | - | - | - | [1] 96 96 |
767 | MODULEN IBD | - | - | - | - | [1] 96 96 |
768 | MODULEN IBD (R) (specific Enteral Nutrition) | - | - | - | - | [1] 96 96 |
769 | Mongersen | [1] Mongersen Mongersen | [1] D10956
D10956
| [1] SMAD7 SMAD7 💬 | [2] Hippo signaling pathway Hippo signaling pathway, TGF-beta signaling pathway 💬 | [2] 96 96, 97 |
770 | Monoclonal antibodies | - | - | - | - | [1] 96 96 |
771 | MONOCLONAL ANTIBODY ANTI-IGG1 | - | - | - | - | [3] 37 37, 96, 97 |
772 | Monoclonal antibody cA2 | - | - | - | - | [1] 96 96 |
773 | Mosapride | [1] Mosapride Mosapride | [1] D08236
D08236
| [1] HTR4 HTR4 💬 | [4] Calcium signaling pathway Calcium signaling pathway, Neuroactive ligand-receptor interaction, Serotonergic synapse, cAMP signaling pathway 💬 | [1] 96 96 |
774 | Movprep | - | - | - | - | [1] 96 96 |
775 | MSC | - | - | - | - | [6] 6 6, 51, 60, 96, 97, 271 |
776 | MSC injection 01 | - | - | - | - | [1] 96 96 |
777 | MSC injection 02 | - | - | - | - | [1] 96 96 |
778 | MSC treatment 01 | - | - | - | - | [1] 96 96 |
779 | MSC treatment 02 | - | - | - | - | [1] 96 96 |
780 | MSC-AFP | - | - | - | - | [1] 96 96 |
781 | MT-1303 | - | - | - | - | [3] 13 13, 96, 97 |
782 | MTX | - | - | - | - | [14] 13 13, 35, 40, 46, 49, 50, 51, 60, 84, 96, 97, 107, 162, 271 |
783 | MVA | - | - | - | - | [1] 96 96 |
784 | MVA HAV | - | - | - | - | [1] 96 96 |
785 | Mycodigest supplement | - | - | - | - | [2] 96 96, 97 |
786 | Mycophenolate | [1] Mycophenolic acid Mycophenolic acid | [1] D05096
D05096
| [2] IMPDH1 IMPDH1, IMPDH2 💬 | [3] Drug metabolism - other enzymes Drug metabolism - other enzymes, Metabolic pathways, Purine metabolism 💬 | [36] 2 2, 11, 13, 19, 20, 28, 35, 36, 42, 43, 44, 45, 49, 51, 53, 60, 61, 62, 65, 66, 84, 85, 93, 95, 96, 162, 164, 222, 224, 226, 228, 234, 283, 284, 285, 300 |
787 | Mycophenolate mofetil | [2] Mycophenolate mofetil Mycophenolate mofetil, Mycophenolic acid | [4] D00752
D00752
,
D05094
,
D05095
,
D05096
| [2] IMPDH1 IMPDH1, IMPDH2 💬 | [3] Drug metabolism - other enzymes Drug metabolism - other enzymes, Metabolic pathways, Purine metabolism 💬 | [34] 2 2, 11, 13, 19, 20, 28, 35, 36, 42, 43, 44, 45, 49, 51, 53, 60, 61, 62, 65, 66, 85, 93, 95, 96, 162, 164, 222, 224, 226, 234, 283, 284, 285, 300 |
788 | Mycophenolic acid | [1] Mycophenolic acid Mycophenolic acid | [1] D05096
D05096
| [2] IMPDH1 IMPDH1, IMPDH2 💬 | [3] Drug metabolism - other enzymes Drug metabolism - other enzymes, Metabolic pathways, Purine metabolism 💬 | [8] 11 11, 43, 49, 51, 60, 66, 96, 222 |
789 | N-3 Polyunsaturated Fatty Acids | - | - | - | - | [1] 96 96 |
790 | N-{4-Chloro-2-[(1-oxido-4-pyridinyl)carbonyl]phenyl}-4-(1,1-dimethylethyl)benzenesulfonamide, sodium | - | - | - | - | [1] 96 96 |
791 | N-{4-Chloro-2-[(1-oxido-4-pyridinyl)carbonyl]phenyl}-4-(1,1-dimethylethyl)benzenesulfonamidesodium | - | - | - | - | [1] 96 96 |
792 | N.a. | - | - | - | - | [10] 3 3, 6, 8, 13, 46, 96, 97, 240, 256, 271 |
793 | Naltrexone | [1] Naltrexone Naltrexone | [2] D02095
D02095
,
D05113
| [3] OPRD1 OPRD1, OPRK1, OPRM1 💬 | [5] Estrogen signaling pathway Estrogen signaling pathway, Morphine addiction, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway, cGMP-PKG signaling pathway 💬 | [12] 6 6, 10, 13, 40, 41, 42, 43, 44, 45, 96, 97, 226 |
794 | NALTREXONE HYDROCHLORIDE | [1] Naltrexone Naltrexone | [2] D02095
D02095
,
D05113
| [3] OPRD1 OPRD1, OPRK1, OPRM1 💬 | [5] Estrogen signaling pathway Estrogen signaling pathway, Morphine addiction, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway, cGMP-PKG signaling pathway 💬 | [8] 10 10, 40, 41, 42, 43, 44, 45, 96 |
795 | Naltrexone-HCl | [1] Naltrexone Naltrexone | [2] D02095
D02095
,
D05113
| [3] OPRD1 OPRD1, OPRK1, OPRM1 💬 | [5] Estrogen signaling pathway Estrogen signaling pathway, Morphine addiction, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway, cGMP-PKG signaling pathway 💬 | [1] 96 96 |
796 | Nap | - | - | - | - | [2] 96 96, 240 |
797 | NATALIZUMAB | [1] Natalizumab Natalizumab | [1] D06886
D06886
| [1] ITGA4 ITGA4 💬 | [14] Arrhythmogenic right ventricular cardiomyopathy Arrhythmogenic right ventricular cardiomyopathy, Cell adhesion molecules, Dilated cardiomyopathy, ECM-receptor interaction, Focal adhesion, Hematopoietic cell lineage, Human papillomavirus infection, Hypertrophic cardiomyopathy, Intestinal immune network for IgA production, Leishmaniasis, Leukocyte transendothelial migration, PI3K-Akt signaling pathway, Regulation of actin cytoskeleton, Yersinia infection 💬 | [5] 13 13, 15, 25, 46, 96 |
798 | Neomycin | [1] Neomycin Neomycin | [1] D08260
D08260
| - | - | [3] 96 96, 97, 296 |
799 | Nessuno | - | - | - | - | [1] 96 96 |
800 | NI-0401 (anti-CD3 mAB) | [1] Muromonab Muromonab | [1] D05092
D05092
| [3] CD3D CD3D, CD3E, CD3G 💬 | [11] Chagas disease Chagas disease, Epstein-Barr virus infection, Hematopoietic cell lineage, Human T-cell leukemia virus 1 infection, Human immunodeficiency virus 1 infection, Measles, PD-L1 expression and PD-1 checkpoint pathway in cancer, Primary immunodeficiency, T cell receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation 💬 | [1] 96 96 |
801 | Nitazoxanide | [1] Nitazoxanide Nitazoxanide | [1] D02486
D02486
| - | - | [2] 96 96, 97 |
802 | Nivolumab | [1] Nivolumab Nivolumab | [1] D10316
D10316
| [1] PDCD1 PDCD1 💬 | [3] Cell adhesion molecules Cell adhesion molecules, PD-L1 expression and PD-1 checkpoint pathway in cancer, T cell receptor signaling pathway 💬 | [12] 13 13, 26, 41, 46, 49, 50, 51, 53, 85, 96, 97, 159 |
803 | NNC 0142-0000-0002 | - | - | - | - | [2] 46 46, 96 |
804 | NNC0114-0006 | - | - | - | - | [3] 46 46, 49, 96 |
805 | NNC0142-0000-0002 | - | - | - | - | [1] 96 96 |
806 | NNC142-0002 | - | - | - | - | [1] 96 96 |
807 | NO | - | - | - | - | [12] 6 6, 13, 46, 58, 62, 86, 96, 97, 222, 226, 299, 321 |
808 | None | - | - | - | - | [16] 6 6, 46, 51, 65, 78, 84, 85, 96, 97, 140, 160, 161, 171, 231, 271, 299 |
809 | None at this time | [1] Interleukin-1 alpha, human recombinant Interleukin-1 alpha, human recombinant | - | - | - | [2] 96 96, 140 |
810 | Normal Saline | - | - | - | - | [18] 6 6, 13, 17, 22, 36, 46, 49, 60, 70, 94, 96, 210, 211, 226, 271, 276, 296, 299 |
811 | Normix | - | - | - | - | [1] 96 96 |
812 | NORMIX*AD 12CPR RIV 200MG | - | - | - | - | [1] 96 96 |
813 | NSP001 | - | - | - | - | [1] 96 96 |
814 | Null | - | - | - | - | [16] 6 6, 13, 15, 28, 37, 46, 49, 51, 63, 86, 90, 96, 97, 107, 145, 271 |
815 | Nutraceutical Combination | - | - | - | - | [1] 96 96 |
816 | Nutrition treat | - | - | - | - | [1] 96 96 |
817 | Nutritional dietary intervention | - | - | - | - | [2] 96 96, 97 |
818 | NutropinAq 10mg/2ml solution for injection | [1] Somatotropin Somatotropin | [1] D02691
D02691
| [1] GHR GHR 💬 | [5] Cytokine-cytokine receptor interaction Cytokine-cytokine receptor interaction, Growth hormone synthesis, secretion and action, JAK-STAT signaling pathway, Neuroactive ligand-receptor interaction, PI3K-Akt signaling pathway 💬 | [1] 96 96 |
819 | NutropinAq® | [1] Somatotropin Somatotropin | [1] D02691
D02691
| [1] GHR GHR 💬 | [5] Cytokine-cytokine receptor interaction Cytokine-cytokine receptor interaction, Growth hormone synthesis, secretion and action, JAK-STAT signaling pathway, Neuroactive ligand-receptor interaction, PI3K-Akt signaling pathway 💬 | [1] 96 96 |
820 | OL adalimumab 40 mg | [1] Adalimumab Adalimumab | [1] D02597
D02597
| [1] TNF TNF 💬 | [67] AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | [1] 96 96 |
821 | Oligofructose enriched inulin | [1] Inulin Inulin | [1] D00171
D00171
| - | - | [1] 96 96 |
822 | Olokizumab | [1] Olokizumab Olokizumab | - | - | - | [2] 46 46, 96 |
823 | Olokizumab (OKZ) | [1] Olokizumab Olokizumab | - | - | - | [1] 96 96 |
824 | Omega-3 | [1] Omega-3 fatty acids Omega-3 fatty acids | - | - | - | [7] 13 13, 46, 49, 66, 79, 96, 299 |
825 | Omegaven | - | - | - | - | [1] 96 96 |
826 | Omegaven 10% | - | - | - | - | [1] 96 96 |
827 | Omeprazole | [1] Omeprazole Omeprazole | [4] D00455
D00455
,
D01207
,
D05259
,
D05261
| [2] ATP4A ATP4A, ATP4B 💬 | [4] Collecting duct acid secretion Collecting duct acid secretion, Gastric acid secretion, Metabolic pathways, Oxidative phosphorylation 💬 | [16] 6 6, 8, 13, 21, 46, 51, 85, 96, 97, 98, 225, 271, 282, 294, 298, 299 |
828 | Omeprazole 20 mg | [1] Omeprazole Omeprazole | [4] D00455
D00455
,
D01207
,
D05259
,
D05261
| [2] ATP4A ATP4A, ATP4B 💬 | [4] Collecting duct acid secretion Collecting duct acid secretion, Gastric acid secretion, Metabolic pathways, Oxidative phosphorylation 💬 | [2] 96 96, 97 |
829 | Omeprazole 40 mg | [1] Omeprazole Omeprazole | [4] D00455
D00455
,
D01207
,
D05259
,
D05261
| [2] ATP4A ATP4A, ATP4B 💬 | [4] Collecting duct acid secretion Collecting duct acid secretion, Gastric acid secretion, Metabolic pathways, Oxidative phosphorylation 💬 | [1] 96 96 |
830 | Only 1 arm: treatment with MSC-AFP | - | - | - | - | [1] 96 96 |
831 | Ontamalimab | [1] Ontamalimab Ontamalimab | - | - | - | [2] 96 96, 97 |
832 | OPC-6535 | - | - | - | - | [2] 96 96, 97 |
833 | OPC-6535(Tetomilast) | [1] Tetomilast Tetomilast | - | - | - | [2] 96 96, 97 |
834 | OPS-2071 | - | - | - | - | [1] 96 96 |
835 | OPS-2071 150 mg | - | - | - | - | [1] 96 96 |
836 | OPS-2071 300 mg | - | - | - | - | [1] 96 96 |
837 | OPS-2071 600 mg | - | - | - | - | [1] 96 96 |
838 | Optison | [1] Perflutren Perflutren | [1] D01738
D01738
| - | - | [1] 96 96 |
839 | Oral prednisolone | [1] Prednisolone Prednisolone | [8] D00472
D00472
,
D00980
,
D00981
,
D00982
,
D01239
,
D01998
,
D02156
,
D03301
| [1] NR3C1 NR3C1 💬 | [1] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | [3] 49 49, 96, 145 |
840 | ORENCIA | [1] Abatacept Abatacept | [1] D03203
D03203
| [2] CD80 CD80, CD86 💬 | [12] Allograft rejection Allograft rejection, Autoimmune thyroid disease, Cell adhesion molecules, Graft-versus-host disease, Intestinal immune network for IgA production, Kaposi sarcoma-associated herpesvirus infection, Rheumatoid arthritis, Systemic lupus erythematosus, Toll-like receptor signaling pathway, Transcriptional misregulation in cancer, Type I diabetes mellitus, Viral myocarditis 💬 | [14] 44 44, 46, 49, 50, 51, 53, 65, 84, 96, 97, 107, 160, 222, 271 |
841 | Originator (legacy) drug | - | - | - | - | [4] 46 46, 96, 97, 271 |
842 | Ossium vBM-MSC | - | - | - | - | [1] 96 96 |
843 | Other Biologic Therapies | - | - | - | - | [2] 96 96, 97 |
844 | Other biological agent | - | - | - | - | [2] 46 46, 96 |
845 | Other: 100% pomegranate juice | [1] Pomegranate Pomegranate | - | - | - | [2] 96 96, 97 |
846 | Other: 5-ASA Withdrawal | [1] Mesalazine Mesalazine | [1] D00377
D00377
| - | - | [1] 96 96 |
847 | Other: Acute response to high-impact exercise | - | - | - | - | [1] 96 96 |
848 | Other: Blood test | - | - | - | - | [2] 83 83, 96 |
849 | Other: CD LFD | - | - | - | - | [1] 96 96 |
850 | Other: CD-TREAT diet | - | - | - | - | [1] 96 96 |
851 | Other: Coffee | [1] Arabica coffee bean Arabica coffee bean | - | - | - | [1] 96 96 |
852 | Other: Control Diet | - | - | - | - | [1] 96 96 |
853 | Other: Crohn's disease exclusion diet (CDED) | - | - | - | - | [1] 96 96 |
854 | Other: Crohn's Disease TReatment-with-EATing diet (CD-TREAT diet) | - | - | - | - | [1] 96 96 |
855 | Other: Crohns Disease Exclusion Diet | - | - | - | - | [1] 96 96 |
856 | Other: Diet-CD | - | - | - | - | [1] 96 96 |
857 | Other: Digestible Maltodextrin | [1] Maltodextrin Maltodextrin | [1] D02329
D02329
| - | - | [1] 96 96 |
858 | Other: enteral nutrition | - | - | - | - | [1] 96 96 |
859 | Other: Exclusion Diet | - | - | - | - | [1] 96 96 |
860 | Other: Exclusive enteral nutrition | - | - | - | - | [1] 96 96 |
861 | Other: Exclusive Enteral Nutrition (EEN) | - | - | - | - | [1] 96 96 |
862 | Other: Fractional Exhaled NO (FENO) | - | - | - | - | [1] 96 96 |
863 | Other: Green tea (Camellia sinensis) | [1] Green tea leaf Green tea leaf | [1] D06903
D06903
| - | - | [1] 96 96 |
864 | Other: Groningen Anti-Inflammatory Diet (GrAID) | - | - | - | - | [1] 96 96 |
865 | Other: High energy / protein diet. | - | - | - | - | [1] 96 96 |
866 | Other: high performance liquid chromatography | - | - | - | - | [1] 96 96 |
867 | Other: High-impact exercise intervention | - | - | - | - | [1] 96 96 |
868 | Other: Hyperbaric oxygen | [1] Oxygen Oxygen | [1] D00003
D00003
| - | - | [1] 96 96 |
869 | Other: infliximab (IFX) infusion | [1] Infliximab Infliximab | [1] D02598
D02598
| [1] TNF TNF 💬 | [67] AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | [1] 96 96 |
870 | Other: Intensify treatment with the existing drug | - | - | - | - | [2] 96 96, 97 |
871 | Other: IV saline infusion | - | - | - | - | [1] 96 96 |
872 | Other: Laboratory Biomarker Analysis | - | - | - | - | [21] 11 11, 13, 14, 26, 28, 34, 49, 51, 60, 62, 65, 89, 96, 97, 205, 232, 283, 284, 285, 298, 331 |
873 | Other: Lengthening adalimumab dosing interval | [1] Adalimumab Adalimumab | [1] D02597
D02597
| [1] TNF TNF 💬 | [67] AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | [1] 96 96 |
874 | Other: Leukapheresis- Collection of stem cells | - | - | - | - | [1] 96 96 |
875 | Other: Low n-6 PUFA Diet | - | - | - | - | [1] 96 96 |
876 | Other: Measurement of drug (Adalimumab/Infliximab) | [2] Adalimumab Adalimumab, Infliximab | [2] D02597
D02597
,
D02598
| [1] TNF TNF 💬 | [67] AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | [2] 96 96, 97 |
877 | Other: Methacholine Challenge Test | [1] Methacholine Methacholine | - | - | - | [1] 96 96 |
878 | Other: NO intervention | - | - | - | - | [4] 13 13, 70, 96, 97 |
879 | Other: normal diet | - | - | - | - | [1] 96 96 |
880 | Other: NS | - | - | - | - | [1] 96 96 |
881 | Other: Other Biologic Agents | - | - | - | - | [2] 96 96, 97 |
882 | Other: PCDAI | - | - | - | - | [1] 96 96 |
883 | Other: Quality-of-Life Assessment | - | - | - | - | [9] 34 34, 36, 51, 62, 65, 96, 283, 286, 298 |
884 | Other: Questionnaires | - | - | - | - | [5] 6 6, 13, 41, 93, 96 |
885 | Other: Standard nutrition | - | - | - | - | [1] 96 96 |
886 | Other: standard of care | - | - | - | - | [7] 13 13, 49, 64, 85, 96, 245, 246 |
887 | Other: Stem Cell Transplant | - | - | - | - | [1] 96 96 |
888 | Other: Surgery | - | - | - | - | [2] 74 74, 96 |
889 | Other: Threonine | [1] Threonine Threonine | [1] D00041
D00041
| - | - | [2] 96 96, 97 |
890 | Other: triangular test | - | - | - | - | [1] 96 96 |
891 | Other: UC-MSCs by peripheral intravenous infusion | [1] Human Umbilical Cord Mesenchymal Stem Cells Human Umbilical Cord Mesenchymal Stem Cells | - | - | - | [1] 96 96 |
892 | Ova-Treg | - | - | - | - | [1] 96 96 |
893 | Ovasave | - | - | - | - | [1] 96 96 |
894 | Oxadrop | - | - | - | - | [1] 96 96 |
895 | Oxygen | [1] Oxygen Oxygen | [1] D00003
D00003
| - | - | [20] 6 6, 13, 19, 46, 49, 70, 84, 85, 86, 88, 90, 96, 97, 168, 193, 226, 271, 294, 299, 330 |
896 | Ozanimod | [1] Ozanimod Ozanimod | [1] D10968
D10968
| [5] S1PR1 S1PR1, S1PR2, S1PR3, S1PR4, S1PR5 💬 | [3] FoxO signaling pathway FoxO signaling pathway, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway 💬 | [3] 13 13, 96, 97 |
897 | Ozanimod hydrochloride | [1] Ozanimod Ozanimod | [1] D10968
D10968
| [5] S1PR1 S1PR1, S1PR2, S1PR3, S1PR4, S1PR5 💬 | [3] FoxO signaling pathway FoxO signaling pathway, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway 💬 | [3] 13 13, 96, 97 |
898 | P28GST | - | - | - | - | [1] 96 96 |
899 | Partial Enteral Nutrition | - | - | - | - | [1] 96 96 |
900 | PDA001 | - | - | - | - | [2] 46 46, 96 |
901 | Pectin | [1] Pectin Pectin | [1] D02316
D02316
| - | - | [1] 96 96 |
902 | PEG | - | - | - | - | [12] 6 6, 13, 41, 46, 65, 78, 96, 97, 140, 144, 240, 299 |
903 | Pegylated interferon alfa | [1] Interferon alfa Interferon alfa | [1] D03305
D03305
| [2] IFNAR1 IFNAR1, IFNAR2 💬 | [18] Coronavirus disease - COVID-19 Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway 💬 | [1] 96 96 |
904 | Pending | - | - | - | - | [6] 13 13, 19, 96, 97, 113, 302 |
905 | Pentasa | [1] Mesalazine Mesalazine | [1] D00377
D00377
| - | - | [2] 96 96, 97 |
906 | PENTASA Sachet | [1] Mesalazine Mesalazine | [1] D00377
D00377
| - | - | [2] 96 96, 97 |
907 | Pentasa Sachet 1 g | [1] Mesalazine Mesalazine | [1] D00377
D00377
| - | - | [2] 96 96, 97 |
908 | Pentasa Sachet 1 g prolonged release granules | [2] Manganese citrate Manganese citrate, Mesalazine | [1] D00377
D00377
| - | - | [1] 96 96 |
909 | Pentoxifylline | [1] Pentoxifylline Pentoxifylline | [1] D00501
D00501
| - | - | [10] 26 26, 56, 84, 93, 96, 113, 220, 222, 296, 298 |
910 | Peptidic+Probiotic | - | - | - | - | [1] 96 96 |
911 | Peripheral Blood Stem Cell Infusion | - | - | - | - | [1] 96 96 |
912 | PF 06687234 | - | - | - | - | [2] 96 96, 97 |
913 | PF-00547659 | - | - | - | - | [2] 96 96, 97 |
914 | PF-00547659 SC injection | - | - | - | - | [2] 96 96, 97 |
915 | PF-04236921 | - | - | - | - | [2] 49 49, 96 |
916 | PF-04236921 SC injection | - | - | - | - | [1] 96 96 |
917 | PF-06651600 | [1] PF-06651600 PF-06651600 | - | - | - | [3] 46 46, 96, 97 |
918 | PF-06651600 50 mg | [1] PF-06651600 PF-06651600 | - | - | - | [2] 96 96, 97 |
919 | PF-06651600 50mg | [1] PF-06651600 PF-06651600 | - | - | - | [1] 96 96 |
920 | PF-06651600-15 | [1] PF-06651600 PF-06651600 | - | - | - | [2] 96 96, 97 |
921 | PF-06700841 | [1] PF-06700841 PF-06700841 | - | - | - | [3] 49 49, 96, 97 |
922 | PF-06700841 25 mg | [1] PF-06700841 PF-06700841 | - | - | - | [2] 96 96, 97 |
923 | PF-06700841 5 mg | [1] PF-06700841 PF-06700841 | - | - | - | [3] 49 49, 96, 97 |
924 | PF-06700841-15 | [1] PF-06700841 PF-06700841 | - | - | - | [3] 49 49, 96, 97 |
925 | Pharmacokinetics of certolizumab pegol | [1] Certolizumab pegol Certolizumab pegol | [1] D03441
D03441
| [1] TNF TNF 💬 | [67] AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | [2] 46 46, 96 |
926 | Phase1 : CDED/Modulen™IBD® + Maintenance therapy | - | - | - | - | [1] 96 96 |
927 | Phase2 and 3 : | - | - | - | - | [1] 96 96 |
928 | Phosphate | [1] Phosphate ion Phosphate ion | - | - | - | [33] 2 2, 3, 6, 11, 12, 13, 15, 28, 36, 46, 49, 51, 53, 60, 62, 65, 70, 78, 81, 83, 90, 96, 97, 164, 235, 238, 256, 276, 283, 284, 285, 286, 299 |
929 | Phylloquinone | [1] Phylloquinone Phylloquinone | [1] D00148
D00148
| - | - | [1] 96 96 |
930 | Phylloquinone (vitamin K1) | [1] Phylloquinone Phylloquinone | [1] D00148
D00148
| - | - | [1] 96 96 |
931 | Physician standard-of-care | - | - | - | - | [1] 96 96 |
932 | Pioglitazone | [1] Pioglitazone Pioglitazone | [2] D00945
D00945
,
D08378
| [1] PPARG PPARG 💬 | [11] AMPK signaling pathway AMPK signaling pathway, Huntington disease, Lipid and atherosclerosis, Longevity regulating pathway, Non-alcoholic fatty liver disease, Osteoclast differentiation, PPAR signaling pathway, Pathways in cancer, Thermogenesis, Thyroid cancer, Transcriptional misregulation in cancer 💬 | [17] 2 2, 6, 13, 15, 20, 46, 49, 65, 67, 78, 81, 86, 96, 229, 265, 298, 299 |
933 | Pioglitazone 15 mg | [1] Pioglitazone Pioglitazone | [2] D00945
D00945
,
D08378
| [1] PPARG PPARG 💬 | [11] AMPK signaling pathway AMPK signaling pathway, Huntington disease, Lipid and atherosclerosis, Longevity regulating pathway, Non-alcoholic fatty liver disease, Osteoclast differentiation, PPAR signaling pathway, Pathways in cancer, Thermogenesis, Thyroid cancer, Transcriptional misregulation in cancer 💬 | [1] 96 96 |
934 | PL 17901/0122 | - | - | - | - | [1] 96 96 |
935 | PL 20532/0012 | - | - | - | - | [1] 96 96 |
936 | Placebo | - | - | - | - | [27] 3 3, 5, 6, 13, 14, 37, 40, 46, 49, 50, 51, 53, 63, 66, 67, 79, 85, 86, 88, 96, 97, 140, 144, 149, 226, 271, 276 |
937 | Plantain NSP | - | - | - | - | [1] 96 96 |
938 | Plaquenil | - | - | - | - | [4] 46 46, 49, 53, 96 |
939 | Plasma rico en plaquetas y coagulo de fibrina procesados mediante la tecnología PRGF-System (BTI) | - | - | - | - | [1] 96 96 |
940 | PMA-zeolite | - | - | - | - | [1] 96 96 |
941 | Pnemovax | - | - | - | - | [1] 96 96 |
942 | Pneumovax | - | - | - | - | [3] 46 46, 49, 96 |
943 | Polaprezinc | [1] Polaprezinc Polaprezinc | [1] D01611
D01611
| - | - | [2] 96 96, 97 |
944 | Polyethylene glycol | [1] Polyethylene glycol Polyethylene glycol | [1] D03370
D03370
| - | - | [7] 6 6, 78, 96, 97, 235, 276, 299 |
945 | Polyethylene Glycol 3350 | [1] Polyethylene glycol Polyethylene glycol | [1] D03370
D03370
| - | - | [2] 96 96, 299 |
946 | Pomegranate | [1] Pomegranate Pomegranate | - | - | - | [2] 96 96, 97 |
947 | Posaconazole | [1] Posaconazole Posaconazole | [1] D02555
D02555
| - | - | [4] 60 60, 65, 96, 299 |
948 | Posaconazole Delayed Release Oral Tablet | [1] Posaconazole Posaconazole | [1] D02555
D02555
| - | - | [1] 96 96 |
949 | Positron Emission Tomography | - | - | - | - | [4] 40 40, 46, 49, 96 |
950 | Postoperative 3-month exclusive enteral nutrition | - | - | - | - | [1] 96 96 |
951 | PRA023 | - | - | - | - | [2] 96 96, 97 |
952 | PRA023 IV | - | - | - | - | [3] 51 51, 96, 97 |
953 | Pravastatin | [1] Pravastatin Pravastatin | [2] D00893
D00893
,
D08410
| [1] HMGCR HMGCR 💬 | [4] AMPK signaling pathway AMPK signaling pathway, Bile secretion, Metabolic pathways, Terpenoid backbone biosynthesis 💬 | [9] 13 13, 46, 49, 67, 79, 96, 164, 265, 333 |
954 | Prebiotics | - | - | - | - | [1] 96 96 |
955 | Precedentemente denominato MEDI2070 e AMG 139 | - | - | - | - | [1] 96 96 |
956 | Prednisolon | - | - | - | - | [7] 46 46, 50, 51, 66, 95, 96, 97 |
957 | Prednisolon Jenapharm | - | - | - | - | [2] 96 96, 97 |
958 | PREDNISOLONE | [1] Prednisolone Prednisolone | [8] D00472
D00472
,
D00980
,
D00981
,
D00982
,
D01239
,
D01998
,
D02156
,
D03301
| [1] NR3C1 NR3C1 💬 | [1] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | [43] 3 3, 11, 13, 14, 25, 26, 35, 38, 39, 40, 41, 43, 44, 45, 46, 49, 50, 51, 56, 60, 61, 63, 64, 65, 66, 75, 81, 84, 85, 95, 96, 97, 107, 113, 145, 162, 222, 269, 271, 296, 299, 300, 307 |
959 | Prednisone | [1] Prednisone Prednisone | [1] D00473
D00473
| [1] NR3C1 NR3C1 💬 | [1] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | [48] 2 2, 6, 11, 13, 14, 19, 26, 35, 40, 41, 42, 43, 44, 45, 46, 49, 50, 51, 53, 61, 63, 64, 65, 66, 79, 81, 84, 85, 86, 95, 96, 97, 113, 127, 162, 164, 205, 222, 224, 228, 251, 283, 284, 285, 288, 299, 300, 331 |
960 | Preparative regimen 4-6 weeks after Leukapheresis | - | - | - | - | [1] 96 96 |
961 | Prevenar 13 | [1] Streptococcus pneumoniae type 1 capsular polysaccharide antigen Streptococcus pneumoniae type 1 capsular polysaccharide antigen | - | - | - | [5] 13 13, 14, 46, 96, 222 |
962 | Previously referred to as MEDI2070 and AMG 139 | - | - | - | - | [2] 96 96, 97 |
963 | Previously referred to as MEDI2070 and AMG 139, AGN-151-598 | - | - | - | - | [1] 96 96 |
964 | Probiotic | - | - | - | - | [7] 2 2, 6, 93, 96, 97, 193, 266 |
965 | Probiotic - VSL#3 | - | - | - | - | [1] 96 96 |
966 | Probiotic Mixture | - | - | - | - | [2] 96 96, 97 |
967 | Probiotics | - | - | - | - | [5] 6 6, 94, 96, 97, 291 |
968 | Prochymal | [1] Remestemcel-L Remestemcel-L | [1] D09719
D09719
| - | - | [1] 96 96 |
969 | PROCHYMAL (remestemcel-L) | [1] Remestemcel-L Remestemcel-L | [1] D09719
D09719
| - | - | [1] 96 96 |
970 | PROCHYMAL adult human mesenchymal stem cells | [1] Remestemcel-L Remestemcel-L | [1] D09719
D09719
| - | - | [1] 96 96 |
971 | Prochymal® | [1] Remestemcel-L Remestemcel-L | [1] D09719
D09719
| - | - | [1] 96 96 |
972 | Prochymal™ adult human mesenchymal stem cells | [1] Remestemcel-L Remestemcel-L | [1] D09719
D09719
| - | - | [1] 96 96 |
973 | Promethazine | [1] Promethazine Promethazine | [4] D00480
D00480
,
D00494
,
D01242
,
D03290
| [1] HRH1 HRH1 💬 | [3] Calcium signaling pathway Calcium signaling pathway, Inflammatory mediator regulation of TRP channels, Neuroactive ligand-receptor interaction 💬 | [1] 96 96 |
974 | PRUCALOPRIDE | [1] Prucalopride Prucalopride | [1] D09205
D09205
| [1] HTR4 HTR4 💬 | [4] Calcium signaling pathway Calcium signaling pathway, Neuroactive ligand-receptor interaction, Serotonergic synapse, cAMP signaling pathway 💬 | [3] 13 13, 51, 96 |
975 | PRV-6527 | - | - | - | - | [1] 96 96 |
976 | PRV-6527 (JNJ-40346527) | [1] JNJ-40346527 JNJ-40346527 | - | - | - | [1] 96 96 |
977 | PRV-6527(JNJ-40346527) | [1] JNJ-40346527 JNJ-40346527 | - | - | - | [1] 96 96 |
978 | PTG-200 | - | - | - | - | [1] 96 96 |
979 | Puri Nethol | - | - | - | - | [1] 96 96 |
980 | Puri-Nethol | - | - | - | - | [3] 86 86, 96, 97 |
981 | Puri-Nethol 50 mg | - | - | - | - | [1] 96 96 |
982 | PURINETHOL | [1] Mercaptopurine Mercaptopurine | [2] D00161
D00161
,
D04931
| [1] HPRT1 HPRT1 💬 | [3] Drug metabolism - other enzymes Drug metabolism - other enzymes, Metabolic pathways, Purine metabolism 💬 | [1] 96 96 |
983 | PURINETHOL - 50 MG COMPRESSE25 COMPRESSE | [1] Mercaptopurine Mercaptopurine | [2] D00161
D00161
,
D04931
| [1] HPRT1 HPRT1 💬 | [3] Drug metabolism - other enzymes Drug metabolism - other enzymes, Metabolic pathways, Purine metabolism 💬 | [1] 96 96 |
984 | QAX567 | - | - | - | - | [1] 96 96 |
985 | QAX576 | - | - | - | - | [4] 51 51, 85, 96, 98 |
986 | QBECO | - | - | - | - | [1] 96 96 |
987 | QBECO-SSI | - | - | - | - | [1] 96 96 |
988 | Rabbit | [1] Rabbit Rabbit | - | - | - | [8] 11 11, 13, 49, 51, 60, 65, 96, 285 |
989 | Rabbit anti-human thymocyte immunoglobulin | [2] Antithymocyte immunoglobulin (rabbit) Antithymocyte immunoglobulin (rabbit), Rabbit | - | - | - | [2] 13 13, 96 |
990 | Rabbit antithymocyte globulin | [2] Antithymocyte immunoglobulin (rabbit) Antithymocyte immunoglobulin (rabbit), Rabbit | - | - | - | [3] 49 49, 60, 96 |
991 | Racol | - | - | - | - | [3] 6 6, 96, 291 |
992 | RAD001 | - | - | - | - | [6] 34 34, 67, 89, 96, 158, 228 |
993 | Radiation: Fluorine F 18 Clofarabine | [1] Clofarabine Clofarabine | [1] D03546
D03546
| [3] POLA1 POLA1, POLA2, RRM1 💬 | [6] DNA replication DNA replication, Drug metabolism - other enzymes, Glutathione metabolism, Metabolic pathways, Purine metabolism, Pyrimidine metabolism 💬 | [4] 40 40, 46, 49, 96 |
994 | Radiation: total-body irradiation | - | - | - | - | [9] 28 28, 51, 60, 62, 65, 96, 283, 284, 285 |
995 | Ranolazine | [1] Ranolazine Ranolazine | [2] D05700
D05700
,
D05701
| - | - | [6] 2 2, 58, 86, 96, 113, 114 |
996 | Rapamycin | [1] Sirolimus Sirolimus | [1] D00753
D00753
| [1] MTOR MTOR 💬 | [51] AMPK signaling pathway AMPK signaling pathway, Acute myeloid leukemia, Adipocytokine signaling pathway, Alzheimer disease, Amyotrophic lateral sclerosis, Apelin signaling pathway, Autophagy - animal, Autophagy - other, Breast cancer, Cellular senescence, Central carbon metabolism in cancer, Chemical carcinogenesis - receptor activation, Choline metabolism in cancer, Colorectal cancer, Diabetic cardiomyopathy, EGFR tyrosine kinase inhibitor resistance, Endocrine resistance, ErbB signaling pathway, Gastric cancer, Glioma, Growth hormone synthesis, secretion and action, HIF-1 signaling pathway, Hepatocellular carcinoma, Herpes simplex virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Huntington disease, Insulin resistance, Insulin signaling pathway, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Longevity regulating pathway, Longevity regulating pathway - multiple species, MicroRNAs in cancer, Neutrophil extracellular trap formation, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Phospholipase D signaling pathway, Prostate cancer, Proteoglycans in cancer, Shigellosis, Spinocerebellar ataxia, Th17 cell differentiation, Thermogenesis, Thyroid hormone signaling pathway, Type II diabetes mellitus, mTOR signaling pathway 💬 | [19] 2 2, 15, 34, 35, 46, 49, 51, 60, 61, 67, 86, 89, 96, 157, 158, 193, 256, 278, 279 |
997 | Raptiva | [1] Efalizumab Efalizumab | [1] D03959
D03959
| [1] ITGAL ITGAL 💬 | [12] Cell adhesion molecules Cell adhesion molecules, Epstein-Barr virus infection, Human T-cell leukemia virus 1 infection, Leukocyte transendothelial migration, Malaria, Natural killer cell mediated cytotoxicity, Neutrophil extracellular trap formation, Rap1 signaling pathway, Regulation of actin cytoskeleton, Rheumatoid arthritis, Staphylococcus aureus infection, Viral myocarditis 💬 | [9] 11 11, 13, 37, 46, 49, 53, 61, 95, 96 |
998 | Raptiva 100 mg/ml powder and solvent for solution for injection | [1] Efalizumab Efalizumab | [1] D03959
D03959
| [1] ITGAL ITGAL 💬 | [12] Cell adhesion molecules Cell adhesion molecules, Epstein-Barr virus infection, Human T-cell leukemia virus 1 infection, Leukocyte transendothelial migration, Malaria, Natural killer cell mediated cytotoxicity, Neutrophil extracellular trap formation, Rap1 signaling pathway, Regulation of actin cytoskeleton, Rheumatoid arthritis, Staphylococcus aureus infection, Viral myocarditis 💬 | [7] 11 11, 13, 46, 53, 61, 95, 96 |
999 | RbATG | - | - | - | - | [2] 51 51, 96 |
1000 | RCTB-401 | - | - | - | - | [1] 96 96 |
1001 | Received hormone maintenance therapy | - | - | - | - | [1] 96 96 |
1002 | Recombinant growth hormone | [1] Somatotropin Somatotropin | [1] D02691
D02691
| [1] GHR GHR 💬 | [5] Cytokine-cytokine receptor interaction Cytokine-cytokine receptor interaction, Growth hormone synthesis, secretion and action, JAK-STAT signaling pathway, Neuroactive ligand-receptor interaction, PI3K-Akt signaling pathway 💬 | [2] 78 78, 96 |
1003 | Recombinant human Insulin-like Growth Factor | [1] Insulin human Insulin human | [2] D00085
D00085
,
D03230
| [1] INSR INSR 💬 | [22] AMPK signaling pathway AMPK signaling pathway, Adherens junction, Aldosterone-regulated sodium reabsorption, Alzheimer disease, Diabetic cardiomyopathy, FoxO signaling pathway, HIF-1 signaling pathway, Insulin resistance, Insulin signaling pathway, Longevity regulating pathway, Longevity regulating pathway - multiple species, MAPK signaling pathway, Non-alcoholic fatty liver disease, Ovarian steroidogenesis, PI3K-Akt signaling pathway, Phospholipase D signaling pathway, Rap1 signaling pathway, Ras signaling pathway, Regulation of lipolysis in adipocytes, Type II diabetes mellitus, cGMP-PKG signaling pathway, mTOR signaling pathway 💬 | [1] 96 96 |
1004 | Recombinant Human Interleukin-11 (rhIL-11) | [1] Oprelvekin Oprelvekin | [1] D05266
D05266
| [1] IL11RA IL11RA 💬 | [3] Cytokine-cytokine receptor interaction Cytokine-cytokine receptor interaction, Hematopoietic cell lineage, JAK-STAT signaling pathway 💬 | [1] 96 96 |
1005 | Red light photopheresis | - | - | - | - | [1] 96 96 |
1006 | Release | [1] Manganese citrate Manganese citrate | - | - | - | [12] 6 6, 8, 13, 46, 65, 78, 81, 96, 97, 206, 226, 299 |
1007 | Remestemcel-L | [1] Remestemcel-L Remestemcel-L | [1] D09719
D09719
| - | - | [2] 96 96, 97 |
1008 | Remicade | [1] Infliximab Infliximab | [1] D02598
D02598
| [1] TNF TNF 💬 | [67] AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | [9] 40 40, 46, 49, 56, 84, 85, 96, 97, 271 |
1009 | REMICADE (INFLIXIMAB) | [1] Infliximab Infliximab | [1] D02598
D02598
| [1] TNF TNF 💬 | [67] AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | [3] 46 46, 96, 97 |
1010 | Remicade 100 mg | [1] Infliximab Infliximab | [1] D02598
D02598
| [1] TNF TNF 💬 | [67] AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | [2] 56 56, 96 |
1011 | Remicade 100 mg powder for concentrate for solution for infusion. | [1] Infliximab Infliximab | [1] D02598
D02598
| [1] TNF TNF 💬 | [67] AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | [2] 96 96, 97 |
1012 | Remicade 100 mg pulver til konsentrat til infusjonsvæske, oppløsning | [1] Infliximab Infliximab | [1] D02598
D02598
| [1] TNF TNF 💬 | [67] AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | [4] 46 46, 96, 97, 271 |
1013 | Remisma | - | - | - | - | [1] 96 96 |
1014 | REMSIMA | [1] Infliximab Infliximab | [1] D02598
D02598
| [1] TNF TNF 💬 | [67] AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | [4] 46 46, 96, 97, 271 |
1015 | Remsima (infliximab) | [1] Infliximab Infliximab | [1] D02598
D02598
| [1] TNF TNF 💬 | [67] AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | [3] 46 46, 96, 97 |
1016 | REMSIMA - 100 MG POLVERE PER CONCENTRATO PER SOLUZIONE PER INFUSIONE - USO ENDOVENOSO - FLANCONCINO (VETRO) - 1 FLACONCINO | [1] Infliximab Infliximab | [1] D02598
D02598
| [1] TNF TNF 💬 | [67] AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | [4] 46 46, 96, 97, 271 |
1017 | Remsima 100 mg pulver til konsentrat til infusjonsvæske, oppløsning | [1] Infliximab Infliximab | [1] D02598
D02598
| [1] TNF TNF 💬 | [67] AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | [4] 46 46, 96, 97, 271 |
1018 | Remsima and Inflectra | [1] Infliximab Infliximab | [1] D02598
D02598
| [1] TNF TNF 💬 | [67] AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | [2] 96 96, 97 |
1019 | REMSINA | - | - | - | - | [1] 96 96 |
1020 | Rhamnose | [1] Rhamnose Rhamnose | - | - | - | [1] 96 96 |
1021 | RHB-104 | - | - | - | - | [2] 13 13, 96 |
1022 | RhGH | [1] Somatotropin Somatotropin | [1] D02691
D02691
| [1] GHR GHR 💬 | [5] Cytokine-cytokine receptor interaction Cytokine-cytokine receptor interaction, Growth hormone synthesis, secretion and action, JAK-STAT signaling pathway, Neuroactive ligand-receptor interaction, PI3K-Akt signaling pathway 💬 | [4] 76 76, 78, 96, 193 |
1023 | RhIGF (Increlex) | [1] Mecasermin Mecasermin | [2] D03297
D03297
,
D04870
| [2] GHR GHR, IGF1R 💬 | [33] AMPK signaling pathway AMPK signaling pathway, Adherens junction, Autophagy - animal, Breast cancer, Cytokine-cytokine receptor interaction, EGFR tyrosine kinase inhibitor resistance, Endocrine resistance, Endocytosis, Focal adhesion, FoxO signaling pathway, Glioma, Growth hormone synthesis, secretion and action, HIF-1 signaling pathway, Hepatocellular carcinoma, JAK-STAT signaling pathway, Long-term depression, Longevity regulating pathway, Longevity regulating pathway - multiple species, MAPK signaling pathway, Melanoma, Neuroactive ligand-receptor interaction, Oocyte meiosis, Ovarian steroidogenesis, PI3K-Akt signaling pathway, Pathways in cancer, Progesterone-mediated oocyte maturation, Prostate cancer, Proteoglycans in cancer, Rap1 signaling pathway, Ras signaling pathway, Signaling pathways regulating pluripotency of stem cells, Transcriptional misregulation in cancer, mTOR signaling pathway 💬 | [1] 96 96 |
1024 | RhumAb to Il-17A (IgG1-k-class) | - | - | - | - | [4] 13 13, 46, 56, 96 |
1025 | RhumAb to Il-17A (IgG1-k-class) rhumAb to Il-17A (IgG1-k-class) | - | - | - | - | [1] 96 96 |
1026 | RIBAVIRIN | [1] Ribavirin Ribavirin | [1] D00423
D00423
| - | - | [2] 2 2, 96 |
1027 | Riboflavin | [1] Riboflavin Riboflavin | [3] D00050
D00050
,
D01622
,
D01913
| - | - | [8] 13 13, 38, 46, 96, 97, 162, 168, 265 |
1028 | Riboflavin Sodium Phosphate Injection | [2] Phosphate ion Phosphate ion, Riboflavin | [3] D00050
D00050
,
D01622
,
D01913
| - | - | [1] 96 96 |
1029 | Riboflavin supplementation | [1] Riboflavin Riboflavin | [3] D00050
D00050
,
D01622
,
D01913
| - | - | [1] 96 96 |
1030 | RIFABUTIN | [1] Rifabutin Rifabutin | [1] D00424
D00424
| - | - | [1] 96 96 |
1031 | Rifabutin, Clarithromycin, and Clofazimine | [3] Clarithromycin Clarithromycin, Clofazimine, Rifabutin | [3] D00276
D00276
,
D00278
,
D00424
| - | - | [1] 96 96 |
1032 | Rifaximin | [1] Rifaximin Rifaximin | [1] D02554
D02554
| - | - | [7] 6 6, 65, 93, 96, 97, 99, 296 |
1033 | Rifaximin Delayed Release (DR) | [1] Rifaximin Rifaximin | [1] D02554
D02554
| - | - | [1] 96 96 |
1034 | Rifaximin delayed release 400 mg film coated tablet | [1] Rifaximin Rifaximin | [1] D02554
D02554
| - | - | [1] 96 96 |
1035 | Rifaximin delayed release tablets | [1] Rifaximin Rifaximin | [1] D02554
D02554
| - | - | [1] 96 96 |
1036 | Rifaximin EIR | [1] Rifaximin Rifaximin | [1] D02554
D02554
| - | - | [1] 96 96 |
1037 | Rifaximin+omeprazole+miralax | [2] Omeprazole Omeprazole, Rifaximin | [5] D00455
D00455
,
D01207
,
D02554
,
D05259
,
D05261
| [2] ATP4A ATP4A, ATP4B 💬 | [4] Collecting duct acid secretion Collecting duct acid secretion, Gastric acid secretion, Metabolic pathways, Oxidative phosphorylation 💬 | [1] 96 96 |
1038 | Rifaximin-EIR | [1] Rifaximin Rifaximin | [1] D02554
D02554
| - | - | [1] 96 96 |
1039 | RIFAXIMINA | [1] Rifaximin Rifaximin | [1] D02554
D02554
| - | - | [1] 96 96 |
1040 | Risankizumab | [1] Risankizumab Risankizumab | [1] D11052
D11052
| [1] IL23A IL23A 💬 | [9] C-type lectin receptor signaling pathway C-type lectin receptor signaling pathway, Cytokine-cytokine receptor interaction, Inflammatory bowel disease, JAK-STAT signaling pathway, Pathways in cancer, Pertussis, Rheumatoid arthritis, Th17 cell differentiation, Tuberculosis 💬 | [4] 37 37, 96, 97, 271 |
1041 | Risankizumab 10 mg/ml | [1] Risankizumab Risankizumab | [1] D11052
D11052
| [1] IL23A IL23A 💬 | [9] C-type lectin receptor signaling pathway C-type lectin receptor signaling pathway, Cytokine-cytokine receptor interaction, Inflammatory bowel disease, JAK-STAT signaling pathway, Pathways in cancer, Pertussis, Rheumatoid arthritis, Th17 cell differentiation, Tuberculosis 💬 | [1] 96 96 |
1042 | Risankizumab 180 mg SC | [1] Risankizumab Risankizumab | [1] D11052
D11052
| [1] IL23A IL23A 💬 | [9] C-type lectin receptor signaling pathway C-type lectin receptor signaling pathway, Cytokine-cytokine receptor interaction, Inflammatory bowel disease, JAK-STAT signaling pathway, Pathways in cancer, Pertussis, Rheumatoid arthritis, Th17 cell differentiation, Tuberculosis 💬 | [1] 96 96 |
1043 | Risankizumab 600 mg IV | [1] Risankizumab Risankizumab | [1] D11052
D11052
| [1] IL23A IL23A 💬 | [9] C-type lectin receptor signaling pathway C-type lectin receptor signaling pathway, Cytokine-cytokine receptor interaction, Inflammatory bowel disease, JAK-STAT signaling pathway, Pathways in cancer, Pertussis, Rheumatoid arthritis, Th17 cell differentiation, Tuberculosis 💬 | [1] 96 96 |
1044 | Risankizumab 90 mg/ml | [1] Risankizumab Risankizumab | [1] D11052
D11052
| [1] IL23A IL23A 💬 | [9] C-type lectin receptor signaling pathway C-type lectin receptor signaling pathway, Cytokine-cytokine receptor interaction, Inflammatory bowel disease, JAK-STAT signaling pathway, Pathways in cancer, Pertussis, Rheumatoid arthritis, Th17 cell differentiation, Tuberculosis 💬 | [1] 96 96 |
1045 | Risankizumab IV | [1] Risankizumab Risankizumab | [1] D11052
D11052
| [1] IL23A IL23A 💬 | [9] C-type lectin receptor signaling pathway C-type lectin receptor signaling pathway, Cytokine-cytokine receptor interaction, Inflammatory bowel disease, JAK-STAT signaling pathway, Pathways in cancer, Pertussis, Rheumatoid arthritis, Th17 cell differentiation, Tuberculosis 💬 | [2] 96 96, 97 |
1046 | Risankizumab On-Body Injector (OBI) | [1] Risankizumab Risankizumab | [1] D11052
D11052
| [1] IL23A IL23A 💬 | [9] C-type lectin receptor signaling pathway C-type lectin receptor signaling pathway, Cytokine-cytokine receptor interaction, Inflammatory bowel disease, JAK-STAT signaling pathway, Pathways in cancer, Pertussis, Rheumatoid arthritis, Th17 cell differentiation, Tuberculosis 💬 | [1] 96 96 |
1047 | Risankizumab SC | [1] Risankizumab Risankizumab | [1] D11052
D11052
| [1] IL23A IL23A 💬 | [9] C-type lectin receptor signaling pathway C-type lectin receptor signaling pathway, Cytokine-cytokine receptor interaction, Inflammatory bowel disease, JAK-STAT signaling pathway, Pathways in cancer, Pertussis, Rheumatoid arthritis, Th17 cell differentiation, Tuberculosis 💬 | [2] 96 96, 97 |
1048 | Risedronate | [1] Risedronic acid Risedronic acid | [3] D00942
D00942
,
D03234
,
D08484
| [1] FDPS FDPS 💬 | [4] Human T-cell leukemia virus 1 infection Human T-cell leukemia virus 1 infection, Influenza A, Metabolic pathways, Terpenoid backbone biosynthesis 💬 | [7] 46 46, 50, 66, 96, 107, 113, 274 |
1049 | Ritlecitinib 50 mg | - | - | - | - | [2] 96 96, 97 |
1050 | Ritlecitinib 50mg | - | - | - | - | [1] 96 96 |
1051 | Rituximab | [1] Rituximab Rituximab | [1] D02994
D02994
| [1] MS4A1 MS4A1 💬 | [1] Hematopoietic cell lineage Hematopoietic cell lineage 💬 | [49] 6 6, 11, 13, 14, 17, 19, 35, 36, 41, 42, 43, 44, 45, 46, 49, 50, 51, 52, 53, 55, 56, 60, 61, 63, 64, 65, 66, 83, 84, 85, 86, 93, 94, 96, 97, 127, 162, 222, 229, 256, 271, 274, 283, 284, 285, 288, 296, 300, 331 |
1052 | Rizankisumab | - | - | - | - | [1] 96 96 |
1053 | Rizankizumab | - | - | - | - | [1] 96 96 |
1054 | Ro 549-0261/F04-02 | - | - | - | - | [1] 96 96 |
1055 | Ro 549-0261/F08-02 | - | - | - | - | [1] 96 96 |
1056 | Ro549-0261/F04-02 | - | - | - | - | [1] 96 96 |
1057 | Rosuvastatin | [1] Rosuvastatin Rosuvastatin | [2] D01915
D01915
,
D08492
| [1] HMGCR HMGCR 💬 | [4] AMPK signaling pathway AMPK signaling pathway, Bile secretion, Metabolic pathways, Terpenoid backbone biosynthesis 💬 | [11] 6 6, 18, 46, 49, 51, 56, 79, 96, 97, 271, 299 |
1058 | Rosuvastatin 10 mg | [1] Rosuvastatin Rosuvastatin | [2] D01915
D01915
,
D08492
| [1] HMGCR HMGCR 💬 | [4] AMPK signaling pathway AMPK signaling pathway, Bile secretion, Metabolic pathways, Terpenoid backbone biosynthesis 💬 | [1] 96 96 |
1059 | Routine drainage surgery | - | - | - | - | [1] 96 96 |
1060 | Routine Treatment of CD | - | - | - | - | [1] 96 96 |
1061 | RPC0163 | - | - | - | - | [1] 96 96 |
1062 | RPC1063 | - | - | - | - | [3] 13 13, 96, 97 |
1063 | RPC1063 (equivalent to ozanimod | [1] Ozanimod Ozanimod | [1] D10968
D10968
| [5] S1PR1 S1PR1, S1PR2, S1PR3, S1PR4, S1PR5 💬 | [3] FoxO signaling pathway FoxO signaling pathway, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway 💬 | [1] 96 96 |
1064 | RPC1063 (equivalent to ozanimod HCl) | [1] Ozanimod Ozanimod | [1] D10968
D10968
| [5] S1PR1 S1PR1, S1PR2, S1PR3, S1PR4, S1PR5 💬 | [3] FoxO signaling pathway FoxO signaling pathway, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway 💬 | [1] 96 96 |
1065 | RPC1063 equiv to ozanimod HCI | [1] Ozanimod Ozanimod | [1] D10968
D10968
| [5] S1PR1 S1PR1, S1PR2, S1PR3, S1PR4, S1PR5 💬 | [3] FoxO signaling pathway FoxO signaling pathway, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway 💬 | [1] 96 96 |
1066 | RPC1063 equiv. to ozanimod HCI | [1] Ozanimod Ozanimod | [1] D10968
D10968
| [5] S1PR1 S1PR1, S1PR2, S1PR3, S1PR4, S1PR5 💬 | [3] FoxO signaling pathway FoxO signaling pathway, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway 💬 | [1] 96 96 |
1067 | RR110 (Tamibarotene) | [1] Tamibarotene Tamibarotene | [1] D01418
D01418
| [1] RARA RARA 💬 | [5] Acute myeloid leukemia Acute myeloid leukemia, Estrogen signaling pathway, Pathways in cancer, Th17 cell differentiation, Transcriptional misregulation in cancer 💬 | [1] 96 96 |
1068 | RVG 05565 | - | - | - | - | [1] 96 96 |
1069 | RVG 07151 | - | - | - | - | [1] 96 96 |
1070 | RVG 114681 | - | - | - | - | [1] 96 96 |
1071 | RVG 116648 | - | - | - | - | [1] 96 96 |
1072 | RVG00859 | - | - | - | - | [1] 96 96 |
1073 | RYAH-Medtech Inhaler | - | - | - | - | [5] 2 2, 6, 13, 96, 97 |
1074 | S38 | - | - | - | - | [1] 96 96 |
1075 | Salmon | [1] Salmon, unspecified Salmon, unspecified | - | - | - | [3] 96 96, 97, 225 |
1076 | Salofalk | [1] Mesalazine Mesalazine | [1] D00377
D00377
| - | - | [2] 96 96, 97 |
1077 | Salofalk 500 mg | [1] Mesalazine Mesalazine | [1] D00377
D00377
| - | - | [1] 96 96 |
1078 | Sandostatine | - | - | - | - | [1] 96 96 |
1079 | Sargramostim | [1] Sargramostim Sargramostim | [1] D05803
D05803
| [1] CSF2RA CSF2RA 💬 | [4] Cytokine-cytokine receptor interaction Cytokine-cytokine receptor interaction, Hematopoietic cell lineage, JAK-STAT signaling pathway, Pathways in cancer 💬 | [7] 6 6, 28, 60, 62, 96, 229, 285 |
1080 | Sargramostim (Leukine) | [1] Sargramostim Sargramostim | [1] D05803
D05803
| [1] CSF2RA CSF2RA 💬 | [4] Cytokine-cytokine receptor interaction Cytokine-cytokine receptor interaction, Hematopoietic cell lineage, JAK-STAT signaling pathway, Pathways in cancer 💬 | [1] 96 96 |
1081 | SB5 | - | - | - | - | [5] 46 46, 96, 97, 107, 271 |
1082 | SC12267 | [1] SC12267 SC12267 | - | - | - | [3] 46 46, 96, 97 |
1083 | SC12267 (4SC-101) | [1] SC12267 SC12267 | - | - | - | [3] 46 46, 96, 97 |
1084 | Search for exocrine pancreatic insufficiency at week 0 and 12 | - | - | - | - | [1] 96 96 |
1085 | Selective Immunosuppressive agents | - | - | - | - | [1] 96 96 |
1086 | Selenium | [1] Selenium Selenium | - | - | - | [4] 13 13, 96, 278, 298 |
1087 | Semapimod | [1] Semapimod Semapimod | - | - | - | [1] 96 96 |
1088 | Serine | [1] Serine Serine | [1] D00016
D00016
| - | - | [4] 2 2, 6, 86, 96 |
1089 | SERUM ALBUMINE 5% | - | - | - | - | [1] 96 96 |
1090 | Serum bovine immunoglobulin | - | - | - | - | [2] 96 96, 97 |
1091 | Serum physiologique 0.9 % | - | - | - | - | [1] 96 96 |
1092 | Seton Placement | - | - | - | - | [1] 96 96 |
1093 | Sezione * D.3.6.2.1 - valore: 400mg alla settimana 0, in seguito 200mg ogni due settimane | - | - | - | - | [1] 96 96 |
1094 | Shingrix | [1] Varicella zoster vaccine (recombinant) Varicella zoster vaccine (recombinant) | - | - | - | [3] 46 46, 96, 97 |
1095 | SHP647 | - | - | - | - | [2] 96 96, 97 |
1096 | SHR0302 | - | - | - | - | [4] 46 46, 96, 97, 271 |
1097 | Sibofimloc | [1] Sibofimloc Sibofimloc | [1] D11825
D11825
| - | - | [1] 96 96 |
1098 | Simethicone | [1] Simethicone Simethicone | [1] D05841
D05841
| - | - | [2] 13 13, 96 |
1099 | Sivelestat | [1] Sivelestat Sivelestat | [1] D03788
D03788
| [1] ELANE ELANE 💬 | [3] Neutrophil extracellular trap formation Neutrophil extracellular trap formation, Systemic lupus erythematosus, Transcriptional misregulation in cancer 💬 | [3] 13 13, 85, 96 |
1100 | Small bowel follow trough | - | - | - | - | [1] 96 96 |
1101 | SMOFLipid | [1] Medium-chain triglycerides Medium-chain triglycerides | - | - | - | [1] 96 96 |
1102 | Smoking cigarettes | - | - | - | - | [2] 96 96, 97 |
1103 | Smoking of cannabis | [1] Medical Cannabis Medical Cannabis | - | - | - | [2] 96 96, 97 |
1104 | Sodium chloride | [2] Chloride ion Chloride ion, Sodium chloride | [1] D02056
D02056
| - | - | [21] 6 6, 11, 13, 14, 34, 46, 50, 51, 53, 60, 65, 67, 78, 96, 168, 193, 227, 228, 271, 288, 299 |
1105 | Solid food-based intervention | - | - | - | - | [1] 96 96 |
1106 | Somatropin | [1] Somatotropin Somatotropin | [1] D02691
D02691
| [1] GHR GHR 💬 | [5] Cytokine-cytokine receptor interaction Cytokine-cytokine receptor interaction, Growth hormone synthesis, secretion and action, JAK-STAT signaling pathway, Neuroactive ligand-receptor interaction, PI3K-Akt signaling pathway 💬 | [19] 2 2, 3, 19, 46, 65, 74, 75, 78, 96, 107, 113, 187, 193, 195, 238, 265, 274, 276, 299 |
1107 | Somatropin [rDNA origin] for injection | [1] Somatotropin Somatotropin | [1] D02691
D02691
| [1] GHR GHR 💬 | [5] Cytokine-cytokine receptor interaction Cytokine-cytokine receptor interaction, Growth hormone synthesis, secretion and action, JAK-STAT signaling pathway, Neuroactive ligand-receptor interaction, PI3K-Akt signaling pathway 💬 | [2] 46 46, 96 |
1108 | Somatropin(rhGH) | [1] Somatotropin Somatotropin | [1] D02691
D02691
| [1] GHR GHR 💬 | [5] Cytokine-cytokine receptor interaction Cytokine-cytokine receptor interaction, Growth hormone synthesis, secretion and action, JAK-STAT signaling pathway, Neuroactive ligand-receptor interaction, PI3K-Akt signaling pathway 💬 | [1] 96 96 |
1109 | SonoVue | [1] Sulfur hexafluoride Sulfur hexafluoride | [1] D05962
D05962
| - | - | [1] 96 96 |
1110 | Soy protein | - | - | - | - | [2] 6 6, 96 |
1111 | Soya Bean oil | [1] Bean Bean | - | - | - | [1] 96 96 |
1112 | Spesolilmab | - | - | - | - | [1] 96 96 |
1113 | Spesolimab | [1] Spesolimab Spesolimab | [1] D12066
D12066
| [1] IL1RL2 IL1RL2 💬 | [1] Cytokine-cytokine receptor interaction Cytokine-cytokine receptor interaction 💬 | [3] 37 37, 96, 97 |
1114 | ST10 | - | - | - | - | [1] 96 96 |
1115 | ST10-021 | - | - | - | - | [2] 96 96, 97 |
1116 | STA-5326 | - | - | - | - | [2] 65 65, 96 |
1117 | STA-5326 mesylate | - | - | - | - | [1] 96 96 |
1118 | STA-6838, STA-5326 m, S38 | - | - | - | - | [1] 96 96 |
1119 | Stable isotope infusions | - | - | - | - | [1] 96 96 |
1120 | Standard 2 hours-infusion | - | - | - | - | [2] 96 96, 97 |
1121 | Standard step-up care | - | - | - | - | [1] 96 96 |
1122 | Standart of care | - | - | - | - | [1] 96 96 |
1123 | Start adalimumab in monotherapy | [1] Adalimumab Adalimumab | [1] D02597
D02597
| [1] TNF TNF 💬 | [67] AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | [1] 96 96 |
1124 | Stelara | [1] Ustekinumab Ustekinumab | [1] D09214
D09214
| [3] IL12A IL12A, IL12B, IL23A 💬 | [28] African trypanosomiasis African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Amoebiasis, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Herpes simplex virus 1 infection, Inflammatory bowel disease, Influenza A, JAK-STAT signaling pathway, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, Malaria, Measles, Pathways in cancer, Pertussis, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus 💬 | [6] 49 49, 56, 96, 97, 269, 271 |
1125 | STELARA - 45 MG SOLUZIONE INIETTABILE - USO SOTTOCUTANEO - FLACONCINO (VETRO) 0.5 ML (90 MG/ML) 1 FLACONCINO | [1] Ustekinumab Ustekinumab | [1] D09214
D09214
| [3] IL12A IL12A, IL12B, IL23A 💬 | [28] African trypanosomiasis African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Amoebiasis, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Herpes simplex virus 1 infection, Inflammatory bowel disease, Influenza A, JAK-STAT signaling pathway, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, Malaria, Measles, Pathways in cancer, Pertussis, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus 💬 | [1] 96 96 |
1126 | STELARA - 90 MG - SOLUZIONE INIETTABILE IN SIRINGHE PRERIEMPITE - USO SOTTOCUTANEO - SIRINGA PRERIEMPITA(VETRO) 1 ML(90MG/ML) 1 SIRINGA PRERIEMPITA DA 1 ML | [1] Ustekinumab Ustekinumab | [1] D09214
D09214
| [3] IL12A IL12A, IL12B, IL23A 💬 | [28] African trypanosomiasis African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Amoebiasis, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Herpes simplex virus 1 infection, Inflammatory bowel disease, Influenza A, JAK-STAT signaling pathway, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, Malaria, Measles, Pathways in cancer, Pertussis, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus 💬 | [1] 96 96 |
1127 | STELARA - 90 MG SOLUZIONE INIETTABILE - USO SOTTOCUTANEO - FLACONCINO (VETRO) 1.0 ML (90 MG/ML) 1 FLACONCINO | [1] Ustekinumab Ustekinumab | [1] D09214
D09214
| [3] IL12A IL12A, IL12B, IL23A 💬 | [28] African trypanosomiasis African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Amoebiasis, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Herpes simplex virus 1 infection, Inflammatory bowel disease, Influenza A, JAK-STAT signaling pathway, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, Malaria, Measles, Pathways in cancer, Pertussis, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus 💬 | [2] 96 96, 97 |
1128 | STELARA 130 mg concentrate for solution for infusion | [1] Ustekinumab Ustekinumab | [1] D09214
D09214
| [3] IL12A IL12A, IL12B, IL23A 💬 | [28] African trypanosomiasis African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Amoebiasis, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Herpes simplex virus 1 infection, Inflammatory bowel disease, Influenza A, JAK-STAT signaling pathway, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, Malaria, Measles, Pathways in cancer, Pertussis, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus 💬 | [1] 96 96 |
1129 | Stelara 130mg / 26mL concentrate for solution for | [1] Ustekinumab Ustekinumab | [1] D09214
D09214
| [3] IL12A IL12A, IL12B, IL23A 💬 | [28] African trypanosomiasis African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Amoebiasis, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Herpes simplex virus 1 infection, Inflammatory bowel disease, Influenza A, JAK-STAT signaling pathway, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, Malaria, Measles, Pathways in cancer, Pertussis, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus 💬 | [1] 96 96 |
1130 | Stelara 130mg / 26mL concentrate for solution for infusion | [1] Ustekinumab Ustekinumab | [1] D09214
D09214
| [3] IL12A IL12A, IL12B, IL23A 💬 | [28] African trypanosomiasis African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Amoebiasis, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Herpes simplex virus 1 infection, Inflammatory bowel disease, Influenza A, JAK-STAT signaling pathway, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, Malaria, Measles, Pathways in cancer, Pertussis, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus 💬 | [1] 96 96 |
1131 | STELARA 90 mg solution for injection in pre-filled syringe | [1] Ustekinumab Ustekinumab | [1] D09214
D09214
| [3] IL12A IL12A, IL12B, IL23A 💬 | [28] African trypanosomiasis African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Amoebiasis, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Herpes simplex virus 1 infection, Inflammatory bowel disease, Influenza A, JAK-STAT signaling pathway, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, Malaria, Measles, Pathways in cancer, Pertussis, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus 💬 | [1] 96 96 |
1132 | Stelara 90mg/1ml solution for injecti | [1] Ustekinumab Ustekinumab | [1] D09214
D09214
| [3] IL12A IL12A, IL12B, IL23A 💬 | [28] African trypanosomiasis African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Amoebiasis, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Herpes simplex virus 1 infection, Inflammatory bowel disease, Influenza A, JAK-STAT signaling pathway, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, Malaria, Measles, Pathways in cancer, Pertussis, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus 💬 | [1] 96 96 |
1133 | Stelara 90mg/1ml solution for injection in pre-filled syringe (PFS) | [1] Ustekinumab Ustekinumab | [1] D09214
D09214
| [3] IL12A IL12A, IL12B, IL23A 💬 | [28] African trypanosomiasis African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Amoebiasis, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Herpes simplex virus 1 infection, Inflammatory bowel disease, Influenza A, JAK-STAT signaling pathway, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, Malaria, Measles, Pathways in cancer, Pertussis, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus 💬 | [1] 96 96 |
1134 | Stelara, Remicade, Entyvio, Humira, Remsima, Flixabi, Inflectra | [3] Infliximab Infliximab, Ustekinumab, Vedolizumab | [3] D02598
D02598
,
D08083
,
D09214
| [6] IL12A IL12A, IL12B, IL23A, ITGA4, ITGB7, TNF 💬 | [81] AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Arrhythmogenic right ventricular cardiomyopathy, Asthma, C-type lectin receptor signaling pathway, Cell adhesion molecules, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, ECM-receptor interaction, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Focal adhesion, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Intestinal immune network for IgA production, JAK-STAT signaling pathway, Legionellosis, Leishmaniasis, Leukocyte transendothelial migration, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, Measles, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathogenic Escherichia coli infection, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Regulation of actin cytoskeleton, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toll-like receptor signaling pathway, Toxoplasmosis, Transcriptional misregulation in cancer, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | [1] 96 96 |
1135 | STELARA® | [1] Ustekinumab Ustekinumab | [1] D09214
D09214
| [3] IL12A IL12A, IL12B, IL23A 💬 | [28] African trypanosomiasis African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Amoebiasis, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Herpes simplex virus 1 infection, Inflammatory bowel disease, Influenza A, JAK-STAT signaling pathway, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, Malaria, Measles, Pathways in cancer, Pertussis, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus 💬 | [3] 49 49, 96, 97 |
1136 | STELARA¿ | [1] Ustekinumab Ustekinumab | [1] D09214
D09214
| [3] IL12A IL12A, IL12B, IL23A 💬 | [28] African trypanosomiasis African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Amoebiasis, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Herpes simplex virus 1 infection, Inflammatory bowel disease, Influenza A, JAK-STAT signaling pathway, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, Malaria, Measles, Pathways in cancer, Pertussis, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus 💬 | [1] 96 96 |
1137 | Stem Cells | - | - | - | - | [4] 2 2, 4, 96, 113 |
1138 | Step-up | - | - | - | - | [1] 96 96 |
1139 | Steroids | - | - | - | - | [7] 46 46, 50, 51, 63, 66, 96, 97 |
1140 | Stromal vascular fraction (SVF) | - | - | - | - | [1] 96 96 |
1141 | SUB20016 | - | - | - | - | [1] 96 96 |
1142 | Sucrose | [1] Sucrose Sucrose | [1] D00025
D00025
| - | - | [3] 62 62, 96, 97 |
1143 | Sugar Extract | - | - | - | - | [2] 96 96, 97 |
1144 | Sulfate | [1] Sulfate ion Sulfate ion | - | - | - | [27] 2 2, 3, 6, 11, 13, 26, 28, 34, 36, 46, 49, 53, 60, 64, 66, 79, 85, 86, 96, 111, 218, 222, 226, 265, 296, 297, 299 |
1145 | SULFUR HEXAFLUORIDE | [1] Sulfur hexafluoride Sulfur hexafluoride | [1] D05962
D05962
| - | - | [2] 96 96, 215 |
1146 | Sulphur hexafluoride | [1] Sulfur hexafluoride Sulfur hexafluoride | [1] D05962
D05962
| - | - | [1] 96 96 |
1147 | Suspension containing 250 embryonated, viable Trichuris suis ova (TSO)/15ml | - | - | - | - | [1] 96 96 |
1148 | Suspension containing 250 embryonated, viable TSO/15ml | - | - | - | - | [1] 96 96 |
1149 | Suspension containing 2500 embryonated, viable Trichuris suis ova (TSO)/15ml | - | - | - | - | [1] 96 96 |
1150 | Suspension containing 2500 embryonated, viable TSO/15ml | - | - | - | - | [1] 96 96 |
1151 | Suspension containing 7500 embryonated, viable Trichuris suis ova (TSO)/15ml | - | - | - | - | [1] 96 96 |
1152 | Suspension of 7500 embryonated, viable TSO/15ml | - | - | - | - | [1] 96 96 |
1153 | Suspension of adipose derived autologous adult stem cells | - | - | - | - | [1] 96 96 |
1154 | Synbiotic | - | - | - | - | [1] 96 96 |
1155 | Synbiotic (Synergy I / B.longum) | - | - | - | - | [1] 96 96 |
1156 | T2 | - | - | - | - | [1] 96 96 |
1157 | TA-650 | - | - | - | - | [4] 37 37, 56, 96, 97 |
1158 | Tacrolimus | [1] Tacrolimus Tacrolimus | [2] D00107
D00107
,
D08556
| [5] PPP3CA PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 💬 | [33] Alzheimer disease Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Axon guidance, B cell receptor signaling pathway, C-type lectin receptor signaling pathway, Calcium signaling pathway, Cellular senescence, Dopaminergic synapse, Glucagon signaling pathway, Glutamatergic synapse, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Kaposi sarcoma-associated herpesvirus infection, Lipid and atherosclerosis, Long-term potentiation, MAPK signaling pathway, Natural killer cell mediated cytotoxicity, Oocyte meiosis, Osteoclast differentiation, Oxytocin signaling pathway, PD-L1 expression and PD-1 checkpoint pathway in cancer, Pathways of neurodegeneration - multiple diseases, Prion disease, Renin secretion, T cell receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, Tuberculosis, VEGF signaling pathway, Wnt signaling pathway, cGMP-PKG signaling pathway 💬 | [34] 2 2, 6, 11, 13, 36, 46, 49, 50, 51, 53, 56, 60, 61, 62, 65, 66, 85, 95, 96, 97, 113, 151, 158, 164, 222, 224, 226, 227, 228, 283, 284, 285, 286, 299 |
1159 | TAK-018 | - | - | - | - | [1] 96 96 |
1160 | Tamibarotene | [1] Tamibarotene Tamibarotene | [1] D01418
D01418
| [1] RARA RARA 💬 | [5] Acute myeloid leukemia Acute myeloid leukemia, Estrogen signaling pathway, Pathways in cancer, Th17 cell differentiation, Transcriptional misregulation in cancer 💬 | [2] 26 26, 96 |
1161 | Tasty&Healthy intervention group | - | - | - | - | [1] 96 96 |
1162 | TBC | - | - | - | - | [3] 85 85, 94, 96 |
1163 | TD-1473 | - | - | - | - | [2] 96 96, 97 |
1164 | Teduglutide | [1] Teduglutide Teduglutide | [1] D06053
D06053
| [1] GLP2R GLP2R 💬 | [1] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | [1] 96 96 |
1165 | Teduglutide (ALX-0600) | [1] Teduglutide Teduglutide | [1] D06053
D06053
| [1] GLP2R GLP2R 💬 | [1] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | [1] 96 96 |
1166 | Teduglutide 0.05 | [1] Teduglutide Teduglutide | [1] D06053
D06053
| [1] GLP2R GLP2R 💬 | [1] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | [1] 96 96 |
1167 | Teduglutide 0.05 dose | [1] Teduglutide Teduglutide | [1] D06053
D06053
| [1] GLP2R GLP2R 💬 | [1] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | [1] 96 96 |
1168 | Teduglutide 0.1 mg dose | [1] Teduglutide Teduglutide | [1] D06053
D06053
| [1] GLP2R GLP2R 💬 | [1] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | [1] 96 96 |
1169 | Teduglutide 0.2 mg | [1] Teduglutide Teduglutide | [1] D06053
D06053
| [1] GLP2R GLP2R 💬 | [1] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | [1] 96 96 |
1170 | Terbinafine | [1] Terbinafine Terbinafine | [2] D02219
D02219
,
D02375
| - | - | [3] 96 96, 97, 271 |
1171 | Tetomilast | [1] Tetomilast Tetomilast | - | - | - | [2] 96 96, 97 |
1172 | TH-SC01 | - | - | - | - | [1] 96 96 |
1173 | Thalidomide | [1] Thalidomide Thalidomide | [1] D00754
D00754
| [1] TNF TNF 💬 | [67] AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | [20] 2 2, 16, 20, 28, 49, 51, 53, 56, 65, 84, 85, 94, 96, 97, 227, 271, 280, 298, 300, 331 |
1174 | THALIDOMIDE CELGENE - 50 MG CAPSULA RIGIDA - USO ORALE - BLISTER (PVC/PE/ACLAR/ALU) 28 CAPSULE | [1] Thalidomide Thalidomide | [1] D00754
D00754
| [1] TNF TNF 💬 | [67] AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | [1] 96 96 |
1175 | Thalidomide Pharmion | [1] Thalidomide Thalidomide | [1] D00754
D00754
| [1] TNF TNF 💬 | [67] AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | [3] 85 85, 96, 97 |
1176 | THC | - | - | - | - | [5] 8 8, 13, 36, 46, 96 |
1177 | THC 5mg/ml and CBS 50mg/ml | - | - | - | - | [1] 96 96 |
1178 | The investigational medicinal product (IMP) may be labelled as either PF-04236921 106 mg/vial, Clonal SC lyophilized form” or PF-04236921 Powder for Injection, 106 mg/vial”. Supplies labelled with either nomenclature are equivalent. | - | - | - | - | [1] 96 96 |
1179 | The investigational medicinal product (IMP) will be labeled as PF-04236921 106 mg/vial, Clonal SC lyophilized form, which is equivalent to PF-04236921 Powder for Injection, 106 mg/vial as described in the enclosed CTA | - | - | - | - | [1] 96 96 |
1180 | The investigational medicinal product (IMP) will be labeled as PF-04236921 106 mg/vial, Clonal SC lyophilized form, which is equivalent to PF-04236921 Powder for Injection, 106 mg/vial as described in the enclosed CTA. | - | - | - | - | [1] 96 96 |
1181 | Thetanix | - | - | - | - | [1] 96 96 |
1182 | Thiopurine | - | - | - | - | [1] 96 96 |
1183 | Thiosix | - | - | - | - | [1] 96 96 |
1184 | Thiotepa | [1] Thiotepa Thiotepa | [1] D00583
D00583
| - | - | [12] 13 13, 19, 20, 28, 51, 60, 65, 85, 96, 164, 284, 285 |
1185 | Threonine | [1] Threonine Threonine | [1] D00041
D00041
| - | - | [3] 86 86, 96, 97 |
1186 | THRX-139060 | - | - | - | - | [2] 96 96, 97 |
1187 | Thymoglobulin | [1] Antithymocyte immunoglobulin (rabbit) Antithymocyte immunoglobulin (rabbit) | - | - | - | [7] 36 36, 51, 60, 65, 96, 285, 326 |
1188 | THYMOGLOBULINE | [1] Antithymocyte immunoglobulin (rabbit) Antithymocyte immunoglobulin (rabbit) | - | - | - | [5] 13 13, 36, 51, 60, 96 |
1189 | Ticilimumab | [1] Tremelimumab Tremelimumab | [1] D06657
D06657
| [1] CTLA4 CTLA4 💬 | [4] Autoimmune thyroid disease Autoimmune thyroid disease, Cell adhesion molecules, Rheumatoid arthritis, T cell receptor signaling pathway 💬 | [1] 96 96 |
1190 | Time and attention | - | - | - | - | [1] 96 96 |
1191 | Time and attention + active fructooligosaccharide supplementation | - | - | - | - | [1] 96 96 |
1192 | TNF kinoid | - | - | - | - | [2] 46 46, 96 |
1193 | TNF-alpha antagonists | - | - | - | - | [3] 46 46, 96, 271 |
1194 | TNF-K | - | - | - | - | [2] 46 46, 96 |
1195 | TNF-Kinoid | - | - | - | - | [2] 46 46, 96 |
1196 | TNFa Kinoid | - | - | - | - | [2] 46 46, 96 |
1197 | TNFa-Kinoid | - | - | - | - | [1] 96 96 |
1198 | To be determined | - | - | - | - | [2] 96 96, 113 |
1199 | To be requested | - | - | - | - | [2] 96 96, 97 |
1200 | Tofacitinib | [1] Tofacitinib Tofacitinib | [1] D09970
D09970
| [4] JAK1 JAK1, JAK2, JAK3, TYK2 💬 | [37] AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, Chemical carcinogenesis - receptor activation, Chemokine signaling pathway, Cholinergic synapse, Coronavirus disease - COVID-19, EGFR tyrosine kinase inhibitor resistance, Epstein-Barr virus infection, Growth hormone synthesis, secretion and action, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Lipid and atherosclerosis, Measles, NOD-like receptor signaling pathway, Necroptosis, Non-small cell lung cancer, Osteoclast differentiation, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Pathways in cancer, Primary immunodeficiency, Prolactin signaling pathway, Signaling pathways regulating pluripotency of stem cells, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toxoplasmosis, Tuberculosis, Viral carcinogenesis 💬 | [15] 11 11, 40, 44, 46, 49, 50, 51, 53, 65, 84, 96, 97, 107, 256, 271 |
1201 | Tofacitinib (CP-690,550) | [1] Tofacitinib Tofacitinib | [1] D09970
D09970
| [4] JAK1 JAK1, JAK2, JAK3, TYK2 💬 | [37] AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, Chemical carcinogenesis - receptor activation, Chemokine signaling pathway, Cholinergic synapse, Coronavirus disease - COVID-19, EGFR tyrosine kinase inhibitor resistance, Epstein-Barr virus infection, Growth hormone synthesis, secretion and action, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Lipid and atherosclerosis, Measles, NOD-like receptor signaling pathway, Necroptosis, Non-small cell lung cancer, Osteoclast differentiation, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Pathways in cancer, Primary immunodeficiency, Prolactin signaling pathway, Signaling pathways regulating pluripotency of stem cells, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toxoplasmosis, Tuberculosis, Viral carcinogenesis 💬 | [1] 96 96 |
1202 | Tolerogenic dendritic cells | - | - | - | - | [2] 46 46, 96 |
1203 | Top-down | - | - | - | - | [1] 96 96 |
1204 | TR004 (Treg immunotherapy) | - | - | - | - | [1] 96 96 |
1205 | Transfusion | - | - | - | - | [1] 96 96 |
1206 | Treatment according to current standards without knowledge of serum infliximab and anti-infliximab Ab status | [1] Infliximab Infliximab | [1] D02598
D02598
| [1] TNF TNF 💬 | [67] AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | [1] 96 96 |
1207 | Treatment with Adalimumab | [1] Adalimumab Adalimumab | [1] D02597
D02597
| [1] TNF TNF 💬 | [67] AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | [1] 96 96 |
1208 | Triamcinolone | [1] Triamcinolone Triamcinolone | [5] D00385
D00385
,
D00983
,
D00984
,
D00985
,
D06216
| [1] NR3C1 NR3C1 💬 | [1] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | [10] 35 35, 46, 56, 70, 90, 96, 107, 162, 226, 298 |
1209 | Trichuris suis eggs | - | - | - | - | [3] 13 13, 96, 97 |
1210 | Trichuris suis Ova | - | - | - | - | [4] 13 13, 46, 96, 97 |
1211 | Trichuris suis ova (TSO) | - | - | - | - | [2] 96 96, 97 |
1212 | Trichuris trichiura eggs | - | - | - | - | [1] 96 96 |
1213 | Tripterygium | [1] Tripterygium wilfordii whole Tripterygium wilfordii whole | - | - | - | [8] 46 46, 66, 67, 96, 162, 222, 224, 271 |
1214 | Tripterygium glycosides | [1] Tripterygium wilfordii whole Tripterygium wilfordii whole | - | - | - | [1] 96 96 |
1215 | Tris | [1] Tromethamine Tromethamine | [1] D00396
D00396
| - | - | [2] 96 96, 97 |
1216 | TRK-170 | - | - | - | - | [1] 96 96 |
1217 | TSO 250 | - | - | - | - | [1] 96 96 |
1218 | TSO 2500 | - | - | - | - | [1] 96 96 |
1219 | TSO 7500 | - | - | - | - | [1] 96 96 |
1220 | TU-100 | [1] TU-100 TU-100 | - | - | - | [1] 96 96 |
1221 | TV-5600 | - | - | - | - | [3] 8 8, 13, 96 |
1222 | UC-MSCs | [1] Human Umbilical Cord Mesenchymal Stem Cells Human Umbilical Cord Mesenchymal Stem Cells | - | - | - | [2] 46 46, 96 |
1223 | Ultrasound Elastography | - | - | - | - | [1] 96 96 |
1224 | Ultrasound Imaging | - | - | - | - | [1] 96 96 |
1225 | Ultrasound Microbubble Contrast Agent | - | - | - | - | [1] 96 96 |
1226 | Ultrasound Vascularity | - | - | - | - | [1] 96 96 |
1227 | Undetermined | - | - | - | - | [1] 96 96 |
1228 | Upadacitinib | [1] Upadacitinib Upadacitinib | [1] D10994
D10994
| [1] JAK1 JAK1 💬 | [27] Coronavirus disease - COVID-19 Coronavirus disease - COVID-19, EGFR tyrosine kinase inhibitor resistance, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Measles, NOD-like receptor signaling pathway, Necroptosis, Osteoclast differentiation, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Pathways in cancer, Signaling pathways regulating pluripotency of stem cells, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toxoplasmosis, Tuberculosis, Viral carcinogenesis 💬 | [8] 40 40, 41, 46, 49, 96, 97, 107, 271 |
1229 | Upadaticitib | - | - | - | - | [1] 96 96 |
1230 | Ursodeoxycholic acid | [1] Ursodeoxycholic acid Ursodeoxycholic acid | [1] D00734
D00734
| [1] NR1H4 NR1H4 💬 | [1] Bile secretion Bile secretion 💬 | [9] 6 6, 46, 67, 84, 93, 94, 95, 96, 97 |
1231 | Ursofalk | [1] Ursodeoxycholic acid Ursodeoxycholic acid | [1] D00734
D00734
| [1] NR1H4 NR1H4 💬 | [1] Bile secretion Bile secretion 💬 | [4] 93 93, 94, 96, 97 |
1232 | UrsoFalk® 250 mg tabletten. | [1] Ursodeoxycholic acid Ursodeoxycholic acid | [1] D00734
D00734
| [1] NR1H4 NR1H4 💬 | [1] Bile secretion Bile secretion 💬 | [1] 96 96 |
1233 | US TAP Bupivacaine/Epinephrine | [2] Bupivacaine Bupivacaine, Epinephrine | [5] D00095
D00095
,
D00996
,
D01450
,
D02149
,
D07552
| [14] ADRA1A ADRA1A, ADRA1B, ADRA1D, ADRA2A, ADRA2B, ADRA2C, ADRB1, ADRB2, ADRB3, SCN1A, SCN2A, SCN3A, SCN5A, SCN9A 💬 | [16] AMPK signaling pathway AMPK signaling pathway, Adrenergic signaling in cardiomyocytes, Calcium signaling pathway, Chemical carcinogenesis - receptor activation, Dilated cardiomyopathy, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Regulation of lipolysis in adipocytes, Renin secretion, Salivary secretion, Taste transduction, Thermogenesis, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬 | [1] 96 96 |
1234 | Ustekinumab | [1] Ustekinumab Ustekinumab | [1] D09214
D09214
| [3] IL12A IL12A, IL12B, IL23A 💬 | [28] African trypanosomiasis African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Amoebiasis, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Herpes simplex virus 1 infection, Inflammatory bowel disease, Influenza A, JAK-STAT signaling pathway, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, Malaria, Measles, Pathways in cancer, Pertussis, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus 💬 | [17] 37 37, 40, 41, 46, 49, 50, 53, 56, 65, 84, 93, 96, 97, 160, 162, 269, 271 |
1235 | Ustekinumab (6 mg/kg) | [1] Ustekinumab Ustekinumab | [1] D09214
D09214
| [3] IL12A IL12A, IL12B, IL23A 💬 | [28] African trypanosomiasis African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Amoebiasis, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Herpes simplex virus 1 infection, Inflammatory bowel disease, Influenza A, JAK-STAT signaling pathway, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, Malaria, Measles, Pathways in cancer, Pertussis, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus 💬 | [1] 96 96 |
1236 | Ustekinumab (90 mg) | [1] Ustekinumab Ustekinumab | [1] D09214
D09214
| [3] IL12A IL12A, IL12B, IL23A 💬 | [28] African trypanosomiasis African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Amoebiasis, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Herpes simplex virus 1 infection, Inflammatory bowel disease, Influenza A, JAK-STAT signaling pathway, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, Malaria, Measles, Pathways in cancer, Pertussis, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus 💬 | [1] 96 96 |
1237 | Ustekinumab 130 mg IV | [1] Ustekinumab Ustekinumab | [1] D09214
D09214
| [3] IL12A IL12A, IL12B, IL23A 💬 | [28] African trypanosomiasis African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Amoebiasis, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Herpes simplex virus 1 infection, Inflammatory bowel disease, Influenza A, JAK-STAT signaling pathway, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, Malaria, Measles, Pathways in cancer, Pertussis, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus 💬 | [1] 96 96 |
1238 | Ustekinumab 1mg/kg (IP) | [1] Ustekinumab Ustekinumab | [1] D09214
D09214
| [3] IL12A IL12A, IL12B, IL23A 💬 | [28] African trypanosomiasis African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Amoebiasis, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Herpes simplex virus 1 infection, Inflammatory bowel disease, Influenza A, JAK-STAT signaling pathway, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, Malaria, Measles, Pathways in cancer, Pertussis, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus 💬 | [1] 96 96 |
1239 | Ustekinumab 3 mg/kg (IP) | [1] Ustekinumab Ustekinumab | [1] D09214
D09214
| [3] IL12A IL12A, IL12B, IL23A 💬 | [28] African trypanosomiasis African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Amoebiasis, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Herpes simplex virus 1 infection, Inflammatory bowel disease, Influenza A, JAK-STAT signaling pathway, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, Malaria, Measles, Pathways in cancer, Pertussis, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus 💬 | [1] 96 96 |
1240 | Ustekinumab 4.5 mg/kg | [1] Ustekinumab Ustekinumab | [1] D09214
D09214
| [3] IL12A IL12A, IL12B, IL23A 💬 | [28] African trypanosomiasis African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Amoebiasis, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Herpes simplex virus 1 infection, Inflammatory bowel disease, Influenza A, JAK-STAT signaling pathway, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, Malaria, Measles, Pathways in cancer, Pertussis, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus 💬 | [1] 96 96 |
1241 | Ustekinumab 6 mg/kg (IP) | [1] Ustekinumab Ustekinumab | [1] D09214
D09214
| [3] IL12A IL12A, IL12B, IL23A 💬 | [28] African trypanosomiasis African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Amoebiasis, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Herpes simplex virus 1 infection, Inflammatory bowel disease, Influenza A, JAK-STAT signaling pathway, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, Malaria, Measles, Pathways in cancer, Pertussis, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus 💬 | [1] 96 96 |
1242 | Ustekinumab 90 mg | [1] Ustekinumab Ustekinumab | [1] D09214
D09214
| [3] IL12A IL12A, IL12B, IL23A 💬 | [28] African trypanosomiasis African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Amoebiasis, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Herpes simplex virus 1 infection, Inflammatory bowel disease, Influenza A, JAK-STAT signaling pathway, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, Malaria, Measles, Pathways in cancer, Pertussis, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus 💬 | [4] 49 49, 50, 93, 96 |
1243 | Ustekinumab 90 mg (SC) Group 1 | [1] Ustekinumab Ustekinumab | [1] D09214
D09214
| [3] IL12A IL12A, IL12B, IL23A 💬 | [28] African trypanosomiasis African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Amoebiasis, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Herpes simplex virus 1 infection, Inflammatory bowel disease, Influenza A, JAK-STAT signaling pathway, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, Malaria, Measles, Pathways in cancer, Pertussis, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus 💬 | [1] 96 96 |
1244 | Ustekinumab 90 mg (SC) Group 2 | [1] Ustekinumab Ustekinumab | [1] D09214
D09214
| [3] IL12A IL12A, IL12B, IL23A 💬 | [28] African trypanosomiasis African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Amoebiasis, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Herpes simplex virus 1 infection, Inflammatory bowel disease, Influenza A, JAK-STAT signaling pathway, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, Malaria, Measles, Pathways in cancer, Pertussis, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus 💬 | [1] 96 96 |
1245 | Ustekinumab 90 mg SC q12w | [1] Ustekinumab Ustekinumab | [1] D09214
D09214
| [3] IL12A IL12A, IL12B, IL23A 💬 | [28] African trypanosomiasis African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Amoebiasis, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Herpes simplex virus 1 infection, Inflammatory bowel disease, Influenza A, JAK-STAT signaling pathway, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, Malaria, Measles, Pathways in cancer, Pertussis, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus 💬 | [1] 96 96 |
1246 | Ustekinumab 90 mg SC q8w | [1] Ustekinumab Ustekinumab | [1] D09214
D09214
| [3] IL12A IL12A, IL12B, IL23A 💬 | [28] African trypanosomiasis African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Amoebiasis, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Herpes simplex virus 1 infection, Inflammatory bowel disease, Influenza A, JAK-STAT signaling pathway, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, Malaria, Measles, Pathways in cancer, Pertussis, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus 💬 | [1] 96 96 |
1247 | Ustekinumab approximately 6 mg/kg (IV) | [1] Ustekinumab Ustekinumab | [1] D09214
D09214
| [3] IL12A IL12A, IL12B, IL23A 💬 | [28] African trypanosomiasis African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Amoebiasis, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Herpes simplex virus 1 infection, Inflammatory bowel disease, Influenza A, JAK-STAT signaling pathway, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, Malaria, Measles, Pathways in cancer, Pertussis, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus 💬 | [1] 96 96 |
1248 | Ustekinumab Injection [Stelara] | [1] Ustekinumab Ustekinumab | [1] D09214
D09214
| [3] IL12A IL12A, IL12B, IL23A 💬 | [28] African trypanosomiasis African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Amoebiasis, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Herpes simplex virus 1 infection, Inflammatory bowel disease, Influenza A, JAK-STAT signaling pathway, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, Malaria, Measles, Pathways in cancer, Pertussis, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus 💬 | [1] 96 96 |
1249 | Ustekinumab IV - Nonresponder - Ustekinumab 90mg SC (MP) | [1] Ustekinumab Ustekinumab | [1] D09214
D09214
| [3] IL12A IL12A, IL12B, IL23A 💬 | [28] African trypanosomiasis African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Amoebiasis, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Herpes simplex virus 1 infection, Inflammatory bowel disease, Influenza A, JAK-STAT signaling pathway, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, Malaria, Measles, Pathways in cancer, Pertussis, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus 💬 | [1] 96 96 |
1250 | Ustekinumab IV - Responder - Ustekinumab 90mg SC (MP) | [1] Ustekinumab Ustekinumab | [1] D09214
D09214
| [3] IL12A IL12A, IL12B, IL23A 💬 | [28] African trypanosomiasis African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Amoebiasis, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Herpes simplex virus 1 infection, Inflammatory bowel disease, Influenza A, JAK-STAT signaling pathway, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, Malaria, Measles, Pathways in cancer, Pertussis, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus 💬 | [1] 96 96 |
1251 | Ustekinumab IV Infusion | [1] Ustekinumab Ustekinumab | [1] D09214
D09214
| [3] IL12A IL12A, IL12B, IL23A 💬 | [28] African trypanosomiasis African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Amoebiasis, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Herpes simplex virus 1 infection, Inflammatory bowel disease, Influenza A, JAK-STAT signaling pathway, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, Malaria, Measles, Pathways in cancer, Pertussis, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus 💬 | [2] 96 96, 97 |
1252 | Ustekinumab SC Injection | [1] Ustekinumab Ustekinumab | [1] D09214
D09214
| [3] IL12A IL12A, IL12B, IL23A 💬 | [28] African trypanosomiasis African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Amoebiasis, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Herpes simplex virus 1 infection, Inflammatory bowel disease, Influenza A, JAK-STAT signaling pathway, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, Malaria, Measles, Pathways in cancer, Pertussis, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus 💬 | [2] 96 96, 97 |
1253 | Usual current care | - | - | - | - | [2] 96 96, 97 |
1254 | UTTR1147A | - | - | - | - | [2] 96 96, 97 |
1255 | UTTR1147A, IL22-Fc, IL-22Fc | [1] Efmarodocokin alfa Efmarodocokin alfa | [1] D11953
D11953
| [1] IL22 IL22 💬 | [4] Cytokine-cytokine receptor interaction Cytokine-cytokine receptor interaction, Inflammatory bowel disease, JAK-STAT signaling pathway, Th17 cell differentiation 💬 | [2] 96 96, 97 |
1256 | UTTR1147A/RO7021610 (Active) | - | - | - | - | [2] 96 96, 97 |
1257 | UVADEX | [1] Methoxsalen Methoxsalen | [1] D00139
D00139
| - | - | [2] 46 46, 96 |
1258 | UVADEX and UVAR XTS Photopheresis System | [1] Methoxsalen Methoxsalen | [1] D00139
D00139
| - | - | [1] 96 96 |
1259 | V565 | - | - | - | - | [2] 96 96, 97 |
1260 | Vancomycin | [1] Vancomycin Vancomycin | [2] D00212
D00212
,
D00926
| - | - | [7] 46 46, 70, 94, 96, 97, 296, 299 |
1261 | VEDOLIZUMAB | [1] Vedolizumab Vedolizumab | [1] D08083
D08083
| [2] ITGA4 ITGA4, ITGB7 💬 | [15] Arrhythmogenic right ventricular cardiomyopathy Arrhythmogenic right ventricular cardiomyopathy, Cell adhesion molecules, Dilated cardiomyopathy, ECM-receptor interaction, Focal adhesion, Hematopoietic cell lineage, Human papillomavirus infection, Hypertrophic cardiomyopathy, Intestinal immune network for IgA production, Leishmaniasis, Leukocyte transendothelial migration, PI3K-Akt signaling pathway, Regulation of actin cytoskeleton, Transcriptional misregulation in cancer, Yersinia infection 💬 | [3] 94 94, 96, 97 |
1262 | Vedolizumab (Genetical Recombination) | [1] Vedolizumab Vedolizumab | [1] D08083
D08083
| [2] ITGA4 ITGA4, ITGB7 💬 | [15] Arrhythmogenic right ventricular cardiomyopathy Arrhythmogenic right ventricular cardiomyopathy, Cell adhesion molecules, Dilated cardiomyopathy, ECM-receptor interaction, Focal adhesion, Hematopoietic cell lineage, Human papillomavirus infection, Hypertrophic cardiomyopathy, Intestinal immune network for IgA production, Leishmaniasis, Leukocyte transendothelial migration, PI3K-Akt signaling pathway, Regulation of actin cytoskeleton, Transcriptional misregulation in cancer, Yersinia infection 💬 | [1] 96 96 |
1263 | Vedolizumab 300 MG Injection [Entyvio] | [1] Vedolizumab Vedolizumab | [1] D08083
D08083
| [2] ITGA4 ITGA4, ITGB7 💬 | [15] Arrhythmogenic right ventricular cardiomyopathy Arrhythmogenic right ventricular cardiomyopathy, Cell adhesion molecules, Dilated cardiomyopathy, ECM-receptor interaction, Focal adhesion, Hematopoietic cell lineage, Human papillomavirus infection, Hypertrophic cardiomyopathy, Intestinal immune network for IgA production, Leishmaniasis, Leukocyte transendothelial migration, PI3K-Akt signaling pathway, Regulation of actin cytoskeleton, Transcriptional misregulation in cancer, Yersinia infection 💬 | [1] 96 96 |
1264 | Vedolizumab intravenous injection | [1] Vedolizumab Vedolizumab | [1] D08083
D08083
| [2] ITGA4 ITGA4, ITGB7 💬 | [15] Arrhythmogenic right ventricular cardiomyopathy Arrhythmogenic right ventricular cardiomyopathy, Cell adhesion molecules, Dilated cardiomyopathy, ECM-receptor interaction, Focal adhesion, Hematopoietic cell lineage, Human papillomavirus infection, Hypertrophic cardiomyopathy, Intestinal immune network for IgA production, Leishmaniasis, Leukocyte transendothelial migration, PI3K-Akt signaling pathway, Regulation of actin cytoskeleton, Transcriptional misregulation in cancer, Yersinia infection 💬 | [2] 96 96, 97 |
1265 | Vedolizumab IV | [1] Vedolizumab Vedolizumab | [1] D08083
D08083
| [2] ITGA4 ITGA4, ITGB7 💬 | [15] Arrhythmogenic right ventricular cardiomyopathy Arrhythmogenic right ventricular cardiomyopathy, Cell adhesion molecules, Dilated cardiomyopathy, ECM-receptor interaction, Focal adhesion, Hematopoietic cell lineage, Human papillomavirus infection, Hypertrophic cardiomyopathy, Intestinal immune network for IgA production, Leishmaniasis, Leukocyte transendothelial migration, PI3K-Akt signaling pathway, Regulation of actin cytoskeleton, Transcriptional misregulation in cancer, Yersinia infection 💬 | [3] 94 94, 96, 97 |
1266 | Vedolizumab IV (Entyvio¿) | [1] Vedolizumab Vedolizumab | [1] D08083
D08083
| [2] ITGA4 ITGA4, ITGB7 💬 | [15] Arrhythmogenic right ventricular cardiomyopathy Arrhythmogenic right ventricular cardiomyopathy, Cell adhesion molecules, Dilated cardiomyopathy, ECM-receptor interaction, Focal adhesion, Hematopoietic cell lineage, Human papillomavirus infection, Hypertrophic cardiomyopathy, Intestinal immune network for IgA production, Leishmaniasis, Leukocyte transendothelial migration, PI3K-Akt signaling pathway, Regulation of actin cytoskeleton, Transcriptional misregulation in cancer, Yersinia infection 💬 | [1] 96 96 |
1267 | Vedolizumab IV (Entyvio™) | [1] Vedolizumab Vedolizumab | [1] D08083
D08083
| [2] ITGA4 ITGA4, ITGB7 💬 | [15] Arrhythmogenic right ventricular cardiomyopathy Arrhythmogenic right ventricular cardiomyopathy, Cell adhesion molecules, Dilated cardiomyopathy, ECM-receptor interaction, Focal adhesion, Hematopoietic cell lineage, Human papillomavirus infection, Hypertrophic cardiomyopathy, Intestinal immune network for IgA production, Leishmaniasis, Leukocyte transendothelial migration, PI3K-Akt signaling pathway, Regulation of actin cytoskeleton, Transcriptional misregulation in cancer, Yersinia infection 💬 | [1] 96 96 |
1268 | Vedolizumab IV 300 mg | [1] Vedolizumab Vedolizumab | [1] D08083
D08083
| [2] ITGA4 ITGA4, ITGB7 💬 | [15] Arrhythmogenic right ventricular cardiomyopathy Arrhythmogenic right ventricular cardiomyopathy, Cell adhesion molecules, Dilated cardiomyopathy, ECM-receptor interaction, Focal adhesion, Hematopoietic cell lineage, Human papillomavirus infection, Hypertrophic cardiomyopathy, Intestinal immune network for IgA production, Leishmaniasis, Leukocyte transendothelial migration, PI3K-Akt signaling pathway, Regulation of actin cytoskeleton, Transcriptional misregulation in cancer, Yersinia infection 💬 | [1] 96 96 |
1269 | Vedolizumab SC | [1] Vedolizumab Vedolizumab | [1] D08083
D08083
| [2] ITGA4 ITGA4, ITGB7 💬 | [15] Arrhythmogenic right ventricular cardiomyopathy Arrhythmogenic right ventricular cardiomyopathy, Cell adhesion molecules, Dilated cardiomyopathy, ECM-receptor interaction, Focal adhesion, Hematopoietic cell lineage, Human papillomavirus infection, Hypertrophic cardiomyopathy, Intestinal immune network for IgA production, Leishmaniasis, Leukocyte transendothelial migration, PI3K-Akt signaling pathway, Regulation of actin cytoskeleton, Transcriptional misregulation in cancer, Yersinia infection 💬 | [2] 96 96, 97 |
1270 | Vedolizumab SC 108 mg | [1] Vedolizumab Vedolizumab | [1] D08083
D08083
| [2] ITGA4 ITGA4, ITGB7 💬 | [15] Arrhythmogenic right ventricular cardiomyopathy Arrhythmogenic right ventricular cardiomyopathy, Cell adhesion molecules, Dilated cardiomyopathy, ECM-receptor interaction, Focal adhesion, Hematopoietic cell lineage, Human papillomavirus infection, Hypertrophic cardiomyopathy, Intestinal immune network for IgA production, Leishmaniasis, Leukocyte transendothelial migration, PI3K-Akt signaling pathway, Regulation of actin cytoskeleton, Transcriptional misregulation in cancer, Yersinia infection 💬 | [2] 96 96, 97 |
1271 | Vedolizumab subcutaneous injection | [1] Vedolizumab Vedolizumab | [1] D08083
D08083
| [2] ITGA4 ITGA4, ITGB7 💬 | [15] Arrhythmogenic right ventricular cardiomyopathy Arrhythmogenic right ventricular cardiomyopathy, Cell adhesion molecules, Dilated cardiomyopathy, ECM-receptor interaction, Focal adhesion, Hematopoietic cell lineage, Human papillomavirus infection, Hypertrophic cardiomyopathy, Intestinal immune network for IgA production, Leishmaniasis, Leukocyte transendothelial migration, PI3K-Akt signaling pathway, Regulation of actin cytoskeleton, Transcriptional misregulation in cancer, Yersinia infection 💬 | [2] 96 96, 97 |
1272 | Vedolizumab-800CW | [1] Vedolizumab Vedolizumab | [1] D08083
D08083
| [2] ITGA4 ITGA4, ITGB7 💬 | [15] Arrhythmogenic right ventricular cardiomyopathy Arrhythmogenic right ventricular cardiomyopathy, Cell adhesion molecules, Dilated cardiomyopathy, ECM-receptor interaction, Focal adhesion, Hematopoietic cell lineage, Human papillomavirus infection, Hypertrophic cardiomyopathy, Intestinal immune network for IgA production, Leishmaniasis, Leukocyte transendothelial migration, PI3K-Akt signaling pathway, Regulation of actin cytoskeleton, Transcriptional misregulation in cancer, Yersinia infection 💬 | [1] 96 96 |
1273 | Vehice Control | - | - | - | - | [1] 96 96 |
1274 | Verapamil | [1] Verapamil Verapamil | [2] D00619
D00619
,
D02356
| [4] CACNA1C CACNA1C, CACNA1D, CACNA1F, CACNA1S 💬 | [37] Adrenergic signaling in cardiomyocytes Adrenergic signaling in cardiomyocytes, Aldosterone synthesis and secretion, Alzheimer disease, Amphetamine addiction, Arrhythmogenic right ventricular cardiomyopathy, Calcium signaling pathway, Carbohydrate digestion and absorption, Cardiac muscle contraction, Cellular senescence, Chemical carcinogenesis - receptor activation, Cholinergic synapse, Circadian entrainment, Cortisol synthesis and secretion, Cushing syndrome, Dilated cardiomyopathy, Dopaminergic synapse, GABAergic synapse, Glutamatergic synapse, GnRH secretion, GnRH signaling pathway, Growth hormone synthesis, secretion and action, Hypertrophic cardiomyopathy, Insulin secretion, Long-term potentiation, MAPK signaling pathway, Oxytocin signaling pathway, Pathways of neurodegeneration - multiple diseases, Prion disease, Renin secretion, Retrograde endocannabinoid signaling, Serotonergic synapse, Taste transduction, Tight junction, Type II diabetes mellitus, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬 | [3] 96 96, 140, 167 |
1275 | VIAGRA | [1] Sildenafil Sildenafil | [2] D02229
D02229
,
D08514
| [1] PDE5A PDE5A 💬 | [3] Metabolic pathways Metabolic pathways, Purine metabolism, cGMP-PKG signaling pathway 💬 | [3] 86 86, 96, 225 |
1276 | VIALEBEX | - | - | - | - | [1] 96 96 |
1277 | Vialebex 200mg | - | - | - | - | [1] 96 96 |
1278 | Vidofludimus | [1] Vidofludimus Vidofludimus | - | - | - | [5] 13 13, 46, 94, 96, 97 |
1279 | VIDOFLUDIMUS CALCIUM | [2] Calcium Calcium, Vidofludimus | - | - | - | [4] 13 13, 94, 96, 97 |
1280 | Vigantol | - | - | - | - | [4] 13 13, 65, 96, 97 |
1281 | Vigantol Oel | - | - | - | - | [3] 13 13, 96, 97 |
1282 | Vigantol Oel TM | - | - | - | - | [2] 96 96, 97 |
1283 | Visilizumab | [1] Visilizumab Visilizumab | [1] D06314
D06314
| [3] CD3D CD3D, CD3E, CD3G 💬 | [11] Chagas disease Chagas disease, Epstein-Barr virus infection, Hematopoietic cell lineage, Human T-cell leukemia virus 1 infection, Human immunodeficiency virus 1 infection, Measles, PD-L1 expression and PD-1 checkpoint pathway in cancer, Primary immunodeficiency, T cell receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation 💬 | [2] 96 96, 97 |
1284 | Vitamin D | [1] Vitamin D Vitamin D | - | - | - | [24] 3 3, 13, 15, 19, 41, 43, 44, 46, 49, 50, 68, 93, 95, 96, 97, 98, 179, 222, 228, 235, 256, 274, 298, 299 |
1285 | Vitamin D drops | [1] Vitamin D Vitamin D | - | - | - | [2] 96 96, 97 |
1286 | Vitamin D3 | [1] Cholecalciferol Cholecalciferol | [1] D00188
D00188
| [1] VDR VDR 💬 | [5] Chemical carcinogenesis - receptor activation Chemical carcinogenesis - receptor activation, Endocrine and other factor-regulated calcium reabsorption, Mineral absorption, Parathyroid hormone synthesis, secretion and action, Tuberculosis 💬 | [12] 6 6, 13, 20, 46, 49, 51, 53, 60, 65, 96, 97, 299 |
1287 | Vitamin D3 3000 UI daily | [1] Cholecalciferol Cholecalciferol | [1] D00188
D00188
| [1] VDR VDR 💬 | [5] Chemical carcinogenesis - receptor activation Chemical carcinogenesis - receptor activation, Endocrine and other factor-regulated calcium reabsorption, Mineral absorption, Parathyroid hormone synthesis, secretion and action, Tuberculosis 💬 | [1] 96 96 |
1288 | Vitamin D3 4000 UI daily | [1] Cholecalciferol Cholecalciferol | [1] D00188
D00188
| [1] VDR VDR 💬 | [5] Chemical carcinogenesis - receptor activation Chemical carcinogenesis - receptor activation, Endocrine and other factor-regulated calcium reabsorption, Mineral absorption, Parathyroid hormone synthesis, secretion and action, Tuberculosis 💬 | [1] 96 96 |
1289 | Vitamin D3 800 UI/day then 800 UI/day | [1] Cholecalciferol Cholecalciferol | [1] D00188
D00188
| [1] VDR VDR 💬 | [5] Chemical carcinogenesis - receptor activation Chemical carcinogenesis - receptor activation, Endocrine and other factor-regulated calcium reabsorption, Mineral absorption, Parathyroid hormone synthesis, secretion and action, Tuberculosis 💬 | [1] 96 96 |
1290 | Vitamin D3: 3000 or 4000 UI/day then 2,000 UI/day | [1] Cholecalciferol Cholecalciferol | [1] D00188
D00188
| [1] VDR VDR 💬 | [5] Chemical carcinogenesis - receptor activation Chemical carcinogenesis - receptor activation, Endocrine and other factor-regulated calcium reabsorption, Mineral absorption, Parathyroid hormone synthesis, secretion and action, Tuberculosis 💬 | [1] 96 96 |
1291 | Vitamin E | [1] Vitamin E Vitamin E | [1] D02331
D02331
| - | - | [11] 2 2, 6, 13, 20, 46, 90, 96, 97, 206, 299, 317 |
1292 | Vitamin E 800IU | [1] Vitamin E Vitamin E | [1] D02331
D02331
| - | - | [2] 96 96, 97 |
1293 | Vitamin K | [1] Phylloquinone Phylloquinone | [1] D00148
D00148
| - | - | [5] 13 13, 46, 96, 97, 299 |
1294 | Vitamin K 10 mg | [1] Phylloquinone Phylloquinone | [1] D00148
D00148
| - | - | [2] 96 96, 97 |
1295 | Vitamin K1 | [1] Phylloquinone Phylloquinone | [1] D00148
D00148
| - | - | [1] 96 96 |
1296 | Vorinostat | [1] Vorinostat Vorinostat | [1] D06320
D06320
| [11] HDAC1 HDAC1, HDAC10, HDAC11, HDAC2, HDAC3, HDAC4, HDAC5, HDAC6, HDAC7, HDAC8, HDAC9 💬 | [17] Alcoholism Alcoholism, Amphetamine addiction, Amyotrophic lateral sclerosis, Apelin signaling pathway, Cell cycle, Chronic myeloid leukemia, Epstein-Barr virus infection, Human papillomavirus infection, Huntington disease, Longevity regulating pathway - multiple species, MicroRNAs in cancer, Neutrophil extracellular trap formation, Notch signaling pathway, Pathways in cancer, Thyroid hormone signaling pathway, Transcriptional misregulation in cancer, Viral carcinogenesis 💬 | [3] 19 19, 75, 96 |
1297 | VSL#3 | - | - | - | - | [4] 96 96, 97, 107, 291 |
1298 | VSL#3 (Original De Simone formulation) | - | - | - | - | [2] 96 96, 97 |
1299 | VSL#3® | - | - | - | - | [2] 96 96, 97 |
1300 | Warfarin | [1] Warfarin Warfarin | [3] D00564
D00564
,
D01280
,
D08682
| [2] NQO1 NQO1, VKORC1 💬 | [7] Biosynthesis of cofactors Biosynthesis of cofactors, Chemical carcinogenesis - reactive oxygen species, Fluid shear stress and atherosclerosis, Hepatocellular carcinoma, Metabolic pathways, Pathways in cancer, Ubiquinone and other terpenoid-quinone biosynthesis 💬 | [13] 6 6, 8, 13, 19, 46, 49, 66, 85, 86, 88, 91, 96, 97 |
1301 | Warfarin 10 mg | [1] Warfarin Warfarin | [3] D00564
D00564
,
D01280
,
D08682
| [2] NQO1 NQO1, VKORC1 💬 | [7] Biosynthesis of cofactors Biosynthesis of cofactors, Chemical carcinogenesis - reactive oxygen species, Fluid shear stress and atherosclerosis, Hepatocellular carcinoma, Metabolic pathways, Pathways in cancer, Ubiquinone and other terpenoid-quinone biosynthesis 💬 | [2] 96 96, 97 |
1302 | Water | [1] Water Water | [1] D00001
D00001
| - | - | [23] 2 2, 5, 6, 13, 17, 19, 22, 35, 46, 51, 53, 56, 57, 63, 65, 67, 78, 84, 96, 97, 226, 278, 299 |
1303 | Wellbutrin (bupropion) | [1] Bupropion Bupropion | [3] D00817
D00817
,
D07591
,
D07938
| [2] SLC6A2 SLC6A2, SLC6A3 💬 | [7] Alcoholism Alcoholism, Amphetamine addiction, Cocaine addiction, Dopaminergic synapse, Parkinson disease, Pathways of neurodegeneration - multiple diseases, Synaptic vesicle cycle 💬 | [1] 96 96 |
1304 | WFI | - | - | - | - | [1] 96 96 |
1305 | Whey protein | - | - | - | - | [2] 6 6, 96 |
1306 | Whole body Protein turnover | - | - | - | - | [4] 19 19, 46, 96, 299 |
1307 | WMT | - | - | - | - | [1] 96 96 |
1308 | Xanthohumol | [1] Xanthohumol Xanthohumol | - | - | - | [1] 96 96 |
1309 | Z-206 | - | - | - | - | [2] 96 96, 97 |
1310 | Zessly | [1] Infliximab Infliximab | [1] D02598
D02598
| [1] TNF TNF 💬 | [67] AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | [2] 96 96, 97 |
1311 | Zoledronic acid | [1] Zoledronic acid Zoledronic acid | [4] D01968
D01968
,
D06378
,
D06379
,
D08689
| [1] FDPS FDPS 💬 | [4] Human T-cell leukemia virus 1 infection Human T-cell leukemia virus 1 infection, Influenza A, Metabolic pathways, Terpenoid backbone biosynthesis 💬 | [12] 5 5, 6, 13, 17, 46, 93, 95, 96, 270, 274, 299, 333 |
1312 | ZP1848 | - | - | - | - | [1] 96 96 |
1313 | ÁCIDO GADOBÉNICO | - | - | - | - | [1] 96 96 |